<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d28166exv2w1.htm
<DESCRIPTION>AGREEMENT AND PLAN OF MERGER
<TEXT>
<HTML>
<HEAD>
<TITLE>exv2w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="right" style="font-size: 10pt; margin-top: 12pt">EXHIBIT 2.1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>BY AND AMONG</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>NORTH AMERICAN SENIOR CARE, INC.,</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>NASC ACQUISITION CORP.,</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>BEVERLY ENTERPRISES, INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS"><B>and</B></FONT>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SBEV PROPERTY HOLDINGS LLC (solely for purposes of Article&nbsp;9)</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS"><B>Dated as of</B></FONT>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>August&nbsp;16, 2005</B>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">TABLE OF CONTENTS</FONT>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;1 Defined Terms and Interpretation</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>1</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;1.1 Certain Definitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;1.2 Terms Defined Elsewhere</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;1.3 Interpretation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;2 The Merger</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>14</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.1 The Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.2 Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.3 Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.4 Effect of the Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.5 Certificate of Incorporation; By-laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.6 Directors and Officers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;3 Conversion of Securities; Exchange of Certificates</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>16</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.1 Conversion of Securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.2 Exchange of Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.3 Dissenters&#146; Rights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.4 Stock Transfer Books</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.5 Company Equity and Long-Term Incentive Awards</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;4 Representations and Warranties of the Company</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>23</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.1 Organization and Qualification; Subsidiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.2 Certificate of Incorporation and By-laws; Corporate Books</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.3 Capitalization; Subsidiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.4 Authority</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.5 No Conflict; Required Filings and Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.6 Compliance with Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.7 SEC Filings; Financial Statements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.8 Proxy Statement and SEC Filings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.9 Absence of Certain Changes or Events</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.10 Benefit Plans; Employees and Employment Practices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.11 Contracts; Debt Instruments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.12 Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.13 Environmental Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.14 Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.15 Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.16 Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.17 Real Estate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.18 Board Approval</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.19 Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.20 Indebtedness</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.21 Identifying Health Care Businesses; Licenses and Permits;
Compliance with Applicable Law; Health Care Regulation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">i
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.22 Restricted Payments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.23 OSHA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;5 Representations and Warranties of Parent and Merger Sub</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>53</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.1 Organization and Qualification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.2 Authority</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.3 No Conflict; Required Filings and Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.4 Compliance With Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.5 Health Care Licensing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.6 Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.7 Ownership of Merger Sub; No Prior Activities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.8 Financing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.9 Vote Required</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.10 Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.11 Ownership of Company Common Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.12 Solvency of the Surviving Corporation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;6 Covenants</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>58</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.1 Conduct of Business by the Company Pending the Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.2 Proxy Statement; Company Stockholders&#146; Meeting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.3 Access to Information; Confidentiality</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.4 No Solicitation of Transactions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.5 Commercially Reasonable Best Efforts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.6 Certain Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.7 Public Announcements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">74</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.8 Employee Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">74</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.9 Indemnification of Directors and Officers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.10 State Takeover Statutes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.11 Section&nbsp;16 Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.12 Confidentiality Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.13 Solvency of the Surviving Corporation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.14 Financing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">82</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.15 Cooperation in Securing Financing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">84</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.16 Further Assurances</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">85</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.17 Existing Obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">87</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.18 Deposit and Letter of Credit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">88</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.19 Title Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;7 Closing Conditions</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>90</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.1 Conditions to Obligations of Each Party Under This Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.2 Additional Conditions to Obligations of Parent and Merger Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">91</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.3 Additional Conditions to Obligations of the Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">94</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.4 Frustration of Closing Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">94</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>




<P align="center" style="font-size: 10pt">ii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;8 Termination, Amendment and Waiver</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>95</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.1 Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">95</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.2 Effect of Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.3 Fees and Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.4 Termination Fee and Parent Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.5 Business Interruption Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.6 Extension; Waiver</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">102</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.7 Amendment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">102</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Article&nbsp;9 General Provisions</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>102</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.1 Non-Survival of Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">102</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.2 Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">103</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.3 Headings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">104</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.4 Severability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">104</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.5 SBEV Obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">104</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.6 Entire Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">106</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.7 Assignment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">106</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.8 Mutual Drafting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">106</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.9 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">107</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.10 Counterparts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">108</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.11 Specific Performance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">108</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.12 Representations and Warranties and Company Disclosure Schedule</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">108</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="83%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EXHIBIT A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merger Sub Certificate of Incorporation and By-laws</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EXHIBIT B
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Letter of Credit</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">iii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT AND PLAN OF MERGER, dated as of August&nbsp;16, 2005, by and among North American Senior
Care, Inc., a Delaware corporation (&#147;<U>Parent</U>&#148;), NASC Acquisition Corp., a Delaware
corporation and a wholly-owned direct Subsidiary of Parent (&#147;<U>Merger Sub</U>&#148;), Beverly
Enterprises, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;) and, solely for purposes of
Article&nbsp;9 hereof, SBEV Property Holdings LLC, a Delaware limited liability company
(&#147;<U>SBEV</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the respective Boards of Directors of Parent, Merger Sub and the Company have
approved and declared advisable the merger of Merger Sub with and into the Company (the
&#147;<U>Merger</U>&#148;) upon the terms and subject to the conditions of this Agreement and Plan of
Merger, including the exhibits and disclosure schedules attached hereto (the &#147;<U>Agreement</U>&#148;)
and in accordance with the General Corporation Law of the State of Delaware (the &#147;<U>DGCL</U>&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the respective Boards of Directors of Parent and the Company have determined that the
Merger is in furtherance of, and consistent with, their respective business strategies and is in
the best interest of their respective stockholders, and Parent has approved this Agreement and the
Merger as the sole stockholder of Merger Sub; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Parent, Merger Sub and the Company wish to make certain representations, warranties,
covenants and agreements in connection with the Merger and also to prescribe certain conditions to
the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the respective representations,
warranties, covenants and agreements set forth in this Agreement and intending to be legally bound
hereby, the Parties agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;1<BR>
Defined Terms and Interpretation</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.1 <U>Certain Definitions</U>. For purposes of this Agreement, the term:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Affiliate</I></B>&#148; shall mean a Person that directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common control with, the first-mentioned
Person, where &#147;<I>control</I>&#148; shall mean the possession, directly or indirectly, or as trustee or executor, of the power to direct or cause the direction of the management or policies of a
Person, whether through the ownership of stock or as trustee or executor, by contract or otherwise.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Ancillary Health Care Business&#148; </I></B>shall mean those entities engaged in the provision of
products or services to the Health Care Facilities or residents or patients residing in the Health
Care Facilities or to unrelated Third Party health care providers and their residents or patients
or directly to their own residents or patients (such as therapy, hospice, home health care, durable
medical equipment, pharmacy, imaging and respiratory services), and includes the Company
Subsidiaries owning or operating each Ancillary Health Care Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Benefit Plan&#148; </I></B>shall mean any employment, consulting, severance, termination, retirement,
profit sharing, bonus, incentive or deferred compensation, retention bonus or change in control
agreement, pension, stock option, restricted stock or other equity-based benefit, profit sharing,
savings, life, health, disability, accident, medical, insurance, vacation, paid time off, long term
care, executive or other employee allowance program, other welfare fringe benefit or other employee
compensation or benefit plan, program, arrangement, agreement, fund or commitment, including any
&#147;employee benefit plan&#148; as defined in Section&nbsp;3(3) of ERISA.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Blue Sky Laws</I></B>&#148; shall mean state securities or &#147;blue sky&#148; laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Business Day</I></B>&#148; shall mean any day other than a Saturday, Sunday and any day which is a legal
holiday under the Laws of the State of New York or is a day on which banking institutions located
in the State of New York are authorized or required by Law or other governmental action to close.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Code</I></B>&#148; shall mean the United States Internal Revenue Code of 1986, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Company Benefit Plan&#148; </I></B>shall mean any Benefit Plan for the benefit or welfare of any director,
officer or employee of the Company or any Company Subsidiary.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company Health Care Business</I></B>&#148; shall mean any of the Company Health Care Facilities or any
Ancillary Health Care Business operated by the Company or any Company Subsidiary.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company Health Care Facility</I></B>&#148; shall mean any skilled nursing home facility or assisted living
facility of the Company or any Company Subsidiary.
</DIV>


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Company Health Care Permits&#148; </I></B>shall mean all permits, licenses, approvals, registrations,
qualifications, certifications, consents, certificates of need and other authorizations of every
nature whatsoever required by, or issued by, any Health Care Governmental Entity, but excluding any
Provider Agreements, participation agreements or other contractual or health plan obligations
arising under or related to any Company Health Care Program.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Company Health Care Program&#148; </I></B>shall mean any Third Party health care payment program in which
the Company or any Company Subsidiary participates with regard to any of their Company Health Care
Facilities or other Company Health Care Businesses, including, without limitation, any program,
plan, insurance or assistance program (<I>e.g., </I>the Medicare, Medicaid, TRICARE programs, the Veterans
Administration or any private insurance, health maintenance organizations, or preferred provider
organizations).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company Material Adverse Effect</I></B>&#148; shall mean any change, circumstance, event or effect that is
materially adverse to (i)&nbsp;the business, properties, assets, results of operations, or financial
condition of the Company and the Company Subsidiaries taken as a whole or (ii)&nbsp;the ability of the
Company to perform its obligations pursuant to this Agreement, other than any of the following or
any change, circumstance, event or effect resulting from any of the following: (a)&nbsp;the execution,
delivery or public announcement of this Agreement or the transactions provided for herein or any
actions required to be taken hereunder or otherwise taken with the consent of Parent, (b)&nbsp;any
change in federal or state health care program reimbursement law, regulations, policies or
procedures, or interpretations thereof applicable or potentially applicable to the services
rendered by the Company or any of the Company Subsidiaries, (c)&nbsp;changes generally affecting the
industries in which the Company or the Company Subsidiaries operate, (d)&nbsp;changes in economic
conditions in the United States, or in any region thereof, and (e)&nbsp;changes in Law or GAAP (or any
interpretation thereof), unless, in the case of the foregoing clauses (b), (c)&nbsp;and (e), such
changes would reasonably be expected to have a materially disproportionate impact on the business,
properties, assets, results of operation or financial condition of the Company and the Company
Subsidiaries taken as a whole relative to other major industry participants.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Company Permits</I></B>&#148; shall mean all Company Health Care Permits and all Other Company Permits.
</DIV>


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Continuing Employee</I></B>&#148; shall mean any Person who is employed by the Company or any Company
Subsidiary as of the Effective Time (including persons on disability or leave of absence, whether
paid or unpaid).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Contract</I></B>&#148; shall mean any note, bond, mortgage, indenture, lease, license, occupancy
agreement, management agreement, permit, concession, franchise, contract, agreement or other
instrument or obligation, including without limitation, any Governmental Agreement and any Provider
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Environmental Laws</I></B>&#148; shall mean any applicable Law relating to the protection of the
environment or to occupational health and safety.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Equity Interest</I></B>&#148; shall mean any share, capital stock, partnership, member or similar interest
in any entity and any option, warrant, right or security convertible, exchangeable or exercisable
therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Exchange Act</I></B>&#148; shall mean the United States Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>GAAP</I></B>&#148; shall mean generally accepted accounting principles as applied in the United States.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Governmental Entity</I></B>&#148; shall mean any federal or state governmental, administrative, judicial
or regulatory authority.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Group</I></B>&#148; shall have the meaning provided in Section 13(d) of the Exchange Act, except where the
context otherwise requires.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Hazardous Materials</I></B>&#148; shall mean (i)&nbsp;any petroleum products or byproducts, radioactive
materials, friable asbestos or polychlorinated biphenyls or (ii)&nbsp;any waste, material or substance
defined as a &#147;hazardous substance,&#148; &#147;hazardous material,&#148; or &#147;hazardous waste,&#148; under any
applicable Environmental Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Health Care Governmental Entity&#148; </I></B>shall mean any Governmental Entity having jurisdiction over
the certification, licensing, evaluation or operation of any of the Company Health Care Businesses.
</DIV>


<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>HSR Act</I></B>&#148; shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and
the rules and regulations promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Institutional Lender&#148; </I></B>shall mean any bank, investment bank or other financial institution
providing loans or other financing in connection with the Merger pursuant to the Debt Commitment
Letters.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Intellectual Property</I></B>&#148; shall mean, collectively, all (i)&nbsp;patents, (ii)&nbsp;trademarks, service
marks, trade dress, logos, trade names, corporate names and domain names, (iii)&nbsp;copyrights and
copyrightable works, (iv)&nbsp;computer software, and (v)&nbsp;trade secrets, and (vi)&nbsp;any applications or
registrations relating to the foregoing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Knowledge</I></B>&#148; shall mean, with respect to any specific matter, (i)&nbsp;in the case of the Company,
the actual knowledge of the Persons listed on Section&nbsp;1.1(a) of the Company Disclosure Schedule,
including the knowledge they have or would have after making reasonable inquiry of the employee of
the Company having principal responsibility for such matter, and (ii)&nbsp;in the case of Parent, Merger
Sub or any other member of the Parent Group, the actual knowledge of the Persons listed on Schedule
1.1(b), including the knowledge they have or would have after making reasonable inquiry of the
employee of the Parent Group having principal responsibility for such matter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Law</I></B>&#148; shall mean any foreign or domestic law, statute, code, ordinance, rule, regulation, or
Order.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Legal Requirement&#148; </I></B>shall mean all applicable Laws, bylaws, restrictions, corporate integrity
agreements and Orders (including, without limitation, all applicable building, fire, health code,
occupational safety and health, zoning, subdivision and other land use, ADA, payment, certificate
of need and health care licensing statutes, ordinances, bylaws, codes, rules, manuals and
regulations), promulgated or issued by any Governmental Entity. Without limiting the generality of
the foregoing, the term Legal Requirements includes all Company Health Care Permits issued or
entered into by any Health Care Governmental Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;License&#148; </I></B>shall mean a license issued by a Health Care Governmental Entity to operate a
facility or services of the Company or any Company Subsidiary.
</DIV>


<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Lien&#148; </I></B>shall mean any mortgage, pledge, security interest, encumbrance, lien or charge of any
kind (including any conditional sale or other title retention agreement or lease in the nature
thereof) other than liens incurred in connection with sale and leaseback transactions in the
ordinary course of business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Medicaid&#148; </I></B>shall mean the medical assistance program established by Title XIX of the Social
Security Act (42 U.S.C. Sections&nbsp;1396 <U>et</U> <U>seq</U>.) and any statute succeeding thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Medicare&#148; </I></B>shall mean the health insurance program for the aged and disabled established by
Title XVIII of the Social Security Act (42 U.S.C. Sections&nbsp;1395 <U>et</U> <U>seq</U>.) and any
statute succeeding thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Multiemployer Plan</I></B>&#148; shall mean any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;3(37)
or 4001(a)(3) of ERISA.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>NYSE</I></B>&#148; shall mean the New York Stock Exchange, Inc.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Order</I></B>&#148; shall mean any order, judgment, writ, stipulation, award, injunction, decree,
arbitration award or finding of any Governmental Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Other Company Permits&#148; </I></B>shall mean all permits, licenses, franchises, certificates of
occupancy, approvals, registrations, qualifications, variances, accreditations, certifications,
consents and other authorizations of every nature whatsoever other than Company Health Care
Permits, that are required by, or issued under, any Laws benefiting, relating to or affecting the
Company&#146;s business or the Company Properties, or the construction, development, expansion,
maintenance, management, use or operation thereof, or the operation of any programs or services in
conjunction with the Company&#146;s business and all renewals, replacements and substitutions therefor,
required or issued by any Governmental Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Parent Expenses&#148; </I></B>shall mean all reasonable and documented out-of-pocket expenses (including,
without limitation, all reasonable fees and expenses of counsel, accountants, investment bankers,
experts and consultants to a Party hereto) incurred by or on behalf of Parent in connection with or
related to the transactions contemplated hereby, including, without limitation, expenses in
connection with due diligence, and the negotiation, execution and performance of this Agreement and
the transactions contemplated hereby.
</DIV>


<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Parent Group&#148; </I></B>shall mean, collectively, Parent, Merger Sub, the Provider Affiliates, and the
Post-Transaction Operators, if any.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Permitted Encumbrances&#148; </I></B>shall mean any and all of the following, whether individually or
collectively: (i)&nbsp;Permitted Liens (except, solely with respect to this definition, Section (ii)&nbsp;of
the definition of &#147;Permitted Liens&#148; shall not apply), (ii) (A)&nbsp;standard and customary exceptions to
title, (B)&nbsp;encumbrances of public record (except to the extent that any such encumbrance is not a
Permitted Lien), utility easements, restrictive covenants and similar defects, imperfections or
irregularities of title and (C)&nbsp;such state of facts as an accurate survey would show, in each case
under (ii)(A) &#150; (C)&nbsp;above, such as would generally be acceptable as encumbrances on collateral in
the reasonable business judgment of banks, investment banks or other financial institutions that
generally conduct business in a marketplace similar to that of an institutional lender similar to
Wachovia Bank, National Association, CapitalSource Finance LLC and Credit Suisse First Boston, LLC,
(iii)&nbsp;encumbrances created by Parent, or its affiliates, successors, or assigns (other than the
Company and the Company Subsidiaries), and (iv)&nbsp;encumbrances imposed under this Agreement. In no
event shall any mark-up of any title commitment provided to the Company by or on behalf of Parent
be deemed to limit, expand, or otherwise modify the definition of &#147;Permitted Encumbrances&#148; or the
interpretation thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Person</I></B>&#148; shall mean an individual, corporation, limited liability company, partnership,
association, trust, unincorporated organization or other entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Post-Transaction Operator&#148; </I></B>shall mean any Person who must obtain licenses, certifications,
Company Health Care Permits, approvals, provider numbers and/or authorizations for the operation of
any of the Company Health Care Businesses following the Effective Time, excluding Parent, Merger
Sub and the Provider Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Provider Affiliate&#148; </I></B>shall mean (i)&nbsp;any Affiliate of Parent or (ii)&nbsp;any Affiliate of any
signatory to the Equity Commitment Letter that owns, operates or leases any health care facility.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Provider Agreements&#148; </I></B>shall mean those agreements or provisions of other agreements pursuant
to which the Company or any Company Subsidiary obtains a provider or supplier number and is
authorized to submit claims for payment for any of its Company Health
</DIV>
<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Care Businesses, including all participation, provider and supplier agreements, whether such
Provider Agreement is express, in writing or as evidenced by tie-in notices or other evidence.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Reimbursement Source Obligations&#148; </I></B>shall mean (a)&nbsp;Medicaid, Medicare or Company Health Care
Program overpayments, recoupments, denials of payment or any other financial obligations arising
from any adjustments or reductions specific to the Company or Company Subsidiary in Medicaid,
Medicare or Company Health Care Program reimbursement; or (b)&nbsp;all other monetary obligations or
liabilities of any kind or nature whatsoever that have arisen or may arise in any manner from the
Company or any Company Subsidiary&#146;s participation in Company Health Care Programs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;SEC&#148; </I></B>shall mean the United States Securities and Exchange Commission.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Securities Act</I></B>&#148; shall mean the United States Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Significant&#148; </I></B>shall mean, when used with respect to any individual item or group of items, an
item or group of items with an aggregate value to the Company of more than $10,000,000.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Subsidiary</I></B>&#148; or &#147;<B><I>Subsidiaries</I></B>&#148; of the Company, the Surviving Corporation or any other Person
shall mean any corporation, partnership, joint venture or other legal entity of which the Company,
the Surviving Corporation or such other Person, as the case may be (either alone or through or
together with any other Subsidiary), owns, directly or indirectly, a majority of the stock or other
Equity Interests the holders of which are generally entitled to vote for the election of the board
of directors or other governing body of such corporation or other legal entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Superior Proposal</I></B>&#148; shall mean a bona fide written Takeover Proposal (with all of the
percentages included in the definition of Takeover Proposal increased to fifty (50)&nbsp;percent) that
is not subject to a financing contingency that results in conditionality less favorable to the
Company than the conditions contained in Article&nbsp;7 (after giving effect to any adjustments to the
terms and provisions of this Agreement committed to in writing by Parent in response to such
Takeover Proposal) and that is reasonably capable of being consummated, taking into account all
legal, financial, regulatory, timing, and similar aspects of, and conditions to, such Takeover
</DIV>
<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Proposal, the likelihood of obtaining necessary financing and the identity of the Person
making such Takeover Proposal, and that, if consummated, would result in a transaction more
favorable to the Company&#146;s stockholders from a financial point of view than the transactions
contemplated by this Agreement (after giving effect to any adjustments to the terms and provisions
of this Agreement committed to in writing by Parent in response to such Takeover Proposal).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Surviving Corporation Benefit Plan&#148; </I></B>shall mean any Benefit Plan for the benefit or welfare of
any Continuing Employee, whether maintained by Parent, the Surviving Corporation or any of their
subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Takeover Proposal</I></B>&#148; shall mean any inquiry, proposal or offer relating to (i)&nbsp;the acquisition
of more than twenty (20)&nbsp;percent of the outstanding shares of capital stock or any other voting
securities of the Company by any Third Party, (ii)&nbsp;a merger, consolidation, business combination,
reorganization, share exchange, sale of assets, recapitalization, liquidation, dissolution or
similar transaction, or a series of any such transactions, which would result in any Third Party
acquiring assets of the Company and the Company Subsidiaries (including capital stock or other
Equity Interests of Company Subsidiaries) representing twenty (20)&nbsp;percent or more of the
consolidated assets, or the consolidated assets that generate twenty (20)&nbsp;percent or more of the
consolidated revenues or earnings, of the Company and the Company Subsidiaries taken as a whole,
(iii)&nbsp;any other transaction which would result in a Third Party acquiring assets of the Company and
the Company Subsidiaries (including capital stock or other Equity Interests of Company
Subsidiaries) representing twenty (20)&nbsp;percent or more of the consolidated assets, or the
consolidated assets that generate twenty (20)&nbsp;percent or more of the consolidated revenues or
earnings, of the Company and the Company Subsidiaries taken as a whole, immediately prior to such
transaction (whether by purchase of assets, acquisition of stock or other Equity Interests of a
Company Subsidiary or otherwise) or (iv)&nbsp;any combination of the foregoing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Tax Returns</I></B>&#148; shall mean any report or return (including any information return) or statement
required to be filed with any Governmental Entity with respect to Taxes, including any amended
report or return.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Taxes</I></B>&#148; shall mean any and all taxes, fees, levies, duties, tariffs, imposts and other similar
charges (together with any and all interest, penalties, additions to tax and additional

<P align="center" style="font-size: 10pt">9
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">amounts imposed with respect thereto) imposed by any Governmental Entity, including those on
or measured by or referred to as income, franchise, windfall or other profits, gross receipts,
property, sales, use, net worth, capital stock, payroll, employment, social security, workers&#146;
compensation, unemployment compensation, excise, withholding, ad valorem, stamp, transfer,
value-added and provider taxes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Third Party</I></B>&#148; shall mean any Person or Group other than the Company, the Company Subsidiaries,
the Parent Group or any Person in the Parent Group.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.2 <U>Terms Defined Elsewhere</U>. The following terms are defined elsewhere in
this Agreement, as indicated below:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="67%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;7 <FONT style="font-size: 70%"><SUP>7</SUP></FONT>/<FONT style="font-size: 60%">8</FONT>% Notes&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.17.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;7 <FONT style="font-size: 70%"><SUP>7</SUP></FONT>/<FONT style="font-size: 60%">8</FONT>% Notes Indenture&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.17.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Agreement&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Recitals</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Alternative Structure&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.5.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Bankruptcy and Equity Exception&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.4.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;BIF Deposit&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.18</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Business Interruption Fee&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;8.5.1(iv)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Certificate of Merger&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;2.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Certificates&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.2.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Closing&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;2.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Closing Date&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;2.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Commitments&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;5.8</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Preamble</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Adverse Recommendation Change&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.4.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Board&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.5.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company By-Laws&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Certificate&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Common Stock&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.1.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Disclosure Schedule&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Article&nbsp;4</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Financial Advisors&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.18</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Form&nbsp;10-K&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.2</I></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">10
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="67%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Leased Health Care Facilities&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.1(c)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Leased Properties&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Options&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.5.1(i)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Other Leased Property&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.1(e)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Other Owned Property&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.1(d)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Owned But Not Operated Property&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.1(g)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Owned Health Care Facilities&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.1(b)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Owned Properties&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Preferred Stock&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.3.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Properties&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.1(a)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Recommendation&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.18</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Representatives&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.3.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Restricted Stock&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.5.1(ii)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Rights&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.1.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Rights Agreement&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.1.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company SEC Filings&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.7.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Selected Contract&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.11</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Stockholders&#146; Meeting&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.2.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Subleased Property&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.1(h)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Company Subsidiary&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Confidentiality Agreement&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.3.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Convertible Notes&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.17.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;D&#038;O Insurance&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.9.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Debt Commitment Letters&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;5.8</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Debt Satisfaction&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.16.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;DGCL&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Recitals</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Director Deferred Unit&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.5.2(ii)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Dissenting Shares&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.1.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Dissenting Stockholders&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.1.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Effective Time&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;2.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Employment Benefit Plan Extension Date&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.8.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Environmental Claims&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.13.2(iii)</I></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">11
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="67%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Equity Commitment Letter&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;5.8</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;ERISA&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.10.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;ERISA Affiliate&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.10.4</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Exchange Agent&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.2.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Exchange Fund&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.2.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Government Consents&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.5.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Governmental Agreements&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.21.6</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Indemnified Parties&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.9.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Initial BIF Deposit&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.18</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;IRS&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.15.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Land Use Requirement&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;7.2.4(ii)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Lease&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.4</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Leased Premises&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.4</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Letter of Credit&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.18</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Material Benefit Cost Increase&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.8.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Merger&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Recitals</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Merger Consideration&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.1.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Merger Sub&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Preamble</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Option Payments&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.5.1(i)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;OSHA&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.23</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Parent&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Preamble</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Parent Disclosure Schedule&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Article&nbsp;5</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Parent Representatives&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.3.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Performance Unit Award&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;3.5.2(i)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Permitted Debt&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.20</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Permitted Liens&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;PLGL&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.16.1(a)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Property Restrictions&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.17.3</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Proxy Statement&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.2.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Purchase Options&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.16.4</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Purchaser Welfare Benefit Plan&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.8.4</I></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">12
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="67%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Return Event&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.18</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;SBEV&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Preamble</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Solvency Opinion&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.13</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Stockholder Approval&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.4.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Subsequent BIF Deposit&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.18</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Subsequent Transactions&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.16.2</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Surviving Corporation&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;2.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Termination Date&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;8.1(b)(ii)</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Termination Fee&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;8.4.1</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Title Company&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;7.2.8</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;Underlying Company Properties&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;6.16.4</I></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B><I>&#147;WARN&#148;</I></B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><I>Section&nbsp;4.10.5(c)</I></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.3 <U>Interpretation</U>. In this Agreement, unless otherwise specified, the
following rules of interpretation apply:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;references to Sections, Subsections, Schedules, Annexes, Exhibits, Clauses and Parties are
references to sections or sub-sections, schedules, annexes, exhibits and clauses of, and parties
to, this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;references to any Person include references to such Person&#146;s successors and permitted
assigns;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;words importing the singular include the plural and vice versa;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;words importing one gender include the other gender;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;references to the word &#147;including&#148; do not imply any limitation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;references to months are to calendar months;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;the words &#147;hereof&#148;, &#147;herein&#148; and &#147;hereunder&#148; and words of similar import, when used in
this Agreement, refer to this Agreement as a whole and not to any particular provision of this
Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;references to &#147;$&#148; or &#147;dollars&#148; refer to U.S. dollars;
</DIV>


<P align="center" style="font-size: 10pt">13
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;to the extent this Agreement refers to information or documents having been made available
(or delivered or provided) to Parent or Merger Sub, the Company shall be deemed to have satisfied
such obligation if the Company or any Company Representatives have made such information or
document available (or delivered or provided such information or document) to any of Parent, Merger
Sub, or any Parent Representatives; <I>provided</I>, that the making available of a document, unless
otherwise provided herein, shall not itself be deemed disclosure on the Company Disclosure
Schedule;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;a defined term has its defined meaning throughout this Agreement and in each Exhibit and
Schedule to this Agreement, regardless of whether it appears before or after the place where it is
defined; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;references to the &#147;Company&#146;s business&#148; or &#147;the business of the Company&#148; or similar phrases
shall be deemed to include the Company Subsidiaries.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;2<BR>
The Merger</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.1 <U>The Merger</U>. Upon the terms and subject to satisfaction or waiver of the
conditions set forth in this Agreement, and in accordance with the DGCL, Merger Sub shall be merged
with and into the Company. As a result of the Merger, the separate corporate existence of Merger
Sub shall cease and the Company shall continue as the surviving corporation of the Merger (the
&#147;<U>Surviving Corporation</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.2 <U>Closing</U>. Subject to the terms and conditions of this Agreement, the
closing of the Merger (the &#147;<U>Closing</U>&#148;) shall take place on a day that is a Business Day (i)
at the offices of Latham &#038; Watkins LLP, 885 Third Avenue, New York, New York 10022 at 10:00&nbsp;a.m.,
New York City time, no later than the second Business Day following the satisfaction of the
conditions set forth in Article&nbsp;7 (other than (a)&nbsp;those conditions that are waived in accordance
with the terms of this Agreement by the Party or Parties for whose benefit such conditions exist
and (b)&nbsp;any such conditions, which by their terms, are not capable of being satisfied until the Closing) or
(ii)&nbsp;at such other place, time and/or date as the Parties may otherwise agree. The date upon which
the Closing shall occur is referred to herein as the &#147;<U>Closing Date</U>&#148;.
</DIV>

<P align="center" style="font-size: 10pt">14
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.3 <U>Effective Time</U>. If all of the conditions to the Merger set forth in
Article&nbsp;7 have been fulfilled or waived and this Agreement shall not have been terminated as
provided in Article&nbsp;8, the Parties shall cause a certificate of merger (the &#147;<U>Certificate of
Merger</U>&#148;) to be properly executed and filed in accordance with the DGCL and the terms of this
Agreement on the Closing Date. The Merger shall become effective at such time as the Certificate
of Merger is duly filed with the Secretary of State of the State of Delaware or at such other time
as is specified by the Parties as the Effective Time in the Certificate of Merger (the
&#147;<U>Effective Time</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.4 <U>Effect of the Merger</U>. At the Effective Time, the effect of the Merger
shall be as provided in the applicable provisions of the DGCL. Without limiting the generality of
the foregoing, at the Effective Time, except as otherwise provided herein, all the property,
rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving
Corporation, and all debts, liabilities and duties of the Company and Merger Sub shall become the
debts, liabilities and duties of the Surviving Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.5 <U>Certificate of Incorporation; By-laws</U>. At the Effective Time, the
Certificate of Incorporation and the By-laws of the Surviving Corporation shall, subject to Section
6.9 hereof, be amended in their entirety to contain the provisions set forth in the Certificate of
Incorporation and the By-laws of Merger Sub, attached as Exhibit&nbsp;A hereto, except that the name of
the Surviving Corporation shall at the Effective Time be changed to the name of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.6 <U>Directors and Officers</U>. The directors of Merger Sub immediately prior to
the Effective Time (and identified as Surviving Corporation Directors in Schedule&nbsp;2.6) shall be the
initial directors of the Surviving Corporation, each to hold office in accordance with the
Certificate of Incorporation and By-laws of the Surviving Corporation. The officers of the Company immediately prior to
the Effective Time, and such other persons as Parent may designate in writing prior to the
Effective Time, shall be the initial officers of the Surviving Corporation, each to hold office in
accordance with the Certificate of Incorporation and By-laws of the Surviving Corporation, and with
respect to such officers, as otherwise provided in this Agreement.
</DIV>

<P align="center" style="font-size: 10pt">15
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;3<BR>
Conversion of Securities; Exchange of Certificates</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.1 <U>Conversion of Securities</U>. At the Effective Time, by virtue of the Merger
and without any action on the part of Merger Sub, the Company or its stockholders, the following
shall occur.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.1.1 Conversion Generally</I>. Each share of common stock, par value $.10 per share, of
the Company (&#147;<U>Company Common Stock</U>&#148;) issued and outstanding immediately prior to the
Effective Time (other than any shares of Company Common Stock to be canceled pursuant to Section
3.1.2 and any shares of Company Common Stock which are held by stockholders exercising appraisal
rights pursuant to Section&nbsp;262 of the DGCL (&#147;<U>Dissenting Stockholders</U>&#148; and such shares being
&#147;<U>Dissenting Shares</U>&#148;), including the associated rights of the Company (the &#147;<U>Company
Rights</U>&#148;) pursuant to the Rights Agreement, dated January&nbsp;26, 2005, between the Company and The
Bank of New York, as Rights Agent, as amended (the &#147;<U>Company Rights Agreement</U>&#148;), shall be
converted, subject to Section&nbsp;3.2.4, into the right to receive $12.80 in cash, payable to the
holder thereof, without interest (the &#147;<U>Merger Consideration</U>&#148;). All shares of Company
Common Stock shall no longer be outstanding and shall automatically be canceled and retired and
shall cease to exist, and each Certificate which immediately prior to the Effective Time
represented such shares shall thereafter represent the right to receive the Merger Consideration
therefor or the right, if any, to receive payment from the Surviving Corporation of the &#147;fair
value&#148; of such shares of Company Common Stock as determined in accordance with Section&nbsp;262 of the
DGCL. Certificates previously representing shares of Company Common Stock (other than Dissenting
Shares) shall be exchanged for the Merger Consideration, without interest, upon the surrender of
such Certificates in accordance with the provisions of Section&nbsp;3.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.1.2 Cancellation of Certain Shares</I>. Each share of Company Common Stock held by
Parent, Merger Sub, any Subsidiary of Parent or Merger Sub, in the treasury of the Company or by
any Company Subsidiary immediately prior to the Effective Time shall be canceled and extinguished
without any conversion thereof and no payment shall be made with respect thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.1.3 Merger Sub</I>. Each share of common stock, par value $0.01 per share, of Merger
Sub issued and outstanding immediately prior to the Effective Time shall be
</DIV>


<P align="center" style="font-size: 10pt">16
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">converted into and be
exchanged for one newly and validly issued, fully paid and nonassessable share of common stock of
the Surviving Corporation. Following the Effective Time, each certificate evidencing ownership of
shares of Merger Sub common stock shall evidence ownership of such shares of the Surviving
Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.1.4 Change in Shares</I>. If between the date of this Agreement and the Effective Time
the outstanding shares of Company Common Stock shall have been changed into a different number of
shares or a different class, by reason of any stock dividend, subdivision, reclassification,
recapitalization, split, combination or exchange of shares, the Merger Consideration shall be
correspondingly adjusted to reflect such stock dividend, subdivision, reclassification,
recapitalization, split, combination or exchange of shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.2 <U>Exchange of Certificates</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.2.1 Exchange Agent</I>. At the Closing, Parent shall deposit, or shall cause to be
deposited (which, for these purposes, shall be deemed to include (i)&nbsp;the BIF Deposit and (ii)&nbsp;funds
provided to the Company as part of Parent&#146;s financing plan and/or real estate sales in each case to
the extent that Parent requests the Company to deposit them), with The Bank of New York or another
bank or trust company designated by Parent and reasonably satisfactory to the Company (the
&#147;<U>Exchange Agent</U>&#148;), for the benefit of the holders of shares of Company Common Stock, for
exchange in accordance with this Article&nbsp;3, through the Exchange Agent, cash in U.S. dollars in an
amount sufficient to pay the Merger Consideration (such cash being hereinafter referred to as the
&#147;<U>Exchange Fund</U>&#148;) payable pursuant to Section&nbsp;3.1 in exchange for outstanding shares of
Company Common Stock. The Exchange Agent shall, pursuant to irrevocable instructions, deliver the Merger Consideration contemplated to be paid pursuant to
Section&nbsp;3.1 out of the Exchange Fund. The Exchange Fund shall be invested by the Paying Agent as
directed by Parent; <I>provided</I>, <I>however</I>, that: (i)&nbsp;no such investment or losses thereon shall affect
the Merger Consideration payable to the holders of Company Common Stock and following any losses
Parent shall promptly provide additional funds to the Exchange Agent for the benefit of the holders
of the shares of the Company Common Stock in the amount of any such losses; and (ii)&nbsp;such
investments shall be in obligations of or guaranteed by the United States of America or any agency
or instrumentality thereof and backed by the full faith and credit of the United States of America,
in commercial paper obligations rated A-1 or P-1 or better by
</DIV>


<P align="center" style="font-size: 10pt">17
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Moody&#146;s Investors Service, Inc. or
Standard &#038; Poor&#146;s Corporation, respectively, or in certificates of deposit, bank repurchase
agreements or banker&#146;s acceptances of commercial banks with capital exceeding $1&nbsp;billion (based on
the most recent financial statements of such bank that are then publicly available). Any net
profit resulting from, or interest or income produced by, such investments shall be payable to the
Surviving Corporation or Parent, as Parent directs. The Exchange Fund shall not be used for any
other purpose.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.2.2 Exchange Procedures</I>. Promptly following the Effective Time (but in no event
later than three (3)&nbsp;Business Days following the Effective Time), Parent shall instruct the
Exchange Agent to mail to each holder of record of a certificate or certificates which immediately
prior to the Effective Time represented outstanding shares of Company Common Stock (the
&#147;<U>Certificates</U>&#148;) (i)&nbsp;a letter of transmittal in customary form (which shall specify that
delivery shall be effected, and risk of loss and title to the Certificates shall pass, only upon
proper delivery of the Certificates to the Exchange Agent and shall be subject to the consent of
the Company prior to the Effective Time, such consent not to be unreasonably withheld) and (ii)
instructions for use in effecting the surrender of the Certificates in exchange for the Merger
Consideration. Upon surrender of a Certificate for cancellation to the Exchange Agent together
with such letter of transmittal, properly completed and duly executed, and such other documents as
may be required pursuant to such instructions (or, if such Shares are held in book-entry or other
uncertificated form, upon the entry through a book-entry transfer agent of the surrender of such
Shares to the Exchange Agent on a book-entry account statement (it being understood that any
references herein to &#147;Certificates&#148; shall be deemed to include references to book-entry account statements relating to the ownership of shares of Company Common Stock)), the holder
of such Certificate shall be entitled to receive in exchange therefor the Merger Consideration
which such holder has the right to receive in respect of the shares of Company Common Stock
formerly represented by such Certificate, and the Certificate so surrendered shall forthwith be
canceled. No interest will be paid or accrued on any Merger Consideration payable to holders of
Certificates. In the event of a transfer of ownership of shares of Company Common Stock which is
not registered in the transfer records of the Company, the Merger Consideration may be issued to a
transferee if the Certificate representing such shares of Company Common Stock is presented to the
Exchange Agent, accompanied by all documents required to evidence and effect
</DIV>


<P align="center" style="font-size: 10pt">18
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such transfer and by
evidence that any applicable stock transfer taxes have been paid. Until surrendered as
contemplated by this Section&nbsp;3.2, each Certificate shall be deemed at any time after the Effective
Time to represent only the right to receive upon such surrender the Merger Consideration or the
right to demand to be paid the &#147;fair value&#148; of the shares represented thereby as contemplated by
Section&nbsp;3.3.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.2.3 Further Rights in Company Common Stock</I>. All Merger Consideration paid in
accordance with the terms hereof shall be deemed to have been issued in full satisfaction of all
rights pertaining to such shares of Company Common Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.2.4 Termination of Exchange Fund</I>. Any portion of the Exchange Fund which remains
undistributed to the holders of Company Common Stock for one (1)&nbsp;year after the Effective Time
shall be delivered to the Surviving Corporation upon demand, and any holders of Company Common
Stock who have not theretofore complied with this Article&nbsp;3 shall thereafter look only to the
Surviving Corporation for the Merger Consideration, without any interest thereon.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.2.5 No Liability</I>. None of Parent, the Company or the Surviving Corporation shall be
liable to any holder of shares of Company Common Stock for any cash from the Exchange Fund
delivered to a public official pursuant to any abandoned property, escheat or similar Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.2.6 Lost Certificates</I>. If any Certificate shall have been lost, stolen or
destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by Parent, the posting by such Person of a bond,
in such reasonable and customary amount as Parent may direct, as indemnity against any claim that
may be made against it with respect to such lost, stolen or destroyed Certificate, the Exchange
Agent will issue in exchange for such lost, stolen or destroyed Certificate the Merger
Consideration without any interest thereon. If any certificate representing Company Options shall
have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person
claiming such certificate representing Company Options to be lost, stolen or destroyed, the Company
will issue in exchange for such lost, stolen or destroyed certificate representing Company Options,
the Option Payment, without any interest thereon.

<P align="center" style="font-size: 10pt">19
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.2.7 Withholding</I>. Parent, the Surviving Corporation or the Exchange Agent shall be
entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement
to any holder of Company Common Stock such amounts as Parent, the Surviving Corporation or the
Exchange Agent are required to deduct and withhold under the Code, or any provision of state, local
or foreign tax Law, with respect to the making of such payment. To the extent that amounts are so
withheld by Parent, the Surviving Corporation or the Exchange Agent, such withheld amounts shall be
treated for all purposes of this Agreement as having been paid to the holder of Company Common
Stock in respect of whom such deduction and withholding was made by Parent, the Surviving
Corporation or the Exchange Agent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.3 <U>Dissenters&#146; Rights</U>. Notwithstanding anything in this Agreement to the
contrary, if any Dissenting Stockholder shall demand to be paid the &#147;fair value&#148; of such Dissenting
Stockholder&#146;s shares of Company Common Stock, as provided in Section&nbsp;262 of the DGCL, such shares
of Company Common Stock shall not be converted into or exchangeable for the right to receive the
Merger Consideration (except as provided in this Section&nbsp;3.3) and shall entitle such Dissenting
Stockholder only to payment of the fair value of such shares of Company Common Stock, in accordance
with Section&nbsp;262 of the DGCL, unless and until such Dissenting Stockholder withdraws (in accordance
with Section 262(k) of the DGCL) or effectively loses the right to dissent. The Company shall not,
except with the prior written consent of Parent, voluntarily make any payment with respect to, or
settle or offer to settle, any such demand for payment of fair value of a Dissenting Stockholder&#146;s
shares of Company Common Stock prior to the Effective Time. The Company shall give Parent notice thereof prior to the Effective Time and Parent
shall have the right to participate at its own expense in all negotiations and proceedings with
respect to any such demands. If any Dissenting Stockholder shall have effectively withdrawn (in
accordance with Section 262(k) of the DGCL) or lost the right to dissent, then as of the later of
the Effective Time or the occurrence of such event, the shares of Company Common Stock held by such
Dissenting Stockholder shall be cancelled and converted into and represent the right to receive the
Merger Consideration, without interest, upon surrender of the Certificates therefor, pursuant to
Section&nbsp;3.1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.4 <U>Stock Transfer Books</U>. At the Effective Time, the stock transfer books of
the Company shall be closed (after giving effect to the Exchange) and thereafter, there shall be no
</DIV>


<P align="center" style="font-size: 10pt">20
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">further registration of transfers of shares of Company Common Stock theretofore outstanding on the
records of the Company. From and after the Effective Time, the holders of Certificates shall cease
to have any rights with respect to such shares of Company Common Stock except as otherwise provided
herein or by Law. On or after the Effective Time, any Certificates presented to the Exchange Agent
or Parent for any reason shall be converted into the Merger Consideration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.5 <U>Company Equity and Long-Term Incentive Awards</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.5.1 </I>Prior to the Effective Time, the Board of Directors of the Company (or, if
appropriate, any committee thereof) (the &#147;<U>Company Board</U>&#148;) shall adopt appropriate
resolutions and take all other actions necessary and appropriate, including actions that the
Company determines are necessary to ensure compliance with a reasonable good faith interpretation
of Code Section&nbsp;409A, to provide that, concurrent with the Effective Time:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) each outstanding, unexpired and unexercised option to purchase Company Common Stock (the
&#147;<U>Company Options</U>&#148;) granted to a director or employee pursuant to the equity compensation
plans set forth in Section&nbsp;3.5.1 of the Company Disclosure Schedule (which Section also contains a
list of all outstanding Company Options, their respective exercise prices, and their respective
holders), whether or not then exercisable, conditioned or vested, shall fully vest and be deemed to
be exercised and cancelled and each holder of a Company Option shall be entitled to receive at the Effective Time, in consideration of the deemed exercise
and cancellation of such Company Option, a payment by the Surviving Corporation (or, at Parent&#146;s
option, Parent) in cash (subject to any applicable withholding or other taxes required by
applicable Law to be withheld), in an amount equal to the product of (x)&nbsp;the total number of shares
of Company Common Stock subject to such Company Option (determined on the basis that such Company
Option is fully vested and currently exercisable) and (y)&nbsp;the excess, if any, of the Merger
Consideration over the exercise price per share of Company Common Stock subject to such Company
Option (such amounts payable hereunder being referred to as the &#147;<U>Option Payments</U>&#148;);
provided, that any holder of certificates representing Company Options shall be required to
surrender such certificate prior to receipt of the Option Payments with respect to the Company
Options represented thereby; and
</DIV>

<P align="center" style="font-size: 10pt">21
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;(ii)&nbsp;all shares of restricted stock (&#147;<U>Company Restricted Stock</U>&#148;) under the equity
compensation plans of the Company as set forth in Section&nbsp;3.5.1 of the Company Disclosure Schedule
(which Section also contains a list of all shares of Company Restricted Stock and their respective
holders), whether or not then vested, shall fully vest and each holder of Company Restricted Stock
shall be entitled to, and shall be paid pursuant to Section&nbsp;3.2, the Merger Consideration pursuant
to Section&nbsp;3.1.1 of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;(iii)&nbsp;at and after the Effective Time, each Company Option shall be cancelled and terminated
and shall only entitle such holder to payment of the Option Payment as described in this Section
3.5.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.5.2 </I>Prior to the Effective Time, the Company Board (or the relevant committee
thereof) shall adopt appropriate resolutions and take all other actions necessary and appropriate
to provide that, subject to obtaining waivers and releases deemed appropriate under the
circumstances in the Company&#146;s reasonable judgment, (i)&nbsp;prior to or concurrent with the Effective
Time, each performance unit set forth in Section&nbsp;3.5.2 of the Company Disclosure Schedule (a
&#147;<U>Performance Unit Award</U>&#148;) shall be treated as fully vested, cancelled and terminated, and
payable in the manner and amount set forth in that Section of the Company Disclosure Schedule, (ii)
concurrent with the Effective Time, each director deferred unit set forth in Section&nbsp;3.5.2 of the
Company Disclosure Schedule (a &#147;<U>Director Deferred Uni</U>t&#148;) shall be cancelled and terminated,
and converted to a share of Company Common Stock, which share shall be converted into the right to receive the Merger Consideration in cash, and (iii)
concurrent with the Effective Time, restricted stock unit awards that were deferred by directors
(as set forth in Section&nbsp;3.5.2 of the Company Disclosure Schedule) shall be treated as fully vested
and converted to shares of Company Common Stock, which shares shall be converted into the right to
receive the Merger Consideration in cash.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;3.5.3 </I>The provisions of this Section&nbsp;3.5 shall survive the consummation of the Merger
and are intended to be for the benefit of, and shall be enforceable by, each holder of any Company
Options, Company Restricted Stock or Performance Unit Awards, and their respective heirs,
beneficiaries and representatives.
</DIV>


<P align="center" style="font-size: 10pt">22
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;4<BR>
Representations and Warranties of the Company</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to such exceptions as are disclosed, in accordance with Section&nbsp;9.12, in the
disclosure schedule (the &#147;<U>Company Disclosure Schedule</U>&#148;) delivered by the Company to Parent
concurrently with the execution and delivery of this Agreement (it being understood that the
disclosure of any matter or item in the Company Disclosure Schedule shall not be deemed to
constitute an acknowledgement that such matter or item is required to be disclosed therein or is
material to a representation or warranty set forth in this Agreement and shall not be used as a
basis for interpreting the terms &#147;Significant,&#148; &#147;material,&#148; &#147;materially,&#148; &#147;materiality&#148; or &#147;Company
Material Adverse Effect&#148; or any word or phrase of similar import and does not mean that such matter
or item would, alone or together with any other matter or item, be reasonably expected to have a
Company Material Adverse Effect), the Company represents and warrants to Parent and Merger Sub as
follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.1 <U>Organization and Qualification; Subsidiaries</U>. The Company is a
corporation duly organized, validly existing and in good standing under the laws of the State of
Delaware. Each Company Subsidiary (&#147;<U>Company Subsidiary</U>&#148;) has been duly organized, and is
validly existing and in good standing under the laws of the jurisdiction of its incorporation or
organization, as the case may be. Section&nbsp;4.1 of the Company Disclosure Schedule contains a
complete list of all of the Company Subsidiaries. The Company and each Company Subsidiary has the
requisite power and authority and all governmental approvals necessary to own, lease and operate its properties and to carry on its
business as it is now being conducted, except for such government approvals, the absence of which,
individually or in the aggregate, is not reasonably expected to have a Company Material Adverse
Effect. The Company and each Company Subsidiary is duly qualified or licensed to do business, and
is in good standing, in each jurisdiction where the character of the properties owned, leased or
operated by it or the nature of its business makes such qualification, licensing or good standing
necessary, except for such failures to be so qualified, licensed or in good standing that,
individually or in the aggregate, are not reasonably expected to have a Company Material Adverse
Effect. The Company has heretofore made available to Parent complete and correct copies of the
certificate of incorporation and by-laws (or similar organizational documents) of the Company and
each Company Subsidiary, and all amendments thereto, as currently in effect.
</DIV>

<P align="center" style="font-size: 10pt">23
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.2 <U>Certificate of Incorporation and By-laws; Corporate Books</U>. The copies of
the Company&#146;s Restated Certificate of Incorporation, as amended (the &#147;<U>Company Certificate</U>&#148;)
and By-laws (the &#147;<U>Company By-laws</U>&#148;) that are filed as exhibits to the Company&#146;s Form 10-K
for the year ended December&nbsp;31, 2004 (the &#147;<U>Company Form&nbsp;10-K</U>&#148;) are complete and correct
copies thereof as in effect on the date hereof. True and complete copies of all minute books of
the Company have been made available by the Company to Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.3 <U>Capitalization; Subsidiaries</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.3.1 </I>The authorized capital stock of the Company consists of 325,000,000 shares of
Company Common Stock and 10,000,000 shares of preferred stock, par value $1.00 per share (the
&#147;<U>Company Preferred Stock</U>&#148;), of which 300,000 shares have been designated shares of Series&nbsp;A
Junior Participating Preferred Stock. As of June&nbsp;30, 2005, there were (a)&nbsp;109,495,202 shares of
Company Common Stock (other than treasury shares) issued and outstanding, (b)&nbsp;8,283,316 shares of
Company Common Stock held in the treasury of the Company, (c)&nbsp;5,836,703 shares of Company Common
Stock issuable upon exercise of outstanding Company Options, (d)&nbsp;1,231,078 shares of Company Common
Stock issuable pursuant to Performance Unit Awards, (e)&nbsp;15,432,080 shares of Company Common Stock issuable upon conversion of the Company&#146;s Convertible Notes and (f)&nbsp;no shares of Company
Preferred Stock issued and outstanding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.3.2 </I>All of the outstanding shares of capital stock of the Company have been duly
authorized and validly issued and are fully paid and nonassessable and free of preemptive rights.
Except for the shares of Company Common Stock issuable upon the conversion of the Convertible Notes
and as set forth in Section&nbsp;4.3.1, there are no options, warrants or other rights, agreements,
arrangements or commitments of any character to which the Company or any Company Subsidiary is a
party or by which the Company or any Company Subsidiary is bound relating to the issued or unissued
Equity Interests of the Company, or securities convertible into or exchangeable for such Equity
Interests, or obligating the Company to issue or sell any shares of its capital stock or other
Equity Interests, or securities convertible
</DIV>


<P align="center" style="font-size: 10pt">24
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">into or exchangeable for such capital stock of, or
other Equity Interests in, the Company. Except as set forth in Section&nbsp;4.3.1, there are no
outstanding contractual obligations of the Company or any Company Subsidiary affecting the voting
rights of or requiring the repurchase, redemption or disposition of, any Equity Interests in the
Company. Except as set forth in Section&nbsp;4.3.1, upon the conversion of the Convertible Notes or as
would otherwise be permitted by this Agreement, since June&nbsp;30, 2005, the Company has not issued any
shares of its capital stock, or securities convertible into or exchangeable for such capital stock
or any other Equity Interests in the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.3.3 </I>Each outstanding share of capital stock or other equity interest of each Company
Subsidiary is duly authorized, validly issued, fully paid, nonassessable and free of preemptive
rights and is held, directly or indirectly, by the Company or another Company Subsidiary free and
clear of all claims, liens and encumbrances. Except as set forth in Section&nbsp;4.3.1, there are no
subscriptions, options, warrants, rights, calls, contracts or other commitments, understandings,
restrictions or arrangements relating to the issuance or sale with respect to any shares of capital
stock or other ownership interests of any Company Subsidiary, including any right of conversion or
exchange under any outstanding security, instrument or agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.4 <U>Authority</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.4.1 </I>The Company has all necessary corporate power and authority to execute and
deliver this Agreement, to perform its obligations hereunder and to consummate the transactions
contemplated by this Agreement. The execution and delivery of this Agreement by the Company and
the consummation by the Company of the transactions contemplated hereby have been duly and validly
authorized by all necessary corporate action and no other corporate proceedings on the part of the
Company and no stockholder votes are necessary to authorize this Agreement or to consummate the
transactions contemplated hereby other than, with respect to the Merger, the affirmative vote of
holders of a majority of outstanding shares of Company Common Stock to adopt this Agreement and
approve the transactions provided for herein (the &#147;<U>Stockholder Approval</U>&#148;). This Agreement
has been duly authorized and validly executed and delivered by the Company and, assuming this
Agreement is a valid and binding obligation of Parent and Merger Sub, this Agreement constitutes a
legal, valid and binding obligation of the Company, enforceable against the Company in accordance
with its terms, subject to bankruptcy, insolvency, reorganization, moratorium and similar Laws of
general applicability relating to or affecting creditors&#146; rights and to general equity principles
(the &#147;<U>Bankruptcy and Equity Exception</U>&#148;).
</DIV>


<P align="center" style="font-size: 10pt">25
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.4.2 </I>The Company has taken all appropriate actions so that the restrictions on
business combinations contained in Section&nbsp;203 of the DGCL will not apply with respect to or as a
result of this Agreement and the transactions contemplated hereby, including the Merger, without
any further action on the part of the stockholders or the Company Board.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.5 <U>No Conflict; Required Filings and Consents</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.5.1 </I>The execution, delivery and performance by the Company of this Agreement does
not (i)&nbsp;assuming the Stockholder Approval is obtained, conflict with or violate any provision of
the Company Certificate or the Company By-laws or any equivalent organizational documents of any
Company Subsidiary, (ii)&nbsp;assuming that all consents, approvals, authorizations and Company Permits
described in Section&nbsp;4.5.2 will have been obtained prior to the Effective Time and all filings and
notifications described in Section&nbsp;4.5.2 will have been made and any waiting periods thereunder
will have terminated or expired prior to the Effective Time, conflict with or violate, in any material respect, any Law applicable to the Company or
by which any Company Owned Health Care Facility, Company Leased Health Care Facility, Company Other
Owned Property, Company Other Leased Property, or other material asset of the Company is bound or
affected or (iii)&nbsp;require the Company to obtain any consent or approval under, result in any
material breach of or any loss of any material benefit under, or constitute a default (or an event
which with notice or lapse of time or both would become a default) under, or give to others any
right of termination, vesting, amendment, acceleration or cancellation of, or result in the
creation of a lien or other encumbrance on any Company Property that constitutes a Company Owned
Health Care Facility, Company Leased Health Care Facility, Company Other Owned Property, Company
Other Leased Property, or other material asset of the Company pursuant to, any Company Selected
Contracts having an aggregate value to the Company over $10,000,000.
</DIV>


<P align="center" style="font-size: 10pt">26
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.5.2 </I>The execution, delivery and performance of this Agreement by the Company does
not require any consent, approval, authorization or Company Permit of, or filing with or
notification to, any Governmental Entity, except (i)&nbsp;under the Exchange Act, any applicable Blue
Sky Law, the rules and regulations of the NYSE, the HSR Act or any other antitrust, competition,
trade or other regulatory Laws, (ii)&nbsp;the filing and recordation of the Certificate of Merger as
required by the DGCL, (iii)&nbsp;under any Company Health Care Program or as required to transfer or
continue operation under a Company Health Care Permit, (iv)&nbsp;with respect to matters other than
those referred to in the previous clauses (i), (ii)&nbsp;and (iii), where failure to obtain such
consents, approvals, authorizations or Company Permits, or to make such filings or notifications
would not (a)&nbsp;prevent or materially delay the consummation of the Merger, (b)&nbsp;otherwise prevent or
materially delay performance by the Company of any of its material obligations under the Agreement,
(c)&nbsp;inhibit the ability to obtain Government Consents necessary for the continued operation
consistent with past practice of any Company Health Care Program, any Company Health Care Facility
or the transfer of any Company Health Care Permit, or (d)&nbsp;result in a material violation of any
Legal Requirement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.6 <U>Compliance with Laws</U>. The Company and each Company Subsidiary holds all
Other Company Permits necessary for the lawful conduct, in all material respects, of its business
or ownership, use, occupancy and operation of the Company Owned Health Care Facilities, Company Leased Health
Care Facilities, Company Other Owned Properties, Company Other Leased Properties and its other
material assets. The Company and each Company Subsidiary is in compliance, in all material
respects, with the terms of such Other Company Permits, except for such matters for which the
Company or Company Subsidiary has received written notice from a Governmental Entity, which notice
asserts a lack of compliance with a particular Other Company Permit (and, in the case of any such
notice received prior to the date hereof, such item is disclosed in Section&nbsp;4.6 of the Company
Disclosure Schedule), but which permits the Company or Company Subsidiary to cure such
non-compliance within a reasonable period of time following the issuance of such notice and which
cure is being undertaken by the Company or Company Subsidiary, and such cure period has not expired
and the cure is reasonably expected to be completed within such cure period and none of the
businesses of the Company or any Company Subsidiary is being conducted in violation, in any
material respect, of any Law (other than any such violations addressed in Section&nbsp;4.21 hereof)
applicable to the Company or such Company Subsidiary or by which any Company Owned Health Care
Facility,
</DIV>

<P align="center" style="font-size: 10pt">27
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company Leased Health Care Facility, Company Other Owned Property, Company Other Leased
Property or other material asset of the Company or Company Subsidiary is bound, except where such
violation is subject to a cure within a reasonable period of time by the Company or Company
Subsidiary, which cure is being undertaken by the Company or Company Subsidiary and such cure
period has not expired and the cure is reasonably expected to be completed within such cure period
(and, in the case of any violation existing on the date hereof, such item is disclosed in Section
4.6 of the Company Disclosure Schedule).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.7 <U>SEC Filings; Financial Statements</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.7.1 Company SEC Filings</I>. The Company has timely filed all forms, reports and other
documents required to be filed by it under the Securities Act or the Exchange Act, as the case may
be, since January&nbsp;1, 2003 (collectively, the &#147;<U>Company SEC Filings</U>&#148;). Each Company SEC
Filing (i)&nbsp;as of its date, complied in all material respects with the requirements of the
Securities Act or the Exchange Act, as the case may be, and (ii)&nbsp;did not, at the time it was filed,
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the
circumstances under which they were made, not misleading. As of the date of this Agreement, no
Company Subsidiary is subject to the periodic reporting requirements of the Exchange Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.7.2 Financial Statements</I>. Each of the consolidated financial statements (including,
in each case, any notes thereto) contained in the Company SEC Filings was prepared in accordance
with GAAP applied (except as may be indicated in the notes thereto and, in the case of unaudited
quarterly financial statements, as permitted by Form 10-Q under the Exchange Act) on a consistent
basis during the periods indicated (except as may be indicated in the notes thereto), and each
presented fairly, in all material respects, the consolidated financial position of the Company as
of the respective dates thereof and the consolidated results of operations and cash flows of the
Company for the respective periods indicated therein (subject, in the case of unaudited statements,
to normal adjustments which, individually or in the aggregate, are not reasonably expected to have
a Company Material Adverse Effect).

<P align="center" style="font-size: 10pt">28
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.7.3 No Undisclosed Liabilities</I>. None of the Company or any consolidated Company
Subsidiary has any Significant liabilities or obligations, individually or in the aggregate, of any
nature (whether accrued, absolute, contingent or otherwise) that would be required to be reflected
on a balance sheet or in notes thereto prepared in accordance with GAAP, except for liabilities or
obligations (i)&nbsp;which are recorded or reserved for in compliance with GAAP on the balance sheet
included in either the Company&#146;s Annual Report on Form 10-K as of December&nbsp;31, 2004, with any
amendment thereto, or the Company&#146;s Quarterly Report on Form 10-Q as of June&nbsp;30, 2005, (ii)&nbsp;that
were incurred or determined after June&nbsp;30, 2005 in the ordinary course of business, consistent with
past practice and not in violation of any of the covenants of the Company set forth in this
Agreement or (iii)&nbsp;that were incurred under this Agreement or in connection with the transactions
contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.8 <U>Proxy Statement and SEC Filings</U>. Subject to the last sentence of this
Section&nbsp;4.8, the Proxy Statement and any other document filed or to be filed with the SEC in
connection with the transactions contemplated hereby will, at the time such documents,
correspondence or supplements thereto, are first mailed to holders of shares of Company Common
Stock or filed with the SEC and, as supplemented by any other such documents, at the time of the Company Stockholders&#146; Meeting,
not contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary in order to make the statements therein, in light of the
circumstances in which they were made, not misleading, and will comply as to form in all material
respects with the provisions of the Securities Act and the Exchange Act. Notwithstanding the
foregoing, the Company makes no representation or warranty with respect to any statements made or
incorporated by reference in the Proxy Statement based on information supplied by Parent or Merger
Sub for inclusion or incorporation by reference therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.9 <U>Absence of Certain Changes or Events</U>. Since December&nbsp;31, 2004, there has
not been any Company Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.10 <U>Benefit Plans; Employees and Employment Practices</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.10.1 </I>Section&nbsp;4.10.1 of the Company Disclosure Schedule contains a true, correct and
complete list of each material Company Benefit Plan maintained or contributed to by the Company or
any Company Subsidiary. The Company has made available to Parent or its agents or representatives
copies of (i)&nbsp;each material Company Benefit Plan, (ii)&nbsp;the most recent annual report (Form&nbsp;5500),
if any, filed with the U.S. Department of Labor with respect to each such Company Benefit Plan, and
(iii)&nbsp;the summary plan description in effect on June&nbsp;30, 2005 for each such Company Benefit Plan
for which a summary plan description is required.
</DIV>

<P align="center" style="font-size: 10pt">29


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.10.2 </I>Except as provided in Section&nbsp;4.10.2 of the Company Disclosure Schedule: (i)
each Company Benefit Plan is in compliance, in all material respects, with any applicable
provisions of the Employee Retirement Income Security Act of 1974, as amended (&#147;<U>ERISA</U>&#148;) and
the applicable provisions of the Code, and each Company Benefit Plan has been administered in
compliance, in all material respects, with its terms; and (ii)&nbsp;the Company and each Company
Subsidiary are in compliance, in all material respects, with the requirements of the applicable
health care continuation and notice provisions of the Consolidated Omnibus Budget Reconciliation
Act of 1985, as amended, and the applicable provisions of the Health
Insurance Portability and Accountability Act of 1996. With respect to each Company Benefit
Plan: (i)&nbsp;all contributions and insurance premiums required as of the Effective Time have been or
will be paid, and to the Knowledge of the Company, there have been no prohibited transactions
(within the meaning of ERISA &#167;406 or Code &#167;4975) with respect to any Company Benefit Plan; (ii)&nbsp;to
the Knowledge of the Company, no fiduciary has any liability for breach of fiduciary duty or any
other failure to act or comply in connection with the administration or investment of the assets of
any Company Benefit Plan; (iii)&nbsp;there is no suit, claim, action, proceeding or investigation
pending or, to the Knowledge of the Company, threatened with respect to the administration or the
investment of the assets of any Company Benefit Plan (other than routine claims for benefits); (iv)
each Company Benefit Plan that is intended to be qualified under Section 401(a) of the Code has
received a determination letter from the IRS that it is so qualified, and, to the Company&#146;s
Knowledge, no fact or event has occurred since the date of such determination letter that could
materially and adversely affect the qualified status of any such Company Benefit Plan; and (v)
neither the Company nor any Company Subsidiary has been notified of any pending audit,
investigation or review by any governmental or law enforcement agency, and to the Knowledge of the
Company, no such audit, investigation or review has been proposed, with respect to any Company
Benefit Plan.
</DIV>


<P align="center" style="font-size: 10pt">30
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.10.3 </I>Except as set forth in Section&nbsp;4.10.3 of the Company Disclosure Schedule,
neither the Company nor any Company Subsidiary has any current or projected material liability in
respect of post-employment or post-retirement health or medical or life insurance benefits for
retired, former or current employees of Company or any Company Subsidiary, except as required to
avoid excise tax under Section&nbsp;4980B of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.10.4 </I>Except as provided in Section&nbsp;4.10.4 of the Company Disclosure Schedule,
neither the Company nor any trade or business that, together with the Company, would be deemed a
single employer within the meaning of Section&nbsp;4001 of ERISA (an &#147;<U>ERISA Affiliate</U>&#148;)
maintains or contributes to any Multiemployer Plan or any &#147;defined benefit plan&#148; (as defined in
Section&nbsp;3(35) of ERISA) subject to Title IV of ERISA. Except as provided in Section&nbsp;4.10.4 of the
Company Disclosure Schedule, neither the Company nor any Company Subsidiary has any obligation to
contribute or pay any &#147;withdrawal liability&#148; to any Multiemployer Plan or can reasonably be
expected to have any such obligation as a result of the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.10.5 </I>Except as provided in Section&nbsp;4.10.5 of the Company Disclosure Schedule:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) (i)&nbsp;neither the Company nor any Company Subsidiary is a party to any collective
bargaining or other labor union contracts and no collective bargaining agreement is being
negotiated by the Company or any Company Subsidiary, (ii)&nbsp;neither the Company nor any Company
Subsidiary is a party to any neutrality agreement with any labor organization, (iii)&nbsp;neither the
Company nor any Company Subsidiary has joined other long-term care providers or any labor
organization to form an alliance, (iv)&nbsp;to the Knowledge of the Company, there is no pending labor
dispute, strike or significant work stoppage against the Company or any Company Subsidiary which
may interfere with the respective business activities of the Company or the Company Subsidiaries,
except where such dispute, strike or work stoppage, individually or in the aggregate, is not
reasonably expected to have a Company Material Adverse Effect, (v)&nbsp;there is no pending charge or
complaint against the Company or any Company Subsidiary by the National Labor Relations Board or
any comparable state agency, except where such unfair labor practice, charge or complaint,
individually or in the aggregate, is not reasonably expected to have a Company Material Adverse
Effect, and (vi)&nbsp;there is no pending arbitration proceeding arising under any collective bargaining
agreement, except where such arbitration proceeding, individually or in the aggregate, is not
reasonably expected to have a Company Material Adverse Effect;
</DIV>


<P align="center" style="font-size: 10pt">31
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company and the Company Subsidiaries are, and have, at all times during the last year,
been in compliance in all material respects with all applicable Laws respecting immigration,
employment and employment practices, and the terms and conditions of employment, including, without
limitation, employment standards, equal employment opportunity, family and medical leave, wages,
hours of work and occupational health and safety;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;During the six (6)&nbsp;month period prior to the date of this Agreement, the Company or any
Company Subsidiary has not effectuated (i)&nbsp;a &#147;plant closing&#148; as defined in the Worker Adjustment
and Retraining Notification Act of 1988 (&#147;<U>WARN</U>&#148;) affecting any site of employment or one or
more facilities or operating units within any site of employment or facility of the Company or any
Company Subsidiary, (ii)&nbsp;a &#147;mass layoff&#148; as defined in WARN affecting any site of employment or
facility of the Company or any Company Subsidiary, or (iii)&nbsp;a transaction or layoffs or employment terminations that triggered application of any similar
applicable state or local law;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company or a Company Subsidiary has provided or will provide Parent with copies of (i)
all applications and petitions for immigration employment and visa benefits submitted on behalf of
current foreign national employees of the Company to the U.S. Department of Labor, U.S. Immigration
and Naturalization Service, and U.S. Department of State and (ii)&nbsp;all government notices regarding
adjudications of such applications and petitions that the Company has in its possession or that it
can reasonably obtain;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The consummation of the transactions contemplated by this Agreement without the
termination of any employee&#146;s employment will not entitle any employee of the Company or any
Company Subsidiary, whether under any individual agreement, Company Benefit Plan or other similar
Company policy, to severance pay or accelerate the time of payment of compensation due to any
employee of the Company or any Company Subsidiary;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Except as provided in Sections&nbsp;4.10.5 or 6.1(l) of this Agreement and the Company
Disclosure Schedule, and other than in the ordinary course of business, subsequent to December&nbsp;31,
2004, there has been no material increase in the compensation payable or to become payable to any
of the Continuing Employees, and there have been no payments or provisions for any material awards,
bonuses, loans, profit sharing, pension, retirement or welfare plans or similar or other
disbursements or arrangements for or on behalf of such employees (or related parties thereof).
</DIV>


<P align="center" style="font-size: 10pt">32
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Except for bonuses that may be due to employees of the Company or any Company Subsidiary
for the current year, as set forth in Section&nbsp;4.10.5 of the Company Disclosure Schedule hereto, all
bonuses heretofore granted to employees of the Company or any Company Subsidiary have been paid in
full to such employees or accrued on the balance sheets contained in the Financial Statements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.11 <U>Contracts; Debt Instruments</U>. Except as disclosed in Section&nbsp;4.10.1,
Section&nbsp;4.11, Section&nbsp;4.17.1(c), 4.17.1(e) and 4.17.1(h) or Section&nbsp;4.21.6 of the Company
Disclosure Schedule, none of the Company or any Company Subsidiary is a party to or bound by any
Contract which (i)&nbsp;as of the date hereof, is a &#147;material contract&#148; (as such term is defined in Item&nbsp;601(b)(10) of Regulation&nbsp;S-K
promulgated by the SEC) or (ii) (a)&nbsp;involves aggregate expenditures in excess of $1,000,000 based
on the stated term of the agreement (without giving effect to any renewal provision), (b)&nbsp;involves
annual expenditures in excess of $1,000,000 and is not cancelable within one year, (c)&nbsp;which would
prohibit or materially delay the consummation of the Merger or (d)&nbsp;contains covenants limiting the
ability of the Company or any Company Subsidiary to engage in any line of business or compete with
any Person or operate at any location or (iii)&nbsp;is a Contract of any of the following types:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Equipment Leases</U>. Any agreement (or group of related agreements, including master
lease agreements) for the lease of medical equipment, motor vehicles, computers and related
devices, telecommunications equipment or other personal property to or from any Person providing
for lease payments in excess of $50,000 per annum.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>National and Blanket Vendor Agreements</U>. Any agreement (or group of related
agreements) for the purchase or sale of medical, pharmaceutical or health care products or
services, food, supplies, maintenance or other products or services the performance of which
extends over a period of more than one (1)&nbsp;year, is not terminable without cause with 180&nbsp;days or
less written notice, and involves consideration in excess of $1,000,000.
</DIV>


<P align="center" style="font-size: 10pt">33
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Joint Venture Agreements</U>. Any agreement concerning a partnership, joint venture,
limited liability company, corporation or other entity which is not a one hundred (100)&nbsp;percent
owned Company Subsidiary, including stockholders, operating, joint venture and related management
agreements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Management Agreements</U>. Any agreement pursuant to which the Company or any Company
Subsidiary manages or operates a Company Health Care Facility not owned or leased by the Company or
a Company Subsidiary, or pursuant to which an unrelated Third Party manages a Company Health Care
Facility which is owned or leased by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Debt Agreements; Mortgages</U>. Any agreement (or group of related agreements) under
which the Company or any Company Subsidiary has created, incurred, assumed, or guaranteed any
indebtedness for borrowed money, or any capitalized lease obligation, in excess of $10,000 or under which there is granted an encumbrance on any of the
assets of the Company or any Company Subsidiary, tangible or intangible.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Agreement for the Provision of Services by the Company</U>. Any agreement (or group
of related agreements) for the provision by the Company or Company Subsidiaries of health care
services to other health care operators, such as therapy, staffing, billing, software, hospice and
training services, which involves consideration in excess of $250,000.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Related Party Agreements</U>. Any agreement between the Company or any Company
Subsidiary on the one hand, and any of their directors, officers, executives, key employees or any
Person affiliated with such individuals on the other.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Employment Agreements</U>. Any employment, executive, management, consulting or
severance agreement with any employee of the Company or any Company Subsidiary involving
compensation of more than $25,000 per annum or which would require any severance, bonus or other
compensation to be paid in connection with a change in control of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Union Agreements</U>. Any collective bargaining or recognition agreement with any
labor organization.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <U>Acquisition Agreements</U>. Any agreements that are (i)&nbsp;either (a)&nbsp;dated within two
years of the date hereof or (b)&nbsp;contain any material obligations that remain to be performed by any
party thereto and (ii)&nbsp;that relate to (a)&nbsp;the acquisition by the Company of the
</DIV>


<P align="center" style="font-size: 10pt">34
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">facilities, assets,
real property, capital stock, business or leases of any Person, (b)&nbsp;the sale or divestiture of any
Company Health Care Facility, real property, lease or business unit of the Company or any Company
Subsidiary or the capital stock of any Company Subsidiary, or (c)&nbsp;any other sale of assets of the
Company or any Company Subsidiary outside the ordinary course of business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <U>Settlement Agreements</U>. Any settlement, stipulation, conciliation or similar
agreement, consent order or administrative order under which material obligations remain to be
performed by any party thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <U>Systems Agreements</U>. Any license or maintenance agreements for computer software
or hardware, telecommunications equipment or services or other technology infrastructure, other
than with respect to off-the-shelf or shrink-wrap software that is material to the ongoing
operation of the Company&#146;s business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) <U>Health Care Operations Agreements</U>. Any Governmental Agreement and Provider
Agreement or evidence thereof, such as a provider number, or any managed care agreements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) <U>Lending/Guaranty Agreements</U>. Any agreement under which the Company or any of the
Company Subsidiaries has advanced or loaned any other Person or guaranteed obligations of any other
Person, an amount individually or in the aggregate exceeding $10,000, including without limitation,
advance deposits to vendors and that is either (i)&nbsp;dated within two years of the date hereof or
(ii)&nbsp;contains any material obligations that remain to be performed by any party thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) <U>License/Franchise Agreements</U>. Any license, franchise or other agreement relating
to the use of patents, trademarks, copyrights, logos, brand names, business formats, or other
intellectual property under to which the Company or any Company Subsidiary is a party, other than
with respect to off-the-shelf or shrink-wrap software, that is material to the ongoing operation of
the Company&#146;s business.
</DIV>


<P align="center" style="font-size: 10pt">35
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) <U>Agreements Relating to Securities</U>. Any agreement with remaining obligations
relating to the subscription for or issuance of, or repurchase or redemption of, or the
registration or transfer of, shares of capital stock of the Company or any Company Subsidiary, or
options, warrants or securities exercisable or convertible therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q) <U>Risk Management Agreements</U>. Any claims management or administration agreement,
stop-loss agreement, risk management agreement, insurance, reinsurance, bonding, consulting or
brokerage agreement or commitments for the placement of insurance, or agreements relating to
captive or self-insurance programs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r) <U>Special Contracts</U>. All contracts, agreements, arrangements or other instruments
relating to off-balance sheet arrangements, loss sharing or loss guarantee and contingent purchase
transactions, special purpose entity transactions or other similar transactions of the Company or any Company Subsidiary, and all obligations assumed by the Company or any
Company Subsidiary under interest rate or currency hedging or swap transactions or any other
derivative transaction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s) <U>Tax Agreements</U>. All tax sharing agreements, tax indemnity agreements or any other
contract or agreement of a similar nature to which the Company or any Company Subsidiary is a party
or by which the Company or any Company Subsidiary is otherwise bound other than any such agreements
other than tax indemnities in agreements relating to the acquisition or disposition of assets
described in Section&nbsp;4.11(k) or in any loan agreement, indenture, credit agreement or similar
agreement relating to the borrowing of money listed in the Company Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t) <U>Real Estate Leases</U>. All Leases.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u) <U>Other Material Agreements</U>. Any other material agreement (or group of related
agreements), regardless of the amount of consideration, pursuant to which the consequences of a
default or termination would result in a Company Material Adverse Change.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Contract of the type described in this Section&nbsp;4.11 (except the Leases, which are
addressed in Section&nbsp;4.17.4 of this Agreement), whether or not set forth in Section&nbsp;4.11 of the
Company Disclosure Schedule, is referred to herein as a &#147;<U>Company Selected Contract</U>.&#148;
Except as would not be Significant to the Company, individually or in the aggregate, the Company
Selected Contracts are legal, valid and binding obligations of the Company or a Company Subsidiary,
as applicable, in full force and effect and enforceable against the Company or a
</DIV>


<P align="center" style="font-size: 10pt">36
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company Subsidiary
in accordance with its terms, subject to the effect of any applicable bankruptcy, insolvency
(including all laws relating to fraudulent transfers), reorganization, moratorium or similar laws
affecting creditors&#146; rights generally and subject to the effect of general principles of equity.
Except as would not be Significant to the Company, individually or in the aggregate, the Company
has not received written notice, and has no reason to believe, that any Company Selected Contracts
are not legal, valid and binding obligations of the counterparty thereto, in full force and effect
and enforceable against such counterparty in accordance with their terms. Except as would not be
Significant to the Company, individually or in the aggregate, neither the Company nor any Company
Subsidiary and, to the Company&#146;s Knowledge, no counterparty, is in material breach or violation of, or default under, any Company Selected
Contract. Except as would not be Significant to the Company, individually or in the aggregate,
none of the Company or any Company Subsidiary has received any claim of default under any Company
Selected Contract. Except as would not be Significant to the Company, individually or in the
aggregate, to the Company&#146;s Knowledge, no event has occurred which would result in a material
breach or violation of, or a material default under, any Company Selected Contract (in each case,
with or without notice or lapse of time or both).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.12 <U>Litigation</U>. Except as set forth in Section&nbsp;4.12 of the Company Disclosure Schedule,
there is no suit, claim, action or proceeding pending or, to the Knowledge
of the Company, threatened, against the Company or any Company Subsidiary and,
to the Knowledge of the Company, there is no investigation by any Governmental
Entity pending or threatened against the Company or any Company Subsidiary and
none of the Company or any of the Company Subsidiaries is subject to any outstanding Order,
in each case other than such suit, claim, action, proceeding, investigation or Order as would
not result in the aggregate in a Significant liability to the Company or any Company Subsidiary.
As of the date hereof, (i)&nbsp;there is no suit, claim, action, proceeding, arbitration or investigation
pending or to the Knowledge of the Company, threatened, against the Company or any Company Subsidiary
which (a)&nbsp;would be reasonably expected to have a Company Material Adverse Effect or (b)&nbsp;seeks to, or
would reasonably be expected to, restrain, enjoin or delay the consummation of the Merger or any of
the other transactions provided for herein or which seeks damages in connection therewith and (ii)
no injunction has been entered or issued with respect to the transactions provided for herein.
</DIV>


<P align="center" style="font-size: 10pt">37
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.13 <U>Environmental Matters</U>. Except as set forth in Section&nbsp;4.13 of the
Company Disclosure Schedule and except for matters, conditions and violations that, individually or
in the aggregate, are not reasonably expected to result in costs, liabilities or damages
Significant to either (a)&nbsp;the Company or (b)&nbsp;any Company Property:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.13.1 General</I>. The Company and each Company Subsidiary is in compliance in all
material respects with Environmental Law. The Company and each Company
Subsidiary possesses and is in compliance in all material respects with all Other Company
Permits issued pursuant to Environmental Law that are required to conduct the Company Health Care
Businesses of the Company and each Company Subsidiary as currently conducted. To the Knowledge of
the Company, neither the Company nor any Company Subsidiary has received any written claim or
notice of violation from any Governmental Entity alleging that the Company or any Company
Subsidiary is in violation of, or liable under, any Environmental Law which could reasonably be
expected to result in a Significant liability to the Company or any Company Subsidiary, except for
any such claims or violations that have been resolved.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.13.2 Environmental Conditions, Etc.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;The Company has not generated, manufactured, refined, treated, stored, handled, disposed,
produced, or processed any Hazardous Material at the Company Health Care Properties or at any other
location, except in compliance in all material respects with all applicable Environmental Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;No Lien has been imposed on the Company Health Care Facilities or any other Company
Properties by any Governmental Entity in connection with the presence on Company Health Care
Facilities of any Hazardous Materials or any violation of Environmental Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Except for any Environmental Claims that have been resolved, the Company has not (A)
entered into or been subject to any consent decree, compliance order, remedial, clean-up or
administrative order under any Environmental Laws with respect to the Company Health Care
Facilities; (B)&nbsp;received written notice under the citizen suit provision of any Environmental Law
in connection with the Company Health Care Facilities; (C)&nbsp;received any written request for
information, notice, demand letter, administrative inquiry, or formal or
</DIV>

<P align="center" style="font-size: 10pt">38
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">informal complaint or
claim relating to the Company Health Care Facilities pursuant to any Environmental Laws; or (D)
been subject to any governmental, private or citizen enforcement action with respect to the Company
Health Care Facilities under any Environmental Laws; and the Company has no Knowledge that any of
the above (collectively, &#147;<U>Environmental Claims</U>&#148;) are pending.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;The Company has provided, or otherwise made reasonably available, to Parent copies of (a)
the Phase I Environmental Site Assessment reports prepared in June, July and August&nbsp;2005 by EMG
Corp. in connection with the transaction contemplated by this Agreement that are listed in Appendix
A to Section&nbsp;4.13 of the Company Disclosure Schedule and (b)&nbsp;any environmental reports, assessments
or audits prepared during the three year period immediately preceding the date hereof to the extent
in the possession of the Company or any Company Subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;The Company and each Company Subsidiary are in compliance in all material respects with
all Environmental Laws relating to the safe and secure storage and disposal of medical waste
materials, including without limitation, infectious waste and radioactive materials, disposition of
pharmaceuticals, drugs and controlled substances, at each Company Health Care Facility and in
connection with the Company Health Care Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.14 <U>Intellectual Property</U>. Except for matters expressly set forth in Section
4.14 of the Company Disclosure Schedule, (i)&nbsp;the Company and each Company Subsidiary own or possess
valid rights to use all Intellectual Property necessary to conduct the business of the Company and
the Company Subsidiaries as it is currently conducted, (ii)&nbsp;true and complete copies of all
Selected Company Contracts whereby any rights in or to any Intellectual Property have been obtained
from, granted to or licensed from or to any Third Party have been delivered to or made available
for review by Parent, except to the extent that disclosure of such Selected Company Contracts is
restricted by obligations of confidentiality, (iii)&nbsp;the execution, delivery and performance of this
Agreement will not result in the loss or impairment of, or give rise to any right of any Third
Party to terminate, the respective rights of the Company in any Intellectual Property licensed
from a Third Party that is material to the business of the Company and the Company Subsidiaries,
(iv)&nbsp;during the past two (2)&nbsp;years (or earlier, if not resolved) the Company has not received any
written complaint, demand or notice alleging that the Company
</DIV>

<P align="center" style="font-size: 10pt">39
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or any Company Subsidiary has
infringed upon or misappropriated any Intellectual Property right of any Third Party, and (v)&nbsp;to
the Company&#146;s Knowledge, no Third Party is currently infringing or misappropriating Intellectual
Property owned by the Company or any Company Subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.15 <U>Taxes</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.1 </I>All Tax Returns required to be filed by or with respect to the Company or any
Company Subsidiary have been timely filed (taking into account any extension of time within which
to file), except where the failure to so timely file such Tax Returns would not result in a
Significant liability in the aggregate to the Company or any Company Subsidiary. All such Tax
Returns are true, correct, and complete in all material respects.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.2 </I>All Significant Taxes of the Company and each Company Subsidiary due and
payable have been timely paid, other than any amount which is being contested in good faith by
appropriate proceedings and for which adequate reserves have been established in accordance with
GAAP on the Company&#146;s and the Company Subsidiaries&#146; financial statements. As of June&nbsp;30, 2005, the
accruals and reserves for Taxes (without regard to deferred tax assets and deferred tax liabilities
associated with temporary differences) of the Company and each Company Subsidiary established in
the Company SEC Filings were complete and adequate to cover any material liabilities for Taxes that
are not yet due and payable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.3 </I>As of the date of this Agreement, no deficiencies for Taxes have been proposed
or assessed in writing against the Company or any Company Subsidiary by any taxing authority, and
neither the Company nor any Company Subsidiary has received any written notice of any claim,
proposal or assessment against the Company or any Company Subsidiary for any such deficiency for
Significant Taxes. To the Knowledge of the Company, as of the date of this Agreement, none of the
Tax Returns of the Company or any Company Subsidiary is currently being examined by the U.S.
Internal Revenue Service (&#147;<U>IRS</U>&#148;) or relevant state, local or foreign taxing authorities.
Neither the Company nor any Company Subsidiary has entered into a closing agreement pursuant to
Section&nbsp;7121 of the Code regarding the five (5)&nbsp;years immediately preceding the date of this
Agreement.
</DIV>



<P align="center" style="font-size: 10pt">40
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.4 </I>The Company and each Company Subsidiary has duly and timely withheld,
collected, paid and reported to the proper Governmental Entity all Significant Taxes required to
have been withheld, collected, paid or reported.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.5 </I>There are no liens or other security interests upon any property or assets of
the Company or any Company Subsidiary for Significant Taxes, except for liens for Taxes not yet due
and payable or the amount or validity of which is being contested in good faith by appropriate
proceedings and for which adequate reserves have been established in accordance with GAAP on the
Company&#146;s and the Company Subsidiaries&#146; financial statements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.6 </I>Neither the Company nor any Company Subsidiary has constituted either a
&#147;distributing corporation&#148; or a &#147;controlled corporation&#148; in a distribution of stock qualifying for
tax-free treatment under Section&nbsp;355 of the Code in the past two (2)&nbsp;years.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.7 </I>Since January&nbsp;1, 1998, neither the Company nor any Company Subsidiary has been
a member of an &#147;affiliated group&#148; as defined in Section 1504(a) of the Code, except for the
affiliated group of which the Company is the common parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.8 </I>At no time has the Company or any Company Subsidiary been a party to a &#147;listed
transaction,&#148; as such term is defined in Section&nbsp;6707A(c)(1) of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.15.9 </I>Neither the Company nor any Company Subsidiary has extended any Statute of
Limitations for the assessment of any Taxes except as set forth on Section&nbsp;4.15.9 of the Company
Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.16 <U>Insurance</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.16.1 </I>Section&nbsp;4.16.1 of the Company Disclosure Schedule sets forth a listing
(including type of coverage, policy limits, carrier and deductibles), and the Company has made
available to Parent accurate and complete copies of:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;all policies of insurance to which the Company or any Company Subsidiary is a party or
under which the Company or any Company Subsidiary or the Company Health Care Facilities or other
assets of the Company is currently covered and all material insurance policies to which the Company
or any Company Subsidiary was a party or under which the Company or any Company Subsidiary has been
covered at any time since January&nbsp;1,
</DIV>


<P align="center" style="font-size: 10pt">41
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">2003, including without limitation, all Professional
Liability/General Liability (&#147;<U>PLGL</U>&#148;), director and officer liability, building, fire, property, flood, motor vehicle, workmen&#146;s
compensation and employer liability insurance;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;all pending applications by the Company or any Company Subsidiary for any such policies of
insurance or renewals thereof; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;any stop-loss, claims management and claims administration agreements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.16.2 </I>Section&nbsp;4.16.2 of the Company Disclosure Schedule describes any material
self-insurance, captive insurance or reserve arrangement established by the Company or any Company
Subsidiary, including, without limitation, with respect to professional and general liability, and
any reserves established thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.16.3 </I>Except as set forth in Section&nbsp;4.16.3 of the Company Disclosure Schedule:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;since January&nbsp;1, 2003, neither the Company nor any Company Subsidiary has received (i)&nbsp;any
written notice of cancellation that any Significant policy of insurance is no longer in full force
or effect or that the issuer of any Significant policy of insurance is not willing or able to
perform its obligations thereunder or (ii)&nbsp;any series of written notices of denial of coverage or
reservation of rights that clearly demonstrates that a material insurer intends not to honor a
Significant insurance coverage; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;since January&nbsp;1, 2003, the Company and the Company Subsidiaries have paid all premiums
due, and have otherwise performed all of their respective obligations, under each Significant
policy of insurance to which it is a party or that provides Significant coverage with respect to
the Company, any Company Subsidiary, the Company Health Care Facilities or other assets used by the
Company or any Company Subsidiary; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;the Company and the Company Subsidiaries have regularly provided each insurer that has
requested such, full loss listings and has provided additional claim specific notice when required
by the terms of the applicable policy and Section&nbsp;4.16.3(c) of the Company Disclosure Schedule sets
forth a list of all material or open known claims that are reasonably expected to be covered under
the policies listed under Section&nbsp;4.16.1 of the Company Disclosure
</DIV>


<P align="center" style="font-size: 10pt">42
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule and also including claims under the Company&#146;s self insurance program for general and
professional liability, auto liability, and workers&#146; compensation; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;to the Knowledge of the Company, and except as listed in Section&nbsp;4.16.3(d) of the Company
Disclosure Schedule, each Significant policy of insurance is legal, valid, binding, enforceable,
and in full force and effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.17 <U>Real Estate</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.17.1 </I>The following lists of real property scheduled for this Agreement are as
follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Section&nbsp;4.17.1(a) of the Company Disclosure Schedule sets forth a comprehensive list of
all real property owned, leased, licensed or occupied by the Company or the Company Subsidiaries
(the &#147;<U>Company Properties</U>&#148;) and sets forth for each such property the following: (i)&nbsp;the
facility number, (ii)&nbsp;the street address, town or city, and state jurisdiction in which such
property is located, (iii)&nbsp;identification as a skilled nursing home facility, assisted living
facility, office, hospice location, homecare location, or other use; (iv)&nbsp;identification of
whether it is operated by the Company or a Company Subsidiary (v)&nbsp;identification as owned in fee,
leased from Third Parties, or leased or subleased to a Third Party, (vi)&nbsp;the identification of the
Company Subsidiary or Company Subsidiaries which own or lease each Company Property, (vii)
identification of any minority interests, joint ventures, contracts of sale, options, management
contracts or other agreements whereby the Company or the Company Subsidiaries do not have one
hundred (100)&nbsp;percent ownership of the Company Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.17.1(b) of the Company Disclosure Schedule lists the Company Health Care
Facilities that are owned and operated by the Company or a Company Subsidiary (the &#147;<U>Company
Owned Health Care Facilities</U>&#148;) and sets forth for each such property the following: (i)&nbsp;the
facility number or other identification of each Company Owned Health Care Facility, (ii)&nbsp;the real
property tax or parcel identification number(s) associated with each Company Owned Health Care
Facility, (iii)&nbsp;identification as a skilled nursing home facility or assisted living facility (iv)
the number of beds for which the Company Owned Health Care Facility is licensed, and (v)&nbsp;the
licensed name.
</DIV>


<P align="center" style="font-size: 10pt">43
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Section&nbsp;4.17.1(c) of the Company Disclosure Schedule lists the Company Health Care
Facilities that are leased and operated by the Company or a Company Subsidiary (the &#147;<U>Company
Leased Health Care Facilities</U>&#148;) and sets forth for each such property the following: (i)&nbsp;the
facility number or other identification of each Company Leased Health Care Facility, (ii)&nbsp;the real
property tax or parcel identification number(s) associated with the Company Leased Health Care
Facility, if any, (iii)&nbsp;identification as a skilled nursing home facility or assisted living
facility, (iv)&nbsp;the number of beds for which the Company Leased Health Care Facility is licensed,
and (v)&nbsp;the licensed name.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Section&nbsp;4.17.1(d) of the Company Disclosure Schedule lists all other real property that
is owned and operated by the Company or a Company Subsidiary (the &#147;<U>Company Other Owned
Property</U>&#148;) and sets forth for each such property the following: (i)&nbsp;the facility number or
other identification of each such property, and (ii)&nbsp;the type of use for each such property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Section&nbsp;4.17.1(e) of the Company Disclosure Schedule lists all other real property that
is leased and operated by the Company or a Company Subsidiary (the &#147;<U>Company Other Leased
Property</U>&#148;) and sets forth for each such property the following: (i)&nbsp;the facility number or
other identification of each such property, and (ii)&nbsp;the type of use for each such property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The Company and the Company Subsidiaries do not (i)&nbsp;manage on behalf of any Third Party
any skilled nursing facility, assisted living facility or other business or (ii)&nbsp;own less than
100% of any Company Owned Property or 100% of the leasehold interest in any Company Leased
Property. The Company or the relevant Company Subsidiary own (A)&nbsp;an 11% fee interest in Facility
Number 2225 (as listed in Section&nbsp;4.17.1(a) of the Company Disclosure Schedule) and (B)&nbsp;a 60% land
trust interest in Facility Number 2588 (as listed in Section&nbsp;4.17.1(a) of the Company Disclosure
Schedule), each as reflected in Section&nbsp;4.17.1(a) of the Company Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Section&nbsp;4.17.1(g) of the Company Disclosure Schedule lists all other real property that
is owned, but not operated, by the Company or a Company Subsidiary (the &#147;<U>Company Owned But Not
Operated Property</U>&#148;) and sets forth for each such property the
</DIV>


<P align="center" style="font-size: 10pt">44
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">following: (i)&nbsp;the facility number or other identification of each such property, (ii)&nbsp;to
the Knowledge of the Company, the type of use for each such property, (iii)&nbsp;the name of the tenant
for such property, (iv)&nbsp;the expiration of the current term of the lease with such tenant, and (v)
the annual rent for such property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Section&nbsp;4.17.1(h) of the Company Disclosure Schedule lists all leased real property of
the Company or a Company Subsidiary that is subleased to a Third Party (the &#147;<U>Company Subleased
Property</U>&#148;) and sets forth for each such property the following: (i)&nbsp;the facility number or
other identification of each such property, (ii)&nbsp;to the Knowledge of the Company, the type of use
for each such property, and (iii)&nbsp;the name of the tenant for such property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.17.2 </I>The Company Owned Healthcare Facilities, the Company Other Owned Properties and
the Company Owned But Not Operated Properties are collectively referred to herein as the
&#147;<U>Company Owned Properties</U>.&#148; The Company Leased Health Care Facilities, the Company Other
Leased Properties, and the Company Subleased Properties are collectively referred to herein as the
&#147;<U>Company Leased Properties</U>.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.17.3 All Company Properties</I>. The Company Properties include all material interests
in real property necessary to conduct the business and operations of the Company and the Company
Subsidiaries in a manner substantially consistent with past practice. The Company or the
respective Company Subsidiary owns fee simple title to each of the Company Owned Properties and has
a valid leasehold interest in each of the Company Leased Properties free and clear of any rights of
way, easements, covenants, conditions, restrictions, other encumbrances, written agreements or
reservations of an interest in title (collectively, &#147;<U>Property Restrictions</U>&#148;), and other
Liens, except for the following (collectively, the &#147;<U>Permitted Liens</U>&#148;): (i)&nbsp;zoning
regulations, building codes and other land use laws regulating the use or occupancy of any of the
Company Properties or the activities conducted thereon provided same are not violated by the
existing improvements on or use of such Company Properties, (ii)&nbsp;Property Restrictions disclosed on
the Schedule&nbsp;B title exceptions to the 2005 title reports identified in Section&nbsp;4.17.1 of the
Company Disclosure Schedule that cover the Company Properties (in either case copies of which title
exceptions, and the available underlying title documents in connection therewith, reports and
surveys have been delivered or made available to
</DIV>


<P align="center" style="font-size: 10pt">45
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Parent), (iii)&nbsp;mechanics&#146;, carriers&#146;, workmen&#146;s, repairmen&#146;s and similar Liens, incurred in
the ordinary course of business; <I>provided</I>, that such Liens are either paid off, bonded or insured
over by the Title Company on or before the Closing, (iv)&nbsp;Liens for Taxes that are not yet due and
payable or the amount or validity of which is being contested in good faith by appropriate
proceedings; <I>provided</I>, that such Liens for contested Taxes are paid off, satisfied, removed from
record or insured over by the Title Company on or before the Closing, (v)&nbsp;in the case of the
Company Subleased Properties, the subleases identified in Section&nbsp;4.17.1(h) of the Company
Disclosure Schedule, (vi)&nbsp;in the case of the Company Owned But Not Operated Properties, the leases
identified in Section&nbsp;4.17.1(g) of the Company Disclosure Schedule, (vii)&nbsp;in the case of any
Company Leased Property, any lien or encumbrance against the fee, and (viii)&nbsp;any current Liens for
indebtedness for borrowed money related to the Company Owned Properties set forth in Section&nbsp;4.17.1
of the Company Disclosure Schedule, <I>provided, </I>that such indebtedness for borrowed money is paid off
and such Liens are satisfied, removed from record or insured over by the Title Company on or before
the Closing; <I>provided</I>, <I>further</I>, that no Lien or Property Restriction shall be a Permitted Lien if
it is reasonably expected to have a Company Material Adverse Effect. Except as identified in
Section&nbsp;4.17.3 of the Company Disclosure Schedule, neither the Company nor any Company Subsidiary
has received any written notice nor has Knowledge to the effect that (i)&nbsp;any condemnation or
rezoning proceedings are pending or threatened with respect to any of the Company Properties or
(ii)&nbsp;any zoning, building or similar requirement of any Governmental Entity is or will be violated
in any material respect for any property by the continued maintenance, operation or use of any
buildings or other improvements on any of the Company Properties or by the continued maintenance,
operation or use of the parking areas.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.17.4 Company Leased Properties. </I>The Company Leased Properties are leased or
licensed to, or occupied by, the Company or a Company Subsidiary pursuant to written leases,
subleases, licenses or occupancy agreements, true, correct and complete copies, including all
amendments thereto, and all overleases in the case of the Company Subleased Properties, of which
have been made available to Parent (each a &#147;<U>Lease</U>&#148; and collectively the &#147;<U>Leases</U>&#148;).
Except as otherwise set forth in Section&nbsp;4.17.4 of the Company Disclosure Schedule, with respect to
each of the Leases for the Company Leased Health Care Facilities, and each of
</DIV>


<P align="center" style="font-size: 10pt">46
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the material Leases for the Company Other Leased Properties and the Company Subleased
Properties, (i)&nbsp;each such Lease is valid, binding, enforceable and in full force and effect except
as limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
or other laws of general application referring to or affecting enforcement of creditors&#146; rights, or
by general equitable principles (regardless of whether enforcement is sought in a proceeding at law
or in equity); (ii)&nbsp;to the Knowledge of the Company, the Company&#146;s or the Company Subsidiary&#146;s
possession and quiet enjoyment of the leased premises under each such Lease (the &#147;<U>Leased
Premises</U>&#148;) has not been disturbed and there are no disputes with respect to each such Lease;
(iii)&nbsp;neither the Company nor any Company Subsidiary has subleased, licensed or otherwise granted
any Person the right to use or occupy the Leased Premises or any portion thereof, other than
residency by the Company&#146;s or any Company Subsidiaries&#146; respective patients or residents in such
capacity only and in the ordinary course of business; (iv)&nbsp;neither the Company nor any Company
Subsidiary has granted or entered into any so called &#147;life care agreements&#148; that are currently in
effect; (v)&nbsp;neither the Company nor any Company Subsidiary has mortgaged, collaterally assigned or
granted any other security interest in any Lease or any interest therein; (vi)&nbsp;all rent due and
owing by the Company or any Company Subsidiary under each Lease has been paid in full; and (vii)
neither the Company nor any Company Subsidiary has received any written notice to the effect that
any such Lease will not be renewed at the termination of the term thereof or that any such Lease
will be renewed only at a substantially higher rent. Section&nbsp;4.17.4(viii) of the Company
Disclosure Schedule sets forth the amount of each security deposit that was deposited with the
relevant landlord under each material Lease and the status thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.17.5 Provisions Affecting all Company Properties</I>. With respect to this Section
4.17.5, except as would not result in a Company Material Adverse Effect: (i)&nbsp;all structural,
mechanical and other physical systems, including but not limited to heating, ventilating, air
conditioning, plumbing, electrical, mechanical, parking, sewer and drainage systems at each Company
Property are in working condition or are undergoing repair or renovation in the ordinary course of
business; (ii)&nbsp;neither the Company nor any Company Subsidiary has received written notice from any
Governmental Entity or other entity having jurisdiction over any Company Property or any portion
thereof describing the violation of any
</DIV>


<P align="center" style="font-size: 10pt">47
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Laws relating to Other Company Permits or any Property Restrictions or other Liens affecting
any Company Property, which violation has not been resolved; (iii)&nbsp;the Company has obtained, or
caused the Company Subsidiaries to obtain, all Other Company Permits necessary for the operation of
the Company Properties, all of which are in full force and effect, and neither the Company nor any
Company Subsidiary has received any written notice from any Governmental Entity or other entity
having jurisdiction over any Company Property or any portion thereof describing a violation of or
threatening a suspension, revocation, modification or cancellation of any Other Company Permits;
(iv)&nbsp;there are no pending, or to the Company&#146;s Knowledge, threatened, condemnation, fire, health,
safety, building, zoning, land use, assessment, or similar proceedings relating to the Company
Property; (v)&nbsp;except for Permitted Liens, there are no parties other than the Company or a Company
Subsidiary in possession of any Company Property and there are no sublease, concession, occupancy,
license or similar arrangements affecting any Company Property (except for residency at any Company
Property by current residents or patients in such capacity only and in the ordinary course of
business); and (vi)&nbsp;no portion of the Company Property or any improvements or buildings thereon has
suffered any material damage by fire, earthquake, flood or other casualty which has not heretofore
been, or is not in the process of being, repaired and restored to operational use and in accordance
with applicable Legal Requirements and the requirements of any Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.18 <U>Board Approval</U>. On or prior to the date of this Agreement, the Company
Board has (i)&nbsp;received from each of Lehman Brothers, Inc., J.P. Morgan Securities, Inc. and CIBC
World Markets Corp. (the &#147;<U>Company Financial Advisors</U>&#148;) its opinion to the effect that, as
of the date of such opinion, the Merger Consideration is fair from a financial point of view to the
holders of Company Common Stock, (ii)&nbsp;determined that this Agreement and the transactions provided
for herein, including the Merger, are fair to and in the best interest of the Company and the
holders of Company Common Stock, and (iii)&nbsp;adopted resolutions (a)&nbsp;approving this Agreement, (b)
declaring this Agreement and the Merger advisable and (c)&nbsp;recommending to the holders of Company
Common Stock that they vote in favor of adopting this Agreement in accordance with the terms hereof
(the &#147;<U>Company Recommendation</U>&#148;). The Company Board has adopted the
resolution contemplated by Section&nbsp;1.3(ii)(z) of the Company Rights Agreement to
</DIV>

<P align="center" style="font-size: 10pt">48
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the effect that Parent, Merger Sub and their respective Affiliates and Associates shall not be, or be deemed
to be, the &#147;beneficial owners&#148; of any Company Common Stock as a result of the execution and
delivery of this Agreement or the consummation of the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.19 <U>Brokers</U>. No broker, finder, financial advisor, investment banker or
other Person (other than the Company Financial Advisors, the fees and expenses of which will be
paid by the Company) is entitled to any brokerage, finder&#146;s, financial advisor&#146;s or other similar
fee or commission in connection with the Merger based upon arrangements made by or on behalf of the
Company or any Company Subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.20 <U>Indebtedness</U>. Except for indebtedness for borrowed money set forth in
Section&nbsp;4.20 of the Company Disclosure Schedule (&#147;<U>Permitted Debt</U>&#148;), all indebtedness for
borrowed money of the Company and the Company Subsidiaries, and Liens securing such indebtedness,
may be prepaid, extinguished and released at or prior to the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.21 <U>Identifying Health Care Businesses; Licenses and Permits; Compliance with
Applicable Law; Health Care Regulation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.1 </I>Section&nbsp;4.21.1 of the Company Disclosure Schedule sets forth a complete list of
all Company Health Care Businesses and (i)&nbsp;the facility number or other identification of the
Company Health Care Business, (ii)&nbsp;the street address, city, county and state of the Company Health
Care Business, (iii)&nbsp;identification of the type of provider or supplier, (iv)&nbsp;identification of
ownership structure, whether owned, leased or subleased to a Third Party, (v)&nbsp;identification of the
Company Subsidiary which owns, leases or manages the Company Health Care Business, and which holds
the Company Health Care Permits therefor, (vi)&nbsp;identification of any minority interests, joint
ventures, contracts of sale, options, management contracts or other agreements whereby the Company
or the Company Subsidiaries do not have one hundred (100)&nbsp;percent ownership and operation of the
Company Health Care Business, and (vii)&nbsp;all intercompany agreements for provision of administrative services of
any nature.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.2 Health Care Regulatory Compliance</I>. The Company, each Company Subsidiary and
each Company Health Care Business is being operated in compliance
</DIV>


<P align="center" style="font-size: 10pt">49
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in all material respects with all Legal Requirements applicable to the operation of such Company Health Care Businesses, including,
but not limited to, Titles XVIII and XIX of the Social Security Act, the federal Anti-kickback
Statute (42 U.S.C. &#167; 1320a-7b(b)), the Stark Law (42 U.S.C. &#167; 1395nn), the civil False Claims Act
(31 U.S.C. &#167;&#167; 3729 <I>et seq</I>.), the administrative False Claims Law (42 U.S.C. &#167; 1320a-7b(a)), the
Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &#167; 1320d <I>et seq</I>.), the
exclusion laws (42 U.S.C. 1320a-7), or the regulations promulgated pursuant to such laws, and
comparable state laws, accreditation standards and all other state and federal laws and regulations
relating to the operation of such Company Health Care Businesses. Except as is otherwise described
in Section&nbsp;4.12, Section&nbsp;4.21.4 or Section&nbsp;4.21.9 of the Company Disclosure Schedule, neither the
Company nor any Company Subsidiary has received notice from a Governmental Entity that it is a
target of, or subject to any action, proceeding, suit, investigation or sanction by or on behalf of
any Governmental Entity or any other person brought pursuant to any Legal Requirement, nor, to the
Knowledge of the Company, has any such action, proceeding, suit, investigation or sanction been
threatened.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.3 </I>The Company and each Company Subsidiary are operating the Company Health Care
Businesses to comply in all material respects with all applicable contractual obligations, billing
policies, procedures, limitations and restrictions of any Company Health Care Program. All cost
reports and other required claims and filings with Governmental Entities with respect to Medicare
and each state Medicaid program in which the Company or any Company Subsidiary participates that
are required to be filed by or on behalf of the Company or any Company Subsidiary prior to the
Effective Time have been or will have been timely prepared and filed.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.4 </I>All Reimbursement Source Obligations of the Company and the Company
Subsidiaries have been recorded and, if required, reserved, on the Company&#146;s books and records and
on the Company&#146;s financial statements. Set forth in Section&nbsp;4.21.4 of the
Company Disclosure Schedule is a listing of each open Medicare and Medicaid cost report, and
all cost reporting appeals pending before the Medicare or Medicaid program as of June&nbsp;30, 2005, and
all proceedings of any nature with any Company Health Care Program regarding payment issues, and
all anticipated Significant aggregate &#147;periodic interim payment adjustments&#148; from the
</DIV>


<P align="center" style="font-size: 10pt">50
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">date hereof through the Closing. The Company has made provision to pay or otherwise liquidate in the ordinary
course, any liability on all as filed or settled cost reports based on Notices of Program
Reimbursement, or similar documents, received from Medicare or Medicaid for the cost-reporting
periods ended prior to June&nbsp;30, 2005. In the ordinary course under the periodic interim payment
methodology and post-payment medical review applicable to certain Company Health Care Businesses,
some Company Health Care Programs may make adjustments to reimbursement which may result in
Reimbursement Source Obligations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.5 </I>Except as listed in Section&nbsp;4.21.5 of the Company Disclosure Schedule, neither
the Company or any Company Subsidiary, nor any current director or employee of the Company or any
Company Subsidiary, nor any Covered Contractor, as defined in the corporate integrity agreement,
nor to the Knowledge of the Company, any other individual that although not a covered person under
the corporate integrity agreement, nonetheless participated in billings or related submissions by
the Company to federal health care programs, has been debarred, disqualified, suspended or excluded
from any Medicare, Medicaid or any other Company Health Care Program, including, without
limitation, under 42 U.S.C. 1320a-7, or from being a health care provider, owner, operator or
licensee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.6 </I>The Company and each Company Subsidiary are in compliance in all material
respects with all corporate integrity agreements, monitoring agreements, consent and settlement
orders, and similar agreements with or imposed by any Governmental Entity (collectively,
&#147;<U>Governmental Agreements</U>&#148;), all of which are set forth in Section&nbsp;4.21.6 of the Company
Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.7 </I>Section&nbsp;4.21.7 of the Company Disclosure Schedule sets forth a complete list of
each Company Health Care Permit applicable to each Company Health Care Business operated by the
Company and the Company Subsidiaries, each of which is in full force and effect. Each Company
Health Care Business satisfies the applicable Company Health Care Permit requirements of the state
in which such Company Health Care Business is located.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.8 </I>Section&nbsp;4.21.8 of the Company Disclosure Schedule sets forth the list of the
Provider Numbers assigned under Provider Agreements applicable to the Company Health Care
Businesses operated by the Company and the Company Subsidiaries and under
</DIV>


<P align="center" style="font-size: 10pt">51
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">which they are presently receiving payments. The Company and all Company Subsidiaries that operate the Company Health Care
Businesses are, to the extent required to conduct such businesses, certified for participation and
reimbursement under these Provider Agreements and any applicable managed care agreements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.9 </I>The Company Health Care Businesses may be subject to survey by Governmental
Entities which determine compliance with state and federal law and determine eligibility for
Company Health Care Permits and some Provider Agreements. Except as disclosed in Section&nbsp;4.21.9 of
the Company Disclosure Schedule, as of August&nbsp;9, 2005, and as of the Closing Date, no skilled
nursing facility had any material deficiencies at level G or above on its most recent survey
(standard or complaint), or has been cited with any Immediate Jeopardy or substandard quality of
care deficiencies (as that term is defined in Part&nbsp;488 of 42 C.F.R. and implementing policies and
procedures) and no other Company Health Care Business has been cited for any deficiency that would
result in a denial of payment for new admissions, civil monetary penalty, termination, loss of
Health Care Permits or Provider Agreements, decertification or debarment, with no opportunity to
correct prior to termination, for which an acceptable plan of correction has not been timely
submitted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;4.21.10 </I>The Company and each Company Subsidiary have maintained patient deposit funds
in escrow or trust accounts in material compliance with all Legal Requirements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.22 <U>Restricted Payments</U>. The Company has not made, offered or agreed to
offer anything of value to any governmental official, political party or candidate for government
office, nor has it otherwise taken any action that would cause the Company to be in violation of
the Foreign Corrupt Practices Act of 1977, as amended, or any law of similar effect. Neither the
Company nor any Company Subsidiary, nor, to the Knowledge of the Company, any director, officer,
agent, employee of the Company or any Company Subsidiary acting for or on behalf of the Company or
any Subsidiary, has paid or caused to be paid, directly or indirectly, in connection with the
business of the Company or any of the Company Subsidiaries: (i)&nbsp;any bribe, kickback, direct or
indirect unlawful payment or other similar payment to any Governmental Entity or any supplier or
agent of any supplier, or (ii)&nbsp;any contribution, payment, gift or entertainment to any political
party or candidate (other than from personal funds of directors,
officers or employees not reimbursed by their respective employers or other than in compliance with applicable Legal
Requirements).
</DIV>

<P align="center" style="font-size: 10pt">52
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.23 <U>OSHA</U>. Except as set forth in Section&nbsp;4.23 of the Company Disclosure
Schedule, the Company and the Facilities are in compliance, in all material respects, with the
Occupational Health and Safety Act (&#147;<U>OSHA</U>&#148;) and the Company is not subject to any
Significant Order or &#147;Cooperative Compliance Plan&#148; with respect to OSHA.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;5<BR>
Representations and Warranties of Parent and Merger Sub</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to such exceptions as are disclosed in the disclosure schedule (the &#147;<U>Parent
Disclosure Schedule</U>&#148;) delivered by Parent to the Company concurrently with the execution and
delivery of this Agreement (it being understood that the disclosure of any matter or item in the
Parent Disclosure Schedule shall not be deemed to constitute an acknowledgement that such matter or
item is required to be disclosed therein or is material to a representation or warranty set forth
in this Agreement and shall not be used as a basis for interpreting the terms &#147;material,&#148;
&#147;materially&#148; or &#147;materiality&#148; or any word or phrase of similar import), Parent and Merger Sub
jointly and severally represent and warrant to the Company as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.1 <U>Organization and Qualification</U>. Each of Parent and Merger Sub is a
corporation, duly organized, validly existing and in good standing under the laws of the State of
Delaware. Each of Parent and Merger Sub has the requisite power and authority and all necessary
governmental approvals to own, lease and operate its properties and to carry on its business as it
is now being conducted. Each of Parent and Merger Sub is duly qualified or licensed to do
business, and is in good standing, in each jurisdiction where the character of the properties
owned, leased or operated by it or the nature of its business makes such qualification, licensing or good standing necessary. Parent has
heretofore made available to the Company complete and correct copies of the certificate of
incorporation and by-laws of Parent and Merger Sub, together with all amendments thereto, as
currently in effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.2 <U>Authority</U>. Each of Parent and Merger Sub has all necessary corporate
power and authority to execute and deliver this Agreement, to perform its obligations hereunder and
to consummate the transactions provided for herein. The execution and delivery of this Agreement,
</DIV>

<P align="center" style="font-size: 10pt">53
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">by each of Parent and Merger Sub, and the consummation by Parent and Merger Sub of the transactions
provided for herein have been duly and validly authorized by all necessary corporate action on the
part of Parent and Merger Sub, and no other corporate proceedings on the part of Parent or Merger
Sub and no vote of Parent&#146;s stockholders are necessary to authorize this Agreement or to consummate
the transactions provided for herein. This Agreement has been duly authorized and validly executed
and delivered by Parent and Merger Sub and, assuming this Agreement is a valid and binding
obligation of the Company and the other Parties, this Agreement constitutes a legal, valid and
binding obligation of Parent and Merger Sub, enforceable against each of them in accordance with
its terms, subject to the Bankruptcy and Equity Exception.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.3 <U>No Conflict; Required Filings and Consents</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;5.3.1 </I>The execution, delivery and performance by Parent and Merger Sub of this
Agreement do not (i)&nbsp;conflict with or violate any provision of the certificate of incorporation or
by-laws of Parent or Merger Sub, (ii)&nbsp;assuming that all consents, approvals, authorizations and
Company Health Care Permits described in Section&nbsp;5.5 will have been obtained prior to the Effective
Time and all filings and notifications described in Section&nbsp;5.5 will have been made and any waiting
periods thereunder will have terminated or expired prior to the Effective Time, conflict with or
violate, in any material respect, any Law applicable to any member of the Parent Group or by which
any material property or asset of any member of the Parent Group is bound or affected or (iii)
result in any material breach of, any loss of any material benefit under, constitute a default (or
an event which with notice or lapse of time or both would become a default) under, or give to others any right of termination, amendment,
acceleration or cancellation of, or result in the creation of a lien or other encumbrance on any
material property or asset of Parent or Merger Sub pursuant to any Contract.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;5.3.2 </I>The execution, delivery and performance by Parent and Merger Sub of this
Agreement do not require any consent, approval, authorization or permit of, or material filing with
or notification to, any Governmental Entity or other Person, except (i)&nbsp;under the Exchange Act, any
applicable Blue Sky Laws, the rules and regulations of the NYSE, the HSR Act or any other
antitrust, competition, trade or other regulatory Laws, (ii)&nbsp;the filing and recordation of the
Certificate of Merger as required by the DGCL, (iii)&nbsp;under any Company
</DIV>


<P align="center" style="font-size: 10pt">54
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Health Care Program or as required to transfer or continue operation under a Company Health Care Permit, or (iv)&nbsp;with respect
to matters other than those referred to in the previous clauses (i), (ii)&nbsp;and (iii), where failure
to obtain such consents, approvals, authorizations or to make such filings or notifications would
not (a)&nbsp;prevent or materially delay the consummation of the Merger, (b)&nbsp;otherwise prevent or
materially delay performance by Parent or Merger Sub of any of its material obligations under the
Agreement, (c)&nbsp;prohibit the ability to obtain Government Consents with respect to any Company
Health Care Program or Company Health Care Facilities or transfer of any Company Health Care Permit
or (d)&nbsp;result in a material violation of any Legal Requirement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.4 <U>Compliance With Laws</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;5.4.1 General</I>. No member of the Parent Group has been debarred, disqualified,
suspended or excluded from any Medicare, Medicaid or any other health care program, including,
without limitation, under Section&nbsp;42 USC 1320a-7, or from being a health care provider, owner,
operator or licensee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;5.4.2 Adverse Actions</I>. There are no claims, actions, litigations, inquiries,
proceedings, notices of noncompliance, demand letters, audits or investigations pending or, to the
Knowledge of Parent, threatened with respect to a violation by any member of the Parent Group of
any Legal Requirement which would materially impair or delay the ability of Parent to satisfy the
condition set forth in Section&nbsp;7.1.3(ii).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.5 <U>Health Care Licensing</U>. To the Knowledge of the Parent Group, there is no
fact, event or circumstance relating to any member of the Parent Group that would reasonably be
expected to prevent Parent or the Company from obtaining or maintaining all Company Health Care
Permits necessary for the lawful conduct of the business of the Surviving Corporation or ownership
of the Surviving Corporation&#146;s assets and properties (excluding, however, any conditions, facts,
events or circumstances relating to the Company or any Company Subsidiary prior to the Effective
Time).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.6 <U>Litigation</U>. There is no suit, claim, action, proceeding or investigation
pending or, to the Knowledge of Parent, threatened against Parent or Merger Sub and neither Parent
nor Merger Sub is subject to any outstanding Order. As of the date hereof, (i)&nbsp;there is no
</DIV>

<P align="center" style="font-size: 10pt">55
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">suit, claim, action, proceeding, arbitration or investigation pending or to the Knowledge of Parent,
threatened against Parent or Merger Sub which seeks to, or would reasonably be expected to,
restrain, enjoin or delay the consummation of the Merger or any of the other transactions provided
for herein or which seeks damages in connection therewith and (ii)&nbsp;no injunction has been entered
or issued with respect to the transactions provided for herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.7 <U>Ownership of Merger Sub; No Prior Activities</U>. Parent owns one hundred
(100)&nbsp;percent of the issued and outstanding capital stock of Merger Sub. Each of Parent and Merger
Sub was formed solely for the purpose of engaging in the transactions contemplated by this
Agreement. Except for obligations or liabilities incurred in connection with its formation and the
transactions contemplated by this Agreement, Merger Sub has not and will not have incurred,
directly or indirectly, through any Company Subsidiary or Affiliate, any obligations or liabilities
or engaged in any business activities of any type or kind whatsoever or entered into any agreements
or arrangements with any Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.8 <U>Financing</U>. Parent has delivered to the Company true, complete and correct
signed counterparts of (i)&nbsp;debt commitment letters by and between SBEV and Wachovia Bank, National
Association on the one hand, and SBEV and CapitalSource Finance LLC, on the other, pursuant to
which the lenders party thereto have agreed, subject to the terms and conditions set forth therein,
to provide or cause to be provided, debt financing in connection with the transactions provided for
herein (together with the updates thereto, as contemplated herein, the &#147;<U>Debt Commitment Letters</U>&#148;) and (ii)&nbsp;the equity commitment letter, dated as of
the date hereof, by and between SBEV and
Rubin Schron, pursuant to which Mr.&nbsp;Schron
has agreed, subject to the terms and conditions set forth therein, to provide, equity financing in
connection with the transactions provided for herein to SBEV (together with the
updates thereto, as contemplated herein, the &#147;<U>Equity Commitment
Letter</U>&#148; and, together with the Debt Commitment Letters, the &#147;<U>Commitments</U>&#148;). Subject to
such amendments to which the Company provides its prior written consent or for which such consent
is not required pursuant to Section&nbsp;6.14, such consent not to be unreasonably withheld, the
Commitments have not been amended and are (solely to the Knowledge of Parent and Merger Sub, in the
case of the Debt Commitment letters) in full force and effect. The Commitments are subject to no
contingencies or conditions other than those set forth in the copies thereof delivered to the
Company. No event has occurred which, with or without notice, lapse of time or both, would
constitute a default or breach on the part of SBEV,
</DIV>

<P align="center" style="font-size: 10pt">56
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Parent or Merger Sub under any term or condition of the Commitments. Parent has no reason to believe that it or SBEV will be unable to
satisfy on a timely basis any term or condition of closing to be satisfied by it or SBEV contained
in the Commitments. Parent or SBEV has fully paid any and all commitment fees and other fees
required by the Commitments to be paid as of the date hereof. Subject to the terms and conditions
of the Commitments and this Agreement, the Commitments would provide Parent and SBEV with financing
at the Effective Time sufficient to (i)&nbsp;consummate the Merger upon the terms contemplated by this
Agreement, (ii)&nbsp;effect any other repayment or refinancing of debt contemplated in connection with
the Merger or the Commitments, and (iii)&nbsp;pay all related fees and expenses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.9 <U>Vote Required</U>. No vote of the holders of any class or series of capital
stock or other Equity Interests of Parent or Merger Sub is necessary to approve the Merger (other
than in the case of Merger Sub, any required vote by Parent as the holder of one hundred (100)
percent of Merger Sub&#146;s Equity Interests).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.10 <U>Brokers</U>. No broker, finder, financial advisor, investment banker or other Person (other than
Wachovia Securities and MetCap Securities LLC, the fees and expenses of which will be paid by
Parent) is entitled to any brokerage, finder&#146;s, financial advisor&#146;s or other similar fee or
commission in connection with the Merger based upon arrangements made by or on behalf of Parent or
Merger Sub.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.11 <U>Ownership of Company Common Stock</U>. Neither Parent nor Merger Sub is, nor
at any time during the last three (3)&nbsp;years has been, an &#147;interested stockholder&#148; of the Company as
defined in Section&nbsp;203 of the DGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.12 <U>Solvency of the Surviving Corporation</U>. Immediately after giving effect
to the transactions contemplated by this Agreement and actions taken in connection with the
financing of these transactions, and assuming the accuracy in all material respects as of the
Closing Date of the representations and warranties contained in Article&nbsp;4, (i)&nbsp;each of the
Surviving Corporation and its Subsidiaries will not have incurred debts beyond its ability to pay
such debts as they mature or become due, (ii)&nbsp;the then present fair salable value of the assets of
each of the Surviving Corporation and its Subsidiaries will exceed the amount that will be required
to pay their probable liabilities (including the amount necessary to provide for
</DIV>

<P align="center" style="font-size: 10pt">57
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">contingent liabilities) and their respective debts as they become absolute and mature, (iii)&nbsp;the assets of
each of the Surviving Corporation and its Subsidiaries, in each case at a fair valuation, will
exceed their respective debts (including the amount necessary to provide for contingent
liabilities) and (iv)&nbsp;each of the Surviving Corporation and its Subsidiaries will not have
unreasonably small capital to carry on their respective business, either (a)&nbsp;as presently conducted
or (b)&nbsp;as intended by Parent to be conducted. No transfer of property is being made and no
obligation is being incurred in connection with the transactions contemplated by this Agreement
with the intent to hinder, delay or defraud any present or future creditors of the Surviving
Corporation and its Subsidiaries.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;6<BR>
Covenants</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.1 <U>Conduct of Business by the Company Pending the Closing</U>. The Company agrees that, between the date of this Agreement and the Effective Time, except
as set forth in Section&nbsp;6.1 of the Company Disclosure Schedule, as otherwise contemplated by this
Agreement, as required by applicable Law, a pre-existing contractual obligation disclosed in the
Company Disclosure Schedule, or as consented to in writing by Parent (such consent not to be
unreasonably withheld or delayed), the Company will, and will cause each Company Subsidiary to, in
all material respects (it being understood that in no event shall the Company&#146;s participation in
the negotiation (including activities related to due diligence), execution, delivery or public
announcement (in accordance with this Agreement) or the pendency of this Agreement or the
transactions contemplated hereby or any actions taken in good faith compliance herewith or the
consequences thereof on the respective businesses of the Company and the Company Subsidiaries, be
considered a breach of any of the provisions of this Section&nbsp;6.1), (i)&nbsp;conduct its business
substantially in the ordinary course consistent with past practice and (ii)&nbsp;use commercially
reasonable best efforts to keep available the services of the current officers, key employees and
consultants of the Company and each Company Subsidiary and to preserve the current relationships of
the Company and each Company Subsidiary with such of the customers, suppliers and other Persons
with which the Company or any Company Subsidiary has significant business relations as is
reasonably necessary to preserve substantially intact its business organization. Without limiting
the foregoing, and as an extension thereof, except as set forth in
</DIV>

<P align="center" style="font-size: 10pt">58
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section&nbsp;6.1 of the Company
Disclosure Schedule, as otherwise contemplated by this Agreement, as required by applicable Law or
a pre-existing contractual obligation disclosed in the Company Disclosure Schedule, or as consented
to in writing by Parent (such consent not to be unreasonably withheld or delayed), the Company
shall not, and shall not permit any Company Subsidiary to, between the date of this Agreement and
the Effective Time, directly or indirectly, do, or agree to do, any of the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;amend or otherwise change the Company Certificate, the Company By-laws or equivalent
organizational documents;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;issue, deliver, sell, pledge or encumber, or authorize, propose or agree to the issuance,
delivery, sale, pledge or encumbrance of, any shares of its capital stock, or securities
convertible into or exchangeable for, or options, warrants, calls, commitments or rights of any
kind to acquire, any shares of any class or series of its capital stock (other than pursuant to
the exercise of options, warrants, conversion rights and other contractual rights existing on
the date hereof);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;declare, set aside, make or pay any dividend or other distribution (whether payable in
cash, stock, property or a combination thereof) with respect to any of its capital stock (other
than dividends paid by a wholly-owned Company Subsidiary to the Company or to any other
wholly-owned Company Subsidiary) or enter into any agreement with respect to the voting of its
capital stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;reclassify, combine, split, subdivide or redeem, purchase or otherwise acquire, directly
or indirectly, any of its capital stock or other Equity Interests, except pursuant to the exercise
of options, warrants, conversion rights, employee severance, retention, termination, change of
control and other contractual rights existing on the date hereof;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;acquire (including, without limitation, by merger, consolidation, or acquisition of stock
or assets), outside of the ordinary course of business, any interest in any Person or any division
thereof or any assets, other than any acquisitions that are in progress on the date hereof and
identified by the letters of intent or expressions of interest listed in Section&nbsp;6.1(e) of the
Company Disclosure Schedule;
</DIV>



<P align="center" style="font-size: 10pt">59
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;incur any indebtedness for borrowed money or issue any debt securities or assume,
guarantee or endorse, or otherwise as an accommodation become responsible for, the obligations of
any Person (other than a wholly-owned Company Subsidiary) for borrowed money, except for (i)
indebtedness for borrowed money incurred in the ordinary course of business, pursuant to existing
credit lines disclosed in Section&nbsp;6.1(f) of the Company Disclosure Schedule, (ii)&nbsp;indebtedness for
borrowed money (other than indebtedness for borrowed money owing by any wholly-owned Company
Subsidiary to the Company or any other wholly-owned Company Subsidiary) with a maturity of not more
than one year in a principal amount not, in the aggregate, in excess of $25,000,000 for the Company
and the Company Subsidiaries taken as a whole, in each case which can be prepaid without premium or
penalty, and all Liens securing such indebtedness for borrowed money released, at or prior to the
Closing, (iii)&nbsp;indebtedness for borrowed money owing by any wholly-owned Company Subsidiary to the
Company or any other wholly-owned Company Subsidiary and (iv)&nbsp;indebtedness for borrowed money incurred with respect
to actions permitted pursuant to Section&nbsp;6.1 of the Company Disclosure;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;grant any Lien in any of its material assets to secure any indebtedness for borrowed
money, except in connection with such indebtedness permitted under the preceding clause (f);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;issue any debt securities or assume, endorse, or otherwise become responsible for, the
obligations of any person, or make any loans or advances, except in the ordinary course of business
and consistent with past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;except to the extent the amount is reflected in the 2005 and 2006 capital expenditure
budgets provided to Parent, authorize, or make any commitment with respect to, any single capital
expenditure which is in excess of $5,000,000 or capital expenditures which are, in the aggregate,
in excess of $15,000,000 for the Company and the Company Subsidiaries taken as a whole other than
emergency repairs and repairs compelled by (i)&nbsp;legal or safety requirements, (ii)&nbsp;existing leases
or consent requirements thereof, or (iii)&nbsp;up to $15,000,000 to remedy exceptions of title necessary
to meet any condition contained in Article&nbsp;7 hereof, and the Company shall consult with Parent on
all such items in excess of budget;
</DIV>


<P align="center" style="font-size: 10pt">60
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;enter into any new line of business outside of its existing business segments;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;make investments in persons other than wholly-owned Company Subsidiaries, other than
ordinary course cash management investments in accordance with the Company&#146;s existing investment
policy;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;adopt or amend any material Company Benefit Plan, increase in any material manner the
compensation or fringe benefits of any director, officer or employee of the Company or pay any
material benefit not provided for by any existing Company Benefit Plan, in each case except (i)&nbsp;as
set forth in Section&nbsp;6.1(l) of the Company Disclosure Schedule, (ii)&nbsp;as reasonably necessary to
comply with applicable Law, (iii)&nbsp;in the ordinary course of business (including without limitation
to address the requirements of written agreements or contracts the Company and each Company
Subsidiary has entered into as of the date hereof), (iv)&nbsp;in connection with entering into, with
respect to newly hired employees, or extending with respect
to existing employees, any employment or other compensatory agreements with individuals (other
than the named executive officers (as such term is used in Item&nbsp;402 of Regulation&nbsp;S-K promulgated
under the Exchange Act) or directors of the Company or any Company Subsidiary) in the ordinary
course of business, consistent with the Company&#146;s 2005 and 2006 budgets provided to Parent and past
practice, and comparable to compensatory amounts for individuals of similar responsibility in the
Company (v)&nbsp;in connection with entering into any retention agreements or programs determined by the
Board of Directors of the Company as being reasonably necessary in order to maintain its business
operations prior to, and extending through, the Effective Time, <I>provided</I>, that any retention
payments thereunder shall not be made payable to any Company employee with a title of Vice
President or higher nor exceed $5,000,000 in the aggregate, subject in each case to Parent&#146;s
approval, such approval not to be unreasonably withheld, (vi)&nbsp;general compensation increases in the
ordinary course of business consistent with past practice or (vii)&nbsp;the termination or amendment of
any Company Benefit Plan that may be subject to Code Section&nbsp;409A consistent with Code Section&nbsp;409A
and any guidance issued thereunder, <I>provided</I>, that such amendment does not result in an increase in
benefits payable under the applicable Company Benefit Plan;
</DIV>


<P align="center" style="font-size: 10pt">61
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;pay, discharge, settle or satisfy any material claims, liabilities or obligations
(absolute, accrued, contingent or otherwise), other than (i)&nbsp;performance of contractual obligations
in accordance with their terms, (ii)&nbsp;payment, discharge, settlement or satisfaction in the ordinary
course of business or (iii)&nbsp;payment, discharge, settlement or satisfaction in accordance with their
terms, of claims, liabilities or obligations (x)&nbsp;disclosed or reserved in the most recent financial
statements (or the notes thereto) of the Company included in the Company SEC Filings filed prior to
the date hereof or contemplated by documents made available to Parent prior to the date hereof or
(y)&nbsp;incurred since the date of such financial statements in the ordinary course of business;
<I>provided, however, </I>that any such amounts paid pursuant to clause (ii)&nbsp;or (iii), individually or in
the aggregate, in excess of $15,000,000 above the amounts so disclosed or reserved or, shall
require the consent of Parent (such consent not to be unreasonably withheld, conditioned or
delayed);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;except as otherwise contemplated by this Agreement, including Sections&nbsp;6.1(e) and 6.4, or
as otherwise required by Law or Governmental Entity, adopt or enter into a
plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring,
recapitalization or other reorganization of the Company or any Company Subsidiary (other than the
Merger);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;file any Tax Return taking a position inconsistent with the Company&#146;s or any Company
Subsidiaries&#146; past practice, except as required by Law; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p)&nbsp;knowingly commit or agree to take any of the foregoing actions or any action which would
result in any representation or warranty of the Company contained in this Agreement which is
qualified as to materiality becoming untrue as of the Effective Time or any representation not so
qualified becoming untrue in any material respect as of the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.2 <U>Proxy Statement; Company Stockholders&#146; Meeting</U>.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.2.1
Proxy Statement</I>. Subject to the prior performance by Parent of its obligations
under Section&nbsp;6.18 to (A) make the Subsequent BIF Deposit or deliver the Letter of Credit, and (B) provide the updated Equity Commitment Letter,
the Company shall, as promptly as practicable after the execution of this Agreement but in no event later than
the later of (x)&nbsp;50&nbsp;days after the date of this Agreement and (y)&nbsp;ten (10)&nbsp;days after receipt of both (1)
the Subsequent BIF Deposit or Letter of Credit and (2) updated Debt Commitment Letters with any due diligence conditions deleted, the Company shall, with the
</DIV>


<P align="center" style="font-size: 10pt">62
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">assistance and approval
(not to be unreasonably withheld or delayed) of Parent, prepare and file with the SEC a proxy
statement relating to the Company Stockholders&#146; Meeting (together with any amendments thereof or
supplements thereto, the &#147;<U>Proxy Statement</U>&#148;); <I>provided</I>, that the Company shall not be
responsible for any delay in the filing date due to any review by Parent. Parent and the Company
will cooperate with each other in the preparation of the Proxy Statement. The Company, after
consultation with Parent, will use commercially reasonable best efforts to respond to any comments
made by the SEC with respect to the Proxy Statement. Without limiting the generality of the
foregoing: (i)&nbsp;the Company will provide Parent with a reasonable opportunity to review and comment
on the Proxy Statement, any comments made by the SEC with respect to the Proxy Statement and any
proposed amendments to the Proxy Statement, and (ii)&nbsp;Parent and Merger Sub shall furnish all
information as the Company may reasonably request in connection with such actions and the
preparation of the Proxy Statement. As promptly as practicable after the clearance of the Proxy
Statement by the SEC, the Company shall mail the Proxy Statement to the holders of shares of Company Common Stock. Subject to
Section&nbsp;6.4.2, the Proxy Statement shall include the Company Recommendation. The Company will
advise Parent, promptly after it receives notice thereof, of any request by the SEC for amendment
of the Proxy Statement or comments thereon and responses thereto or requests by the SEC for
additional information. If at any time prior to the Company Stockholders Meeting, any event or
circumstance relating to Parent or Merger Sub, or their respective officers or directors, should be
discovered by Parent which should be set forth in an amendment or a supplement to the Proxy
Statement, Parent shall promptly inform the Company. If at any time prior to the Company
Stockholders Meeting, any event or circumstance relating to the Company or any Company Subsidiary,
or their respective officers or directors, should be discovered by the Company which should be set
forth in an amendment or a supplement to the Proxy Statement, the Company shall promptly inform
Parent. All documents that the Company is responsible for filing in connection with the
transactions contemplated herein will comply as to form and substance in all material respects with
the applicable requirements of the Exchange Act and other applicable Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.2.2 Information Supplied by Parent</I>. None of the written information supplied or to
be supplied by Parent or any of its Affiliates, directors, officers, employees, agents
</DIV>


<P align="center" style="font-size: 10pt">63
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or Representatives expressly for inclusion or incorporation by reference in the Proxy Statement or any
other documents filed or to be filed with the SEC in connection with the transactions contemplated
hereby, will, as of the time such documents (or any amendment thereof or supplement thereto) are
mailed to the holders of shares of Company Common Stock and at the time of the Company
Stockholders&#146; Meeting, contain any untrue statement of a material fact, or omit to state any
material fact required to be stated therein in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. All documents that Parent or Merger
Sub is responsible for filing with the SEC in connection with the Merger will comply as to form in
all material respects with the applicable requirements of the Securities Act and the Exchange Act
and will not contain any untrue statement of a material fact, or omit to state any material fact
required to be stated therein in order to make the statements therein, in light of the
circumstances under which they were made, not misleading.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.2.3 Stockholders&#146; Meeting.
Subject to Section&nbsp;6.4 and (i) Parent&#146;s prior performance of its obligation under Section&nbsp;6.18
to make the Subsequent BIF Deposit or deliver the Letter of Credit and deliver the updated Equity Commitment Letter and (ii) to receipt of the updated Debt Commitment Letters described in Section 6.2.1, and whether or not the Company&#146;s
Board has made, modified or withdrawn a Company Recommendation or a Company Adverse Recommendation Change,
the Company shall call and hold a meeting of its stockholders (the &#147;<U>Company Stockholders&#146;
Meeting</U>&#148;) as promptly as practicable following the date on which the Proxy Statement
is cleared by the SEC for the purpose of obtaining the Stockholder Approval.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.2.4 No Restriction.
Nothing in this Section&nbsp;6.2 shall be deemed to prevent the Company or the
Company Board from taking any action they are permitted or required to take
under, and in compliance with, Section&nbsp;6.4 or are required to take under
applicable Law. Nothing contained in this Agreement shall give Parent or
Merger Sub, directly or indirectly, the right to control or direct the Company&#146;s
or Company Subsidiaries&#146; operations prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.3 <U>Access to Information; Confidentiality</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.3.1 Access to Information</I>. From the date of this Agreement to the Effective Time,
the Company shall, and shall cause each Company Subsidiary and each of its and their respective
directors, officers, employees, accountants, consultants, legal counsel,
</DIV>


<P align="center" style="font-size: 10pt">64
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">advisors, and agents and other representatives (collectively, &#147;<U>Company Representatives</U>&#148;) to: (i)&nbsp;provide to Parent
and Merger Sub and each of their respective officers, directors, employees, accountants,
consultants, legal counsel, advisors, agents and other representatives (collectively, &#147;<U>Parent
Representatives</U>&#148;) access at reasonable times during normal business hours, upon prior notice to
a Company Representative designated in Section&nbsp;6.3.1 of the Company Disclosure Schedule, to the
officers, employees, agents, properties, offices and other facilities of the Company or such
Company Subsidiary and to the books and records thereof and (ii)&nbsp;furnish or cause to be furnished
such reasonably available information concerning the business, properties, Contracts, assets,
liabilities, personnel and other aspects of the Company and the Company Subsidiaries as Parent,
Merger Sub or the Parent Representatives may reasonably request. From the date of this Agreement
to the Effective Time, Parent shall, and shall cause Merger Sub and
the Parent Representatives to, (i)&nbsp;provide the Company and the Company Representatives access
at reasonable times during normal business hours, upon prior notice, to the officers, employees,
agents, properties, offices and other facilities of Parent and Merger Sub and to the books and
records thereof and (ii)&nbsp;furnish or cause to be furnished such reasonably available information
concerning the business, properties, Contracts, assets, liabilities, personnel and other aspects of
Parent and Merger Sub as the Company or the Company Representatives may reasonably request,
including for the purpose of confirming that Parent is in compliance with its obligations under
Section&nbsp;6.5 and confirming satisfaction of the condition contained in Section&nbsp;7.3.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.3.2 Confidentiality and Restrictions</I>. With respect to the information disclosed
pursuant to Section&nbsp;6.3.1, the Parties shall comply with, and shall cause their respective
Representatives to comply with, all of their respective obligations under the confidentiality
agreement, dated as of March&nbsp;23, 2005, between the Company and Parent (as such agreement may be
amended from time to time, the &#147;<U>Confidentiality Agreement</U>&#148;) or any similar agreement
entered into between the Company and any Person to whom the Company, any Company Subsidiary or any
Company Representative provides information pursuant to this Section&nbsp;6.3, it being understood and
agreed by the Parties that, notwithstanding Section&nbsp;6.3.1, (i)&nbsp;the Company, the Company
Subsidiaries and the Company Representatives shall have no obligation to furnish, or provide any
access to, any information to any Person not a party to the Confidentiality Agreement or any
similar agreement with respect to such information, (ii)&nbsp;Section&nbsp;6.3.1 shall not
</DIV>


<P align="center" style="font-size: 10pt">65
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">require the Company to take or allow actions that would unreasonably interfere with the Company&#146;s or any
Company Subsidiary&#146;s operation of its business and (iii)&nbsp;the Company shall not be required to provide access to or furnish any information if to do so would contravene any agreement to which
the Company or any Company Subsidiary is party as of the date hereof or violate any Law, or where
such access to information may involve the waiver of a disclosure of privilege or be otherwise
adverse to the interests of the Company or any Company Subsidiary.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.4 <U>No Solicitation of Transactions</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.4.1 </I>The Company shall, and shall cause each Company Subsidiary, and shall direct,
and shall use commercially reasonable best efforts to cause, the Company
Representatives to, immediately cease and cause to be terminated any discussions or
negotiations with any parties (other than Parent, Merger Sub and the Parent Representatives) that
may be ongoing with respect to a Takeover Proposal. The Company shall not, and shall cause each
Company Subsidiary not to, and shall direct, and shall use commercially reasonable best efforts to
cause, the Company Representatives not to, (i)&nbsp;directly or indirectly solicit, initiate, knowingly
encourage or knowingly facilitate any inquiries regarding the making, submission or reaffirmation
of any Takeover Proposal, (ii)&nbsp;approve, recommend to the Company&#146;s Stockholders, or enter into any
agreement, understanding, arrangement, agreement in principle, term sheet or letter of intent with
respect to a Takeover Proposal or (iii)&nbsp;participate in any way in any negotiations or discussions
regarding, or furnish or disclose any information, or provide access to its properties, books or
records, to any Third Party relating to any Takeover Proposal; <I>provided</I>, <I>however</I>, that at any time
prior to obtaining the Stockholder Approval, in response to a bona fide written Takeover Proposal
that was not solicited after the date hereof by the Company, a Company Subsidiary, or a Company
Representative on its behalf, if the Company Board determines in good faith, after consultation
with its outside legal counsel, that such action is necessary in order for the Company Board to
comply with its fiduciary duties to the holders of Company Common Stock under applicable law and,
after consultation with the Company Board&#146;s outside legal counsel and the Company&#146;s financial
advisors, that such Takeover Proposal constitutes, or is reasonably likely to result in, a Superior
Proposal, the Company may, subject to compliance with Section&nbsp;6.4.2 in the circumstances set forth
therein, (i)&nbsp;furnish information and/or draft agreements with respect to the Company and the
Company Subsidiaries
</DIV>


<P align="center" style="font-size: 10pt">66
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to the Person making such Takeover Proposal (and its officers, directors,
employees, accountants, consultants, legal counsel, advisors, agents and other representatives)
pursuant to a customary confidentiality agreement not less favorable to the Company than the
Confidentiality Agreement; <I>provided</I>, that all such information and the material terms of any such
draft agreements have previously been made available to Parent or is made available to Parent prior
to, or concurrently with, the time it is provided to such Person and (ii)&nbsp;participate in
discussions or negotiations with the Person making such Takeover Proposal (and its officers,
directors, employees, accountants, consultants, legal counsel, advisors, agents and other
representatives) regarding such Takeover Proposal.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.4.2 </I>Notwithstanding any provision of this Section&nbsp;6.4 to the contrary, provided that
the Company has complied in all material respects with its obligations under this Section&nbsp;6.4, the
Company Board may (i)&nbsp;withdraw or modify in a manner adverse to Parent (or not continue to make)
the Company Recommendation, and/or (ii)&nbsp;approve or recommend a Takeover Proposal (any action
described in clause (i)&nbsp;or this clause (ii), a &#147;<U>Company Adverse Recommendation Change</U>&#148;), if
(x)&nbsp;the Company Board has determined in good faith after consultation with its financial advisors
and outside legal counsel, that, to the extent such action relates to a Takeover Proposal, any
Takeover Proposal constitutes a Superior Proposal and, after consultation with the Company Board&#146;s
outside legal counsel, that taking such action is necessary for the members of the Company Board to
comply with their fiduciary duties to the holders of shares of Company Common Stock under
applicable Law, and (y)&nbsp;the Company has given Parent five (5)&nbsp;Business Days prior written notice of
its intention to take such action and the Company Board shall have considered in good faith any
proposed changes to this Agreement proposed in writing by Parent (<I>provided</I>, <I>however</I>, that Parent
shall not relinquish any rights or be relieved of any obligations arising under this Agreement as a
result of submitting any proposed changes to this Agreement; <I>provided</I>, <I>further</I>, that nothing herein
shall preclude Parent from terminating this Agreement to the extent entitled to do so pursuant to
Section&nbsp;8.1 hereof) and, after negotiating in good faith with Parent concerning any such proposed
changes during such five (5)&nbsp;Business Day period and after consultation with its outside legal
counsel and financial advisors, shall have determined, other than in the case of an action
described in clause (i)&nbsp;that does not relate to a Takeover Proposal, that the Takeover Proposal
would still constitute a
</DIV>


<P align="center" style="font-size: 10pt">67
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Superior Proposal even if such changes were to be given effect. Notwithstanding the foregoing, if the Company shall deliver the written notice specified in clause (y) of the preceding sentence on or before August 18, 2005, the five (5) Business Day period described therein shall be deemed to expire at noon New York City time on August 23, 2005. Any
Takeover Proposals, bids, offers or other proposals already received by the Company, any Company
Subsidiary or any Company Representatives prior to the date of this Agreement and/or during the bid
process shall be deemed not to be Superior Proposals or reasonably likely to constitute a Superior
Proposal. Subject to Parent&#146;s prior performance of its obligation under Section&nbsp;6.18 to make the
Subsequent BIF Deposit or deliver the Letter of Credit, unless this Agreement has previously been
terminated pursuant to Section&nbsp;8.1, whether or not the Company&#146;s Board has made a Company Adverse
Recommendation Change, or has withdrawn, modified or changed in any manner adverse to the interests
of Parent, the Company Recommendation, or the Company Board has made a Company Adverse Recommendation Change with respect to the Merger, this
Agreement or the transactions contemplated by this Agreement, the Company shall take all steps
necessary (including, without limitation, the preparation (as promptly hereafter as practicable) to
file with the SEC of a Proxy Statement and to duly call, give notice of, convene and hold a Company
Stockholders Meeting to approve the Merger in accordance with this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provision of this Section&nbsp;6.4 to the contrary, if the Company Board has
made a Company Adverse Recommendation Change in compliance with this Section&nbsp;6.4.2, and if the
Company Stockholders&#146; Meeting has been held, a vote has been taken on this Agreement and the
Merger, and Stockholder Approval has not been obtained, the Company Board may terminate this
Agreement in accordance with the provisions of Section&nbsp;8.1(c)(ii) in order to enter into a binding
written agreement regarding a Takeover Proposal if the Company pays Parent the Termination Fee in
accordance with Section&nbsp;8.4 as and to the extent payment of such Termination Fee is required
thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.4.3 </I>The Company shall promptly advise Parent orally and in writing of the Company&#146;s
receipt of any request for information or any Takeover Proposal and the material terms and
conditions of such request or Takeover Proposal and the identity of the Person making such Takeover
Proposal. Promptly upon determination by the Company Board that a Takeover Proposal constitutes a
Superior Proposal, the Company shall deliver to Parent a written notice advising it that the
Company Board has made such determination, specifying the material terms and conditions of such
Superior Proposal and the identity of the Person making such Superior Proposal.
</DIV>


<P align="center" style="font-size: 10pt">68
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.4.4 </I>Nothing contained in this Section&nbsp;6.4 shall prohibit the Company or the Company
Board from (i)&nbsp;taking and disclosing to the stockholders of the Company a position contemplated by
Rule&nbsp;14e-2 promulgated under the Exchange Act or (ii)&nbsp;making any disclosure to the stockholders of
the Company if, in the good faith judgment of the Company Board, such disclosure would be necessary
under applicable Law (including Rule&nbsp;14d-9 and Rule&nbsp;14e-2 promulgated under the Exchange Act);
<I>provided</I>, <I>however</I>, that in no event shall this Section&nbsp;6.4.4 affect the obligations of the Company
specified in Section&nbsp;6.4.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.4.5 </I>To the extent it has not already done so, the Company shall, promptly following
the execution of this Agreement, request each Person which has heretofore executed a
confidentiality agreement with the Company during the twelve (12)&nbsp;months prior to the date of this
Agreement in connection with such Person&#146;s consideration of a possible Takeover Proposal to return
or destroy all confidential information heretofore furnished to such Person by or on behalf of the
Company and, at Parent&#146;s request, the Company shall take reasonable steps to enforce its rights
under such confidentiality agreements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.5 <U>Commercially Reasonable Best Efforts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.5.1 </I>Subject to the terms and conditions of this Agreement, including Section&nbsp;6.4,
each of the Parties shall use its commercially reasonable best efforts to take, or cause to be
taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other
Parties in doing, all things necessary, proper or advisable under applicable Laws to consummate and
make effective, in the most expeditious manner practicable, the transactions provided for in this
Agreement, including (i)&nbsp;preparing and filing, as soon as practicable, all forms, registrations and
notices required to be filed to consummate the transactions contemplated by this Agreement and the
taking of all such actions as are necessary to obtain any requisite approvals, consents, orders,
exemptions or waivers by, or to avoid an action or proceeding by, any Third Party or Governmental
Entity, including filings pursuant to the HSR Act, with the United States Federal Trade Commission
and the Antitrust Division of the United States Department of Justice (and the preparation and
filing, as soon as practicable, of any form or report required by any other Governmental Entity,
relating to antitrust, competition, trade or other regulatory matters), (ii)&nbsp;causing the
satisfaction of all conditions set forth in Article&nbsp;7 (including the prompt termination of any
waiting period under the HSR Act (including any
</DIV>


<P align="center" style="font-size: 10pt">69
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">extension of the initial thirty (30)&nbsp;day waiting period thereunder)), (iii)&nbsp;defending all lawsuits or other legal, regulatory or other proceedings
to which it is a party that challenge or affect this Agreement or the consummation of the
transactions contemplated by this Agreement and (iv)&nbsp;having lifted or rescinded any injunction or
restraining order or other Order which may adversely affect the ability of the Parties to
consummate the transactions contemplated by this Agreement. Notwithstanding any provision of this
Agreement to the contrary, neither the Company nor any
Company Subsidiary shall be required to make any payment to any Person, or agree to the
modification of any Lease or other agreement, in connection with obtaining any consent contemplated
by Section&nbsp;7.2.9 unless such payment or modification is contingent upon the occurrence of the
Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.5.2 </I>Parent and Merger Sub shall, and shall cause each other member of the Parent
Group, if applicable, to, use commercially reasonable best efforts to obtain, as promptly as
practicable following the date hereof, all licenses, certifications, Company Health Care Permits,
approvals, provider numbers and authorizations (&#147;<U>Government Consents</U>&#148;), if any, from all
applicable Governmental Entities in connection with the Merger and as may be required to authorize
Parent, the Surviving Corporation and the other members of the Parent Group, if applicable, to
operate or to continue to operate, as may be applicable, the Company Health Care Businesses as they
are currently operated. Within 45&nbsp;days following the execution of this Agreement, Parent shall,
and shall cause each other member of the Parent Group, if applicable, to, submit all applications
or other materials, if any, required to commence the process of obtaining such Government Consents,
including payment of all required fees related thereto. Parent shall, and shall cause the other
members of the Parent Group, if applicable, to, promptly respond to any request by any relevant
Governmental Entity for supplemental information. Parent shall, and shall cause the other members
of the Parent Group, if applicable, to, take all reasonable measures to shorten the time periods
required under applicable Law for notice, licensure or other similar regulatory requirement in
connection with receipt of Government Consents as described in this Section&nbsp;6.5.2; <I>provided</I>, that
the Parties acknowledge and agree that the mere fact that the Closing Date occurs later than
January&nbsp;1, 2006, shall not be deemed to constitute a breach of this or any associated obligation of
Parent hereunder. Parent shall, and shall cause the other members of the Parent Group, if
applicable, to, pay timely all fees and
</DIV>


<P align="center" style="font-size: 10pt">70
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">expenses required in connection with the matters described
in this Section&nbsp;6.5.2. Parent and Merger Sub shall not be responsible for any delay, or failure,
to obtain Government Consents in connection with the Merger, if such delay or failure is due to any
condition, event, fact or circumstance relating to the Company, any Company Subsidiary, Company
Health Care Program or the Company Health Care Facilities and not due in any part to any event,
fact or circumstance relating to the Parent Group. If after fully complying with this Section
6.5.2, Parent shall have obtained Government Consents necessary to operate at least ninety-five (95)&nbsp;percent, but less
than one hundred (100)&nbsp;percent, of the Company Health Care Facilities as currently operated by and
through the Company Subsidiaries, then Parent shall, and shall cause the other members of the
Parent Group, and the Company shall and shall cause the Company Subsidiaries, if applicable, to use
their respective commercially reasonable best efforts to, implement, subject to the occurrence of
the Effective Time, an &#147;Alternative Structure.&#148; The term &#147;<U>Alternative Structure</U>&#148; shall
mean a structure (including a management agreement, identity of interest transaction, a liquidating
trust for the benefit of the Company&#146;s Shareholders, an informal or preliminary approval
contemplating final approval retroactive to the Effective Time, or other structure) devised in
consultation with the applicable Governmental Entities to obtain the requisite Government Consents
to satisfy the condition set forth in Section&nbsp;7.1.3 or such that closing in the absence of such
Government Consents will not result in a violation of Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.5.3 </I>The Company and Parent shall have the right to review in advance, and to the
extent reasonably practicable each will consult the other on, all the information relating to the
other and each of their respective Subsidiaries and Affiliates, if applicable, that appears in any
filing made with, or written materials submitted to, any Third Party or any Governmental Entity in
connection with the Merger, <I>provided, however, </I>that Parent shall not be responsible for any delay
in the filing dates required by Section&nbsp;6.5.2 due to any review by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.5.4 </I>Each Party shall, and, if applicable, Parent shall cause the other members of
the Parent Group to, promptly inform the others of any communication from any Governmental Entity
regarding any of the transactions contemplated by this Agreement and keep the others informed of
the status of the proceedings related to obtaining any approvals of any Governmental Entity or
Third Party (including with respect to the termination or expiration of
</DIV>


<P align="center" style="font-size: 10pt">71
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any waiting period). To
the greatest extent practicable, each Party shall, and, if applicable, Parent shall cause the other
members of the Parent Group to, consult with the others in advance of any meeting or conference
with a Governmental Entity or, in connection with any proceeding by a Third Party, with any other
Person, relating to this Agreement and the transactions contemplated hereby and, to the extent
permitted by such applicable Governmental Entity or other Person, give the other Parties the
opportunity to attend and participate in such meetings and
conferences. If any Party or, if applicable, the other members of the Parent Group, receives
a request for additional information or documentary material from any such Governmental Entity or
other Person with respect to the transactions provided for in this Agreement, then such Party will,
or, in the case of a member of the Parent Group, Parent will cause such member of the Parent Group
to, endeavor in good faith to make, or cause to be made, as soon as reasonably practicable and
after consultation with the other Party, an appropriate response in compliance with such request.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.5.5 </I>Without limiting the generality of Section&nbsp;6.5.1 hereof, the Parties shall, as
promptly as practicable, prepare and file any notifications required under the HSR Act with respect
to the transactions contemplated hereby. The Parties shall respond as promptly as practicable to
(i)&nbsp;any inquiries or requests received from the Federal Trade Commission or the Department of
Justice for additional information or documentation and (ii)&nbsp;any inquiries or requests received
from any state attorney general, foreign antitrust authority or other Governmental Entity in
connection with antitrust or related matters. Each Party shall (1)&nbsp;give the other Party prompt
notice of the commencement or threat of commencement of any legal proceeding by or before any court
or Governmental Entity with respect to the Merger or any of the other transactions contemplated by
this Agreement, (2)&nbsp;keep the other Party reasonably informed as to the status of any such legal
proceeding or threat, and (3)&nbsp;promptly inform the other Party of any communication to or from the
Federal Trade Commission, the Department of Justice or any other Governmental Entity regarding the
Merger. Except as may be prohibited by any Governmental Entity or by any Legal Requirement,
Parent, on the one hand, and the Company, on the other, will consult and cooperate with one
another, and will consider in good faith the views of one another, in connection with any analysis,
appearance, presentation, memorandum, brief, argument, opinion or proposal made or submitted in
connection with any
</DIV>


<P align="center" style="font-size: 10pt">72
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">legal proceeding under or relating to the HSR Act. Parent, on the one hand,
and the Company, on the other, will permit authorized representatives of the other Party to be
present at each meeting or conference relating to any such legal proceeding and to have access to
and be consulted in connection with any document, opinion or proposal made or submitted to any
Governmental Entity in connection with any such legal proceeding. Nothing herein shall be deemed
to require Parent or Merger Sub to agree to divest, sell, dispose of, hold separate or
otherwise take or commit to take any action that limits its freedom of action with respect to
it or any of its Affiliates&#146; ability to retain, any of its businesses, properties or assets.
Furthermore, neither the Company nor any Company Subsidiary shall agree to divest, sell, dispose
of, hold separate or otherwise take or commit to take any action that limits its freedom of action
with respect to it or any of its Affiliates&#146; ability to retain, any of its businesses, property or
assets, without the prior written consent of Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.6 <U>Certain Notices</U>. From and after the date of this Agreement until the
Effective Time, each Party hereto shall promptly notify the other Party of (i)&nbsp;the occurrence, or
non-occurrence, of any event that would be likely to cause any condition to the obligations of any
Party to effect the Merger and the other transactions provided for in this Agreement not to be
satisfied or (ii)&nbsp;the failure of the Company, Merger Sub or Parent, as the case may be, to comply
with or satisfy any covenant, condition or agreement to be complied with or satisfied by it
pursuant to this Agreement which would reasonably be expected to result in any condition to the
obligations of any Party to effect the Merger and the other transactions provided for in this
Agreement not to be satisfied; <I>provided</I>, <I>however</I>, that the delivery of any notice pursuant to this
Section&nbsp;6.6 shall not cure any breach of any representation or warranty requiring disclosure of
such matter at or prior to the execution of this Agreement or otherwise limit or affect the
remedies available hereunder to the Party receiving such notice.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.7 <U>Public Announcements</U>. None of the Parties shall (and each of the Parties
shall cause its Representatives and, in the case of Parent, the other members of the Parent Group,
if applicable, not to) issue any press release or make any public announcement concerning this
Agreement or the transactions contemplated hereby without obtaining the prior written approval of
(i)&nbsp;the Company, in the event the disclosing party is Parent, Merger Sub, any other member of the
Parent Group, if applicable, or any of their respective Representatives, or (ii)&nbsp;Parent, in the
</DIV>

<P align="center" style="font-size: 10pt">73
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">event the disclosing party is the Company or any of its Representatives, such consent not to be
unreasonably withheld or delayed; <I>provided</I>, <I>however</I>, that if a Party determines, based upon advice
of counsel, that disclosure is otherwise required by applicable Law or the rules or regulations of
any stock exchange upon which the securities of such Party is listed, such Party may make such
disclosure to the extent so required; <I>provided</I>, <I>further</I>, that such disclosure is made in
consultation with the other Parties to this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.8 <U>Employee Matters</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.8.1 </I>Section&nbsp;6.8.1 of the Company Disclosure Schedule sets forth the actions (in
addition to those actions set forth in Section&nbsp;6.1(l) of the Company Disclosure Schedule and
Section&nbsp;3.5 of this Agreement) with respect to Company Benefit Plans that the Company will
implement in connection with the change of control contemplated by this Agreement, effective
concurrent with the Effective Time, including acceleration of vesting, partial or full funding,
amendment, termination or other similar actions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.8.2 Obligations with Respect to Continuing Employees</I>. Parent hereby agrees that,
for the period immediately following the Effective Time through and including the later of (x)
December&nbsp;31, 2006 and (y)&nbsp;the one-year anniversary of the Effective Time (such date, the
&#147;<U>Employment Benefit Plan Extension Date</U>&#148;), it shall, or it shall cause the Surviving
Corporation and its Subsidiaries to, (i)&nbsp;provide each Continuing Employee (other than a Continuing
Employee whose terms and conditions of employment are established through collective bargaining
with a labor organization) with at least the same level of base salary and wages and on
substantially the same terms and conditions as was provided to the Continuing Employee immediately
prior to the Effective Time, and (ii)&nbsp;except with respect to Continuing Employees whose terms and
conditions of employment are established through collective bargaining with a labor organization,
maintain Surviving Corporation Benefit Plans (except to the extent any such plan provides
equity-based compensation or traditional non-qualified deferred compensation benefits) that are
substantially equivalent in the aggregate to those provided to the Continuing Employees immediately
prior to the Effective Time and disclosed in Section&nbsp;4.10.1 of the Company Disclosure Schedule
(determined without regard to any modifications to such plans made pursuant to this Agreement);
<I>provided, however, </I>that in the event the cost of health and welfare benefits incurred by the
Surviving Corporation and its
</DIV>


<P align="center" style="font-size: 10pt">74
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiaries (taken as a whole) increases, or can reasonably be
expected to increase, by more than fifteen (15)&nbsp;percent in one year (a &#147;<U>Material Benefit Cost Increase</U>&#148;), the
Surviving Corporation may take such action as may be reasonably necessary (such as increasing
co-payment obligations or deductible thresholds) to limit the year-to-year increase in the cost of
health and welfare benefits to a level that does not constitute a Material Benefit Cost Increase;
<I>provided</I>, <I>further</I>, that the foregoing shall not obligate Parent or the Surviving Corporation to
employ one or more of the Continuing Employees. Subject to the Company&#146;s compliance with Section
6.1, from and after the Effective Time, Parent shall, or it shall cause the Surviving Corporation
and its Subsidiaries to, honor in accordance with their terms (including, without limitation, terms
which provide for amendment or termination) all contracts, agreements, arrangements, programs,
policies, plans and commitments of the Company and the Company Subsidiaries, as in effect
immediately prior to the Effective Time (and prior to any modifications made pursuant to this
Agreement) and disclosed in Section&nbsp;4.10.1 of the Company Disclosure Schedule that are applicable
to any current or former employees or directors of the Company or any Company Subsidiary, including
without limitation the severance plans and policies adopted by the Company Board, except for any
payments or modifications set forth in this Agreement; <I>provided</I>, <I>however, </I>that except for
contractual obligations which survive beyond the Employee Benefit Plan Extension Date, obligations
of Parent set forth in this sentence shall terminate on the Employee Benefit Plan Extension Date.
Nothing herein shall be deemed to be a guarantee of employment for any Continuing Employee, or to
restrict the right of the Surviving Corporation or its Subsidiaries to terminate any Continuing
Employee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.8.3 Credit for Service</I>. Continuing Employees shall receive credit for all purposes
(including for purposes of eligibility to participate, vesting, benefit accrual and eligibility to
receive benefits) under any Surviving Corporation Benefit Plan under which each Continuing Employee
may be eligible to participate on or after the Effective Time to the same extent recognized by the
Company or any of the Company Subsidiaries under comparable Company Benefit Plans immediately prior
to the Effective Time; <I>provided</I>, <I>however</I>, that such crediting of service shall not operate to
duplicate any benefit or the funding of any such benefit.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.8.4 Welfare Plans</I>. With respect to any Surviving Corporation Benefit Plan that is a
welfare benefit plan, program or arrangement (a &#147;<U>Purchaser Welfare Benefit Plan</U>&#148;)
</DIV>


<P align="center" style="font-size: 10pt">75
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and in which a Continuing Employee may be eligible to participate on or after the
Effective Time, Parent shall, or it shall cause the Surviving Corporation and its Subsidiaries to, (i)
waive, or use commercially reasonable efforts to cause its insurance carrier to waive, all
limitations as to pre-existing, waiting period or actively-at-work conditions, if any, with respect
to participation and coverage requirements applicable to each Continuing Employee under such
Purchaser Welfare Benefit Plan to the same extent waived under a comparable Company Benefit Plan,
and (ii)&nbsp;provide credit to each Continuing Employee (and his/her beneficiaries) for any
co-payments, deductibles and out-of-pocket expenses paid by such Continuing Employee (and his/her
beneficiaries) under the comparable Company Benefit Plan during the relevant plan year, up to and
including the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.8.5 Change in Control, Severance, Retention and Employment Agreements. </I>At least
fifteen (15)&nbsp;days prior to the Company Stockholders&#146; Meeting, Parent shall expressly identify to
the Company in writing any employee of the Company or any Company Subsidiary at the level of pay
band &#147;B&#148; or above as to whom Parent intends as of the Closing or within twelve (12)&nbsp;months after
the Effective Time to either (i)&nbsp;not retain by reason of the consummation of the Merger or (ii)(a)
materially reduce or diminish the duties, responsibilities or authority of such employee subsequent
to the Merger, (b)&nbsp;reduce the employee&#146;s compensation or benefits, or (c)&nbsp;require as a condition to
continued employment with the Surviving Corporation that the employee&#146;s employment be based at a
location other than its location at the Effective Time. At least five (5)&nbsp;days prior to the
Company Stockholders&#146; Meeting, the Company shall use its commercially reasonable efforts to cause
any employee who is party to any change in control, severance, retention and/or employment
agreements with the Company and who intends to terminate his or her employment for &#147;Good Reason&#148;
(as defined in an applicable individual agreement) immediately following the consummation of the
Merger, pursuant to a right to so terminate expressly set forth in such agreement, to notify the
Company of such in writing. Any employee who is identified in (i)&nbsp;above or who notifies the
Company as set forth above that the employee intends to terminate his or her employment for &#147;Good
Reason&#148; immediately following the consummation of this Merger, shall receive, at the Effective
Time, all payments specified in any written change of control, severance, retention and/or
employment agreements or arrangements with the Company or any Company Subsidiary and which are set
</DIV>


<P align="center" style="font-size: 10pt">76
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">forth in Section&nbsp;6.8.5 of the Company Disclosure Schedule. Prior to receiving any such
payments, an employee may rescind his or her notice to terminate employment for &#147;Good Reason&#148;
by providing written notice to the Company. Notwithstanding the foregoing, from and after the
Effective Time, Parent shall cause Surviving Corporation and its Subsidiaries to honor, in
accordance with their terms, all change in control, severance, retention and employment agreements
or arrangements (including an employee&#146;s right to terminate employment for &#147;Good Reason&#148;), in each
case with the current and former employees of the Company and the Company Subsidiaries as set forth
in Section&nbsp;6.8.5 of the Company Disclosure Schedule. The Company shall cooperate reasonably with
Parent and Merger Sub in accelerating to the earlier of the Closing Date or December&nbsp;31, 2005, with
respect to those individuals and specific awards or payments identified by Parent, any one or more
of the following: (i)&nbsp;outstanding bonus awards under the 1998 Annual Incentive Program Plan; (ii)
2003 Cash Bonus Awards (at target) under the 2003 Long-Term Program; (iii)&nbsp;1997 LTIP Performance
Bonus Awards (at target); (iv)&nbsp;benefits under the Enhanced Supplemental Executive Retirement Plan;
(v)&nbsp;benefits under the Supplemental Executive Retirement Plan; and (vi)&nbsp;benefits under the
Executive Deferred Compensation Plan (including the Retirement Enhancement Program); <I>provided</I>,
<I>however</I>, that in the case of any unfunded obligations requested to be accelerated by Parent, the
Company shall be entitled to advance funds, or provide other adequate security upon terms and
conditions satisfactory to the Company and Parent, from Parent as the Company determines may be
necessary to make such accelerated payments
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.9 <U>Indemnification of Directors and Officers</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.9.1 </I>From and after the Effective Time until six (6)&nbsp;years from the Effective Time,
unless otherwise required by Law, the certificate of incorporation and by-laws of the Surviving
Corporation and the comparable organizational documents of its Subsidiaries shall contain
provisions no less favorable with respect to the elimination of liability of directors and
indemnification of directors, officers, employees and agents than are set forth in the Company
Certificate and the Company By-laws (or the equivalent documents of the relevant Company
Subsidiary) as in effect on the date hereof; <I>provided</I>, <I>however</I>, that in the event any claim or
claims are asserted against any individual entitled to the protections of such provisions within
</DIV>


<P align="center" style="font-size: 10pt">77
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such six (6)&nbsp;year period, such provisions shall not be modified until the final disposition of
any such claims.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.9.2 </I>From and after the Effective Time, Parent and the Surviving Corporation, jointly
and severally, shall indemnify, defend and hold harmless, to the fullest extent permitted under
applicable Law and, without limiting the foregoing, as required pursuant to any indemnity
agreements of the Company or any Company Subsidiary, each present and former director and officer
of the Company and each Company Subsidiary (collectively, the &#147;<U>Indemnified Parties</U>&#148;)
against any costs or expenses (including attorneys&#146; fees and expenses), judgments, fines, losses,
claims, settlements, damages or liabilities incurred in connection with any claim, action, suit,
proceeding or investigation, whether civil, criminal, administrative or investigative, arising out
of or pertaining to (i)&nbsp;any and all matters pending, existing or occurring at or prior to the
Effective Time; and (ii)&nbsp;any and all representations and warranties made by Parent and/or Merger
Sub under Article&nbsp;5 hereof, including any matter arising under any claim that the transactions
contemplated herein, and any actions taken by Parent and/or Merger Sub with respect thereto
(including any disposition of assets of the Surviving Corporation or any of its Subsidiaries which
is alleged to have rendered the Surviving Corporation and/or any of its Subsidiaries insolvent).
Without limiting the foregoing, Parent and the Surviving Corporation, jointly and severally, shall
also advance costs and expenses (including attorneys&#146; fees) as incurred by any Indemnified Party
within twenty (20)&nbsp;days after receipt by Parent of a written request for such advance, <I>provided</I>,
that the Person to whom expenses are advanced provides an undertaking in customary form, consistent
with the practices of the Company prior to the Effective Time, to repay such advances if it is
ultimately determined that such Person is not entitled to indemnification (it being understood that
Parent and the Surviving Corporation shall not require any security for such undertaking).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.9.3 </I>For a period of six (6)&nbsp;years after the Effective Time, Parent shall or shall
cause the Surviving Corporation to maintain in effect the Company&#146;s current directors&#146; and
officers&#146; liability insurance (the &#147;<U>D&#038;O Insurance</U>&#148;) in respect of acts or omissions
occurring at or prior to the Effective Time, covering each Person currently covered by the D&#038;O
Insurance (a complete and accurate copy of which has been heretofore made available to Parent), on
terms with respect to the coverage, deductible and amounts no less favorable than those of the D&#038;O
</DIV>


<P align="center" style="font-size: 10pt">78
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Insurance in effect on the date of this Agreement; <I>provided</I>, <I>however</I>, that (i)&nbsp;in satisfying
its obligations under this Section&nbsp;6.9.3, neither Parent nor the Surviving Corporation shall be
obligated to pay annual premiums in excess of three hundred (300)&nbsp;percent of the amount currently
paid by the Company (which premiums are set forth in Section&nbsp;6.9.3 of the Company Disclosure
Schedule), it being understood and agreed that Parent or the Surviving Corporation shall
nevertheless be obligated to provide the maximum amount of such coverage as may be obtained for
such annual three hundred (300)&nbsp;percent amount and (ii)&nbsp;in the event of the application of clause
(i), any present or former officer or director, upon reasonable written notice thereof (which
notice shall be provided no later than thirty (30)&nbsp;days prior to the Effective Time and shall set
forth in reasonable detail for each Person to be covered the policy coverage, premiums,
deductibles, limitations and other pertinent information), who desires to obtain additional
coverage such that, when combined with the coverage obtained by Parent or the Surviving Corporation
in accordance with clause (i), it provides insurance coverage equivalent to the D&#038;O Insurance in
effect on the date hereof, may so elect and Parent shall or shall cause the Surviving Corporation
to acquire such additional coverage on behalf of such Person; <I>provided</I>, <I>further</I>, that in the event
any present or former officer or director makes such an election, such former officer or director
shall pay the portion of the premium of such D&#038;O Insurance in excess of the amount which Parent or
the Surviving Corporation is obligated to pay pursuant to this Section&nbsp;6.9. The insurance
purchased pursuant to this Section&nbsp;6.9 shall be prepaid in full at the Effective Time (or at such
time as it is actually obtained) and shall be non-cancelable. At the request of the Company,
Parent shall arrange for such insurance prior to the Effective Time to be effective only at and
after the Effective Time; <I>provided</I>, that Parent shall pay in full for such insurance coverage no
later than the Effective Time. The Company may acquire a six (6)&nbsp;year tail policy for Persons
currently covered by D&#038;O Insurance that is consistent with the first sentence of this Section&nbsp;6.9.3
so long as the one time premium payment for such tail policy is not more than three hundred (300)
percent of the amount currently paid by the Company on an annual basis and as set forth in Section
6.9.3 of the Company Disclosure Schedule. Such policy shall be prepaid at the Effective Time and
shall be non-cancelable. If the Company acquires such a tail policy, Parent&#146;s obligations pursuant
to the first sentence of this Section&nbsp;6.9.3 shall be deemed completely satisfied. The obligation
to maintain insurance provided in this Section&nbsp;6.9.3
</DIV>


<P align="center" style="font-size: 10pt">79
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall continue in full force and effect for a period of not less than six (6)&nbsp;years from and
after the Effective Time; <I>provided</I>, that in the event any claim or claims are asserted or made
within such six (6)&nbsp;year period, Parent or the Surviving Corporation shall ensure that such
insurance remains in full force and effect with respect to such claims until final disposition
thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.9.4 </I>If Parent or the Surviving Corporation or any of its successors or assigns shall
(i)&nbsp;consolidate with or merge into any other Person and shall not be the continuing or surviving
corporation or entity of such consolidation or merger or (ii)&nbsp;transfer all or substantially all of
its properties and assets to any Person, then, and in each such case, proper provisions shall be
made so that the successors and assigns of Parent or the Surviving Corporation (or acquiror of such
assets), as the case may be, shall assume all of the obligations of Parent or the Surviving
Corporation set forth in this Section&nbsp;6.9.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.9.5 </I>The rights of each Indemnified Party under this Section&nbsp;6.9 shall be in addition
to any right such Person might have under the Company Certificate and the Company By-laws, the
certificate of incorporation and the by-laws of the Surviving Corporation or any comparable
organizational documents of their Subsidiaries, or under any agreement of any Indemnified Party
with the Company, the Surviving Corporation or any of their respective Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.9.6 </I>The provisions of this Section&nbsp;6.9 shall survive the consummation of the Merger
and are intended to be for the benefit of, and shall be enforceable by, each of the Indemnified
Parties, their respective heirs and representatives.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.10 <U>State Takeover Statutes</U>. Parent, the Company and their respective Boards
of Directors shall (i)&nbsp;take all reasonable action necessary to ensure that no state takeover
statute or similar statute or regulation is or becomes applicable to this Agreement or the
transactions provided for in this Agreement and (ii)&nbsp;if any state takeover statute or similar
statute becomes applicable to this Agreement or the transactions contemplated by this Agreement,
take all reasonable action necessary to ensure that the transactions provided for in this Agreement
may be consummated as promptly as practicable on the terms contemplated by this Agreement and
otherwise to minimize the effect of such statute or regulation on this Agreement or the
transactions provided for in this Agreement.
</DIV>



<P align="center" style="font-size: 10pt">80
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.11 <U>Section&nbsp;16 Matters</U>. Prior to the Effective Time, the Company shall take
all such steps as may reasonably be necessary and permitted to cause the transactions contemplated
by this Agreement, including any dispositions of shares of Company Common Stock (including
derivative securities with respect to such Shares of Company Common Stock) by each individual who
is or will be subject to the reporting requirements of Section 16(a) of the Exchange Act with
respect to the Company, to be exempt under Rule&nbsp;16b-3 promulgated under the Exchange Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.12 <U>Confidentiality Agreement</U>. The Confidentiality Agreement shall continue
in full force and effect in accordance with its terms until the earlier of (i)&nbsp;the Effective Time
or (ii)&nbsp;the expiration of the Confidentiality Agreement according to its terms.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.13 <U>Solvency of the Surviving Corporation</U>. Not later than 30&nbsp;days following
the execution of this Agreement, Parent shall cause to be delivered to the Company an opinion from
Houlihan, Lokey, Howard &#038; Zukin, or such other nationally recognized accounting or investment
banking firm as the Company may reasonably approve, valuing the Company as a going-concern
(including goodwill), on a pro forma basis, immediately after and giving effect to the transactions
contemplated hereby and by the Commitments, and opining that, assuming, in each case, the
transactions contemplated hereby and by the Commitments had been consummated as proposed,
immediately after and giving effect to such transactions on a pro forma basis, (i)&nbsp;the fair value
and present fair saleable value to the Company&#146;s assets would exceed the Company&#146;s stated
liabilities and identified contingent liabilities; (ii)&nbsp;the Company should be able to pay its debts
as they become absolute and mature; and (iii)&nbsp;the capital remaining in the Company after the
transactions contemplated hereby would not be unreasonably small for the business in which the
Company is engaged, as management has indicated it is now conducted and is proposed to be conducted
by Parent following the consummation of such transactions, and otherwise in form and substance
reasonably satisfactory to the Company, addressed to the Company Board, supporting the conclusion
that, after giving effect to all of the transactions contemplated by this Agreement, each of Parent
and the Surviving Corporation will be solvent (or the equivalent thereof, as
determined in the reasonable discretion of the Company) (such opinion, the &#147;<U>Solvency
Opinion</U>&#148;). Parent shall obtain a &#147;bring down&#148; of the Solvency Opinion dated as of the Closing
Date, which opinion shall be in form and substance no less favorable to the Company than the
Solvency Opinion, <I>provided</I>, that any assumptions contained
</DIV>

<P align="center" style="font-size: 10pt">81
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in the Solvency Opinion as to which
facts have been ascertained between the date of the original Solvency Opinion and the Closing Date shall be eliminated. Each
of Parent and the Company shall, in connection therewith, use their commercially reasonable best
efforts to (i)&nbsp;make available their respective officers, agents and other Representatives on a
customary basis and upon reasonable notice and (ii)&nbsp;provide or make available such information
concerning the business, properties, contracts, assets and liabilities of the Company as may
reasonably be requested in connection with delivering such a &#147;bring down&#148; of the Solvency Opinion.
Following the Effective Time and until the earlier to occur of six (6)&nbsp;years thereafter or the
expiration of the applicable statute of limitations, Parent shall not take or fail to take any
action that if such action had been deemed to have been taken or such failure to act had been
deemed to have occurred immediately prior to the Effective Time would have caused the
representations and warranties set forth in Section&nbsp;5.12 hereof to be untrue as of the date hereof
or as of the Effective Time. The provisions of this Section&nbsp;6.13 are intended to be for the
benefit of, and will be enforceable by, each officer and director of the Company, each holder of
Company Common Stock and each of their respective successors, heirs and personal representatives.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.14 <U>Financing</U>. Each of Parent and Merger Sub shall use its commercially
reasonable best efforts to complete the transactions contemplated by the Debt Commitment Letters in
accordance with the terms of the Debt Commitment Letters (including obtaining rating agency
approvals, maintaining in effect the Commitments, satisfying on a timely basis all conditions
applicable to SBEV, Parent and Merger Sub to obtaining the financing contemplated by the
Commitments (including by consummating the financing contemplated by the Equity Commitment
Letter(s)), negotiating definitive agreements with respect thereto on terms and conditions
contained therein, satisfying all conditions applicable to SBEV, Parent and Merger Sub in such
definitive agreements that are within its control and, if necessary, borrowing pursuant to the Debt
Commitment Letters in the event the &#147;flex&#148; provisions are exercised), with such changes as
Parent may desire, in order to have available to it the Merger Consideration and other
transaction costs at or prior to the Closing; <I>provided, however, </I>that in no event will Parent make
any changes that would be reasonably expected to have a material adverse effect on the solvency of
the Company upon the consummation of the Merger; <I>provided</I>, <I>further</I>, that, except as expressly
provided in the following sentence, such changes must be approved in writing by
</DIV>

<P align="center" style="font-size: 10pt">82
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Company (such
approval not to be unreasonably withheld). Parent shall keep the Company informed on a reasonably
current basis in reasonable detail of the status of its efforts to comply with the terms of, and
satisfy the conditions contemplated by, the financing contemplated by the Commitments in accordance
with this Section&nbsp;6.14 and shall not permit any amendment or modification to be made to, or any
waiver of any provision or remedy under, the Commitments without obtaining the prior written
consent of the Company (such consent not to be unreasonably withheld, provided the consent of the
Company shall not be required in the event that any such amendment or modification of the Debt
Commitment Letters (A)&nbsp;does not have and could not reasonably be expected to have any adverse
effect on the &#147;bring down&#148; of the Solvency Opinion or Parent&#146;s ability to deliver such &#147;bring down&#148;
to the Company and the Company Board as required by Section&nbsp;6.13 hereof, and (B)&nbsp;involves solely
one or more of the following: (1)&nbsp;a change in the participant Institutional Lenders, provided that
any such substituted participant shall be a bank or private lender with assets exceeding $1
billion; (2)&nbsp;the removal or limitation of contingencies or conditions to the obligations of the
Institutional Lenders thereunder; (3)&nbsp;the shifting between or among Institutional Lenders of their
respective lending obligations to Parent and its affiliates participating directly or indirectly in
the contribution of Merger Consideration; and (4)&nbsp;increases in the overall indebtedness by no more
than $100,000,000 in the aggregate. Parent shall give the Company prompt notice of any material
breach by any party of the Commitments or any termination of any of the Commitments. Parent and Merger Sub shall use their respective commercially reasonable best efforts to cause the updated
Debt Commitment Letters referred to in Section 6.2.1 hereof to be delivered as promptly as is reasonably practicable. For the
avoidance of doubt, if the financing provided for by the Commitments has not been or cannot be
obtained, Parent and Merger Sub shall continue to be obligated to consummate the Merger on the
terms contemplated by this Agreement and subject only to the satisfaction or waiver of the
conditions set forth in Sections&nbsp;7.1 and 7.2 of this Agreement and to Parent&#146;s rights under Section
8.1, regardless of whether Parent and Merger Sub have complied with all of their other obligations
under this Agreement (including their obligations under this Section&nbsp;6.14).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.15 <U>Cooperation in Securing Financing</U>. From the date of this Agreement until
the Closing Date, the Company shall, and shall cause each Company Subsidiary to, provide all
cooperation reasonably requested by Parent (<I>provided</I>, that such requested cooperation does not
unreasonably interfere with the ongoing operations of the Company and the Company Subsidiaries) in
connection with obtaining the financing contemplated by the Debt Commitment
</DIV>

<P align="center" style="font-size: 10pt">83
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Letters, in (i)
supplying to the Institutional Lender or Lenders and equity participants all agreements, documents,
instruments, reports, financial information and statements, and other information regarding the
Company and the Company Subsidiaries, the Company Properties, the Company Health Care Businesses
and the other activities of or related to any of the foregoing in each case as reasonably requested
by them, (ii)&nbsp;attempting to respond to reasonable questions raised by Institutional Lenders and
equity participants, and (iii)&nbsp;permitting reasonable access to the Company Properties during normal
business hours and with reasonable notice; <I>provided</I>, that the provision of information to
Institutional Lenders and equity participants shall be subject to the confidentiality requirements
of Section&nbsp;6.12 above; <I>provided</I>, <I>further</I>, that notwithstanding the foregoing, no officer or
director of the Company shall be required to execute any documents, including, without limitation,
any registration statement to be filed with the SEC, any pledge or security documents or other
definitive financing documents and none of the Company or any Company Subsidiary shall be required
to pay any commitment or other similar fee or incur any other liability in connection with the
financing contemplated by the Commitments prior to the Effective Time. Parent shall, promptly upon
request by the Company, reimburse the Company for all reasonable out-of-pocket costs incurred by
the Company or the Company Subsidiaries in connection with such cooperation. Parent and Merger Sub
shall, on a joint and several basis, indemnify and hold harmless the Company, the Company
Subsidiaries and the Company Representatives from and against any and all liabilities, losses,
damages, claims, costs, expenses, interest, awards, judgments and penalties suffered or incurred by
them in connection with the arrangement of the financing contemplated by the Commitments and any
information utilized in connection therewith. Notwithstanding anything to the contrary, the
condition set forth in Section&nbsp;7.2.2 of this Agreement, as it applies to the Company&#146;s obligations
under this Section&nbsp;6.15, shall be deemed satisfied unless the financing contemplated by the Debt
Commitment Letters has not
been obtained as a result of the Company&#146;s willful and material breach of its obligations
under this Section&nbsp;6.15. All non-public or otherwise confidential information regarding the
Company and the Company Subsidiaries obtained by Parent or the Parent Representatives pursuant to
this Section&nbsp;6.15 shall be kept confidential by Parent in accordance with the Confidentiality
Agreement.
</DIV>

<P align="center" style="font-size: 10pt">84
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.16 <U>Further Assurances</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.16.1 </I>Subject to Section&nbsp;6.15, Parent and the Company shall execute and deliver such
certificates and other documents and take such other actions as may reasonably be requested by the
other Party in order to consummate or implement the transactions contemplated hereby; <I>provided,
however, </I>that nothing in this Section&nbsp;6.16 shall require any Party hereto to waive any condition
set forth in Article&nbsp;VII.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.16.2 </I>The Company shall, to the extent compatible with fulfilling the conditions to
the consummation of this Agreement, and its other obligations under this Agreement, use its
commercially reasonable best efforts to cooperate, and cause the Company Subsidiaries to cooperate,
with Parent in the provision of due diligence information with respect to transactions with respect
to the Company Properties, operations, businesses or assets of the Company or the Company
Subsidiaries and the Company Health Care Businesses which Parent may desire to implement on or
after the Effective Time (&#147;<U>Subsequent Transactions</U>&#148;), including, without limitation, using
its commercially reasonable best efforts to provide assistance in obtaining regulatory approvals
from Governmental Entities, resolving zoning issues, consents, access agreements, lien waivers,
estoppel certificates, subordination, non-disturbance, attornment, and similar agreements from
Third Parties; <I>provided, however, </I>that no Subsequent Transaction or the closing thereof shall be a
condition to the obligations of Parent, Merger Sub or the Company under Article&nbsp;VII of this
Agreement or otherwise delay the Closing; and, <I>provided</I>, <I>further</I>, <I>however</I>, that for purposes of
this Section&nbsp;6.16, the Company and the Company Subsidiaries shall not be required, in connection
with such cooperation, to (i)&nbsp;breach any agreement to which it is a party or otherwise subject,
(ii)&nbsp;incur any costs or expenses to Third Parties unless Parent shall advance any costs or expenses
therefor or (iii)&nbsp;enter into any
agreement or undertake any obligation with respect thereto unless such agreement or obligation
is subject to the Closing and does not become effective until on or after the Effective Time. The
provision of due diligence and other information regarding the Company to counterparties to
Subsequent Transactions shall be subject to the confidentiality requirements of Section&nbsp;6.12 above.
Further, while Parent may file and pursue applications for consents and approvals with
Governmental Entities, including with respect to Licenses, in connection with Subsequent
Transactions, Parent will not take any such actions that could impair any Company Health Care
</DIV>
<P align="center" style="font-size: 10pt">85
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Permits held by the Company or the Company Subsidiaries, result in any delay of Closing or result
in any change of ownership status prior to the Effective Time with respect to any Licenses held by
the Company or the Company Subsidiaries. Parent and the Company shall use commercially reasonable
best efforts to cooperate in the provision of such information as may be reasonably requested by
the issuer of the Solvency Opinion in connection with the preparation and rendering of the Bring
Down Opinion (as defined below).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.16.3 </I>The Company shall use its commercially reasonable best efforts to cooperate,
and cause the Company Subsidiaries to cooperate with Parent, in the negotiation, documentation and
closing of the satisfaction, payoff, defeasance, refinancing or restructuring of any debt
obligations of the Company or the Company Subsidiaries which Parent may desire to implement on or
after the Effective Time and the removal of Liens in connection therewith (collectively, &#147;<U>Debt
Satisfaction</U>&#148;), <I>provided, however, </I>that the Company shall not be required to enter into any
agreement, or amend or modify any existing agreement, or incur any obligation, to effectuate such
Debt Satisfaction unless such agreement, amendment, modification or obligation is subject to the
Closing and does not become effective until on or after the Effective Time, and shall not be
required to pay (other than contemporaneously with the Effective Time in amounts and with funding
arranged and provided by Parent) any amounts to holders of debt obligations of the Company or the
Company Subsidiaries to effectuate such Debt Satisfaction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.16.4 </I>The Company shall use commercially reasonable efforts to cooperate, and cause
the Company Subsidiaries to use commercially reasonable efforts to cooperate with the Parent, in
the exercise and implementation of all purchase options for real property relating to the Leases
(&#147;<U>Underlying Company Properties</U>&#148;), whether set forth in such Leases or negotiated by
Parent, such that the Underlying Company Properties can be acquired by
Parent&#146;s designee at the Effective Time (collectively, the &#147;<U>Purchase Options</U>&#148;),
<I>provided, however, </I>that (a)&nbsp;neither the acquisition of any Underlying Company Property, nor the
obtaining of additional financing with respect thereto shall constitute a condition to or
otherwise delay the Closing and (b)&nbsp;the Company shall not be required to enter into any agreement,
or amend or modify any existing agreement, or incur any obligation, to effectuate the exercise or
implementation of any Purchase Option unless such agreement, amendment, modification or obligation
is subject to the Closing and does not become effective until on or after the Effective
</DIV>
<P align="center" style="font-size: 10pt">86
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Time, and
shall not be required to pay (other than contemporaneously with the Effective Time in amounts and
with funding arranged and provided by the Parent) any amounts to the landlords of Leases to
effectuate such Purchase Options and acquisition of Underlying Company Properties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.17 <U>Existing Obligations</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.17.1 </I>The Company and Parent shall use commercially reasonable best efforts to
cooperate with one another to give notice to the holders of the Company&#146;s 7 7/8% Senior Subordinated
Notes due 2014 (the &#147;<U>7 7/8% Notes</U>&#148;), and to the trustee under the Indenture for the 7 7/8% Notes
(the &#147;<U>7 7/8% Notes Indenture</U>&#148;), that is required in order to exercise on the Closing Date the
Company&#146;s right to redeem the 7 7/8% Notes under Section&nbsp;3.07 of the 7 7/8% Notes Indenture and to
satisfy and discharge the 7 7/8% Notes Indenture pursuant to Section&nbsp;11.01 thereof. Any notice so
provided shall be subject to the review and approval of Parent, which approval shall not be
unreasonably withheld; <I>provided</I>, that, at the option of the Company, such notice of redemption may
be conditioned on the occurrence of the Effective Time. Immediately prior to the Effective Time,
Parent shall deposit or cause to be deposited with the Trustee under the 7 7/8% Notes Indenture funds
sufficient to satisfy and discharge the 7 7/8% Notes Indenture pursuant to Section&nbsp;11.01 thereof. The
Company and Parent shall cooperate in good faith with one another in order to satisfy the
conditions set forth in Section&nbsp;11.01 of the 7 7/8% Notes Indenture as of the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.17.2 </I>The Company and Parent shall cooperate with one another to determine a date
upon which the Company shall give notice to the holders of the Company&#146;s 2.75% Convertible
Subordinated Notes due 2033 (the &#147;<U>Convertible Notes</U>&#148;) and to the Trustee
under the Indenture for the Convertible Notes, that the Company has entered into this
Agreement and that, if the Merger occurs, the Common Stock of the Company then outstanding shall be
converted into the right to receive the Merger Consideration. The Company will make available to
holders of the Convertible Notes procedures reasonably satisfactory to Parent allowing the holders
of the Convertible Notes to surrender Convertible Notes for conversion into Common Stock
conditioned upon the satisfaction or waiver of all conditions to the Merger, with appropriate
assurance that the Convertible Notes will be returned to the holders, or to Persons designated by
such holders, in the event that this Agreement is terminated or the Merger has not occurred by the
Termination Date, as it may be extended.</DIV>

<P align="center" style="font-size: 10pt">87
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;6.17.3 </I>The Company shall take, or shall cause its applicable Affiliates to take, the
vendor-related actions described in Section&nbsp;6.17.3 of the Company Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.18 <U>Deposit and Letter of Credit</U>. In consideration for the Company entering
into, and as an inducement and condition to the willingness of the Company to enter into, this
Agreement, Parent has transferred to the Company $7,000,000 in immediately available funds as a
good faith deposit (the &#147;<U>Initial BIF Deposit</U>&#148;); <I>provided</I>, that the Company shall return the
Initial BIF Deposit and any accrued interest or earnings thereon to Parent in the event Parent
terminates this Agreement pursuant to Section&nbsp;8.1(d)(iv). No later than 5:00 P.M. New York City
time on the 30th day following the date hereof, Parent shall (A) either (i)&nbsp;make an additional
$53,000,000 good faith deposit (the &#147;<U>Subsequent BIF Deposit</U>&#148; and, together with the Initial
BIF Deposit, the &#147;<U>BIF Deposit</U>&#148;) by wire transfer of immediately available funds to an
account specified in writing by the Company or (ii)&nbsp;deliver to the Company an irrevocable letter of
credit duly executed by HSBC USA, N.A., or another financial institution reasonably acceptable to
the Company, in the form of Exhibit&nbsp;B hereto (including any substitute letter of credit as provided
below, the &#147;<U>Letter of Credit</U>&#148;), and (B) provide an updated firm Equity Commitment Letter, which (i) shall provide that (x) the funding obligations thereunder are subject only to the conditions set forth herein and in the Debt Commitment Letters, and (y) that upon the delivery of the updated Debt Commitment Letters referred to in Section 6.2.1, such funding obligations shall be subject only to the conditions set forth herein
and in such updated Debt Commitment Letters, and (ii) shall otherwise be in form and substance reasonably satisfactory to the Company. The Company will retain the BIF Deposit in a separate
account as security for the payment of the Business Interruption Fee pursuant to Section&nbsp;8.5 and
shall not withdraw the BIF Deposit from such account prior to the termination of this Agreement
under circumstances where the Business Interruption Fee is payable to the Company. The BIF Deposit
shall be invested in United States treasury securities. Unless previously returned pursuant to the
first sentence of this Section&nbsp;6.18,
the Company agrees to return the BIF Deposit (and any accrued interest or earnings thereon)
and any Letter of Credit to Parent (or its designee) or if requested by Parent, deposit the BIF
Deposit with the Exchange Agent, upon the earlier to occur of (i)&nbsp;the receipt of the Merger
Consideration by the Exchange Agent or, if later, the Effective Time or (ii)&nbsp;the termination of
this Agreement under circumstances where the Company is not entitled to the Business Interruption
Fee pursuant to Section&nbsp;8.5 (a &#147;<U>Return Event</U>&#148;). The Company and Parent further agree that
if Parent fails to (i) make the Subsequent BIF Deposit or deliver the Letter of Credit or (ii) deliver the updated firm Equity Commitment Letter described above in form and substance reasonably satisfactory to the Company, in each case on or before
5:00 P.M. New York City time on the 30th day following the date hereof, Parent and Merger Sub shall
thereupon be deemed in material breach of this Agreement unless and until Parent makes the
Subsequent BIF Deposit or delivers the
</DIV>

<P align="center" style="font-size: 10pt">88
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Letter of Credit, and the Company shall have the right to
retain the Initial BIF Deposit as the Business Interruption Fee and withdraw it from the separate
account described above. In the event Parent delivers a Letter of Credit, Parent shall cause such
Letter of Credit (or a substitute therefor in the form of Exhibit&nbsp;F hereto from a financial
institution reasonably satisfactory to the Company) to remain in full force and effect until a
Return Event has occurred and the Letter of Credit has been returned to Parent as here and above
provided. In the event the Letter of Credit or any substitute therefor is scheduled to terminate
within ten (10)&nbsp;Business Days and Parent has not provided the Company with a substitute Letter of
Credit with a term of at least 90 additional days, the Company shall have the right to draw the
full amount of the Letter of Credit and hold such funds as the Subsequent BIF Deposit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.19 <U>Title Matters</U>. Without Parent&#146;s prior written consent, such consent not
to be unreasonably withheld, the Company shall not knowingly take, knowingly fail to take or
knowingly permit any action to be taken which shall as of the Closing Date change in any adverse
manner (other than with respect to the creation or maintenance of any Permitted Encumbrance) the
status of title to the Company Owned Properties or the Company Leased Health Care Facilities as
represented by Section&nbsp;4.17, except for any action taken in the ordinary course of business.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;7<BR>
Closing Conditions</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.1 <U>Conditions to Obligations of Each Party Under This Agreement</U>. The respective obligations of each Party to effect the Merger and the other transactions
contemplated herein shall be subject to the satisfaction, or waiver, at or prior to the Closing
Date of the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.1.1 Stockholder Approval</I>. The Stockholder Approval shall have been obtained.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.1.2 HSR Act, Government Consents and Approvals</I>. All filing and waiting periods
applicable (including any extensions thereof) to the consummation of the Merger under the HSR Act
shall have expired or been terminated.

<P align="center" style="font-size: 10pt">89
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.1.3 Consents and Approvals. </I>(i)&nbsp;There shall be no statute, rule, regulation or
executive or any other order or similar action of any Governmental Entity, which would render the
Parties unable to consummate the Merger or make the Merger illegal or prohibit, restrict or delay
consummation of the Merger (other than a de minimus civil violation of any Law that does not affect
the ability of the Surviving Corporation, Parent or their Affiliates to obtain and maintain
licenses, certifications, Company Health Care Permits, approvals, provider numbers and
authorizations for the ownership and operation of Company Health Care Businesses or participation
in any Company Health Care Program) and (ii)&nbsp;Parent shall have obtained the Government Consents
necessary to operate one hundred (100)&nbsp;percent of the Company Health Care Facilities, as currently
operated by and through the Company Subsidiaries, or, if Parent has obtained at least ninety-five
(95)&nbsp;percent but less than one hundred (100)&nbsp;percent, the Company and Parent shall have been able
to implement an Alternative Structure in compliance with all Legal Requirements as to those Company
Health Care Facilities for which Parent did not obtain Government Consents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.1.4 No Injunctions or Restraints</I>. No Law or Order issued by any court of competent
jurisdiction or other Governmental Entity or other legal restraint or prohibition prohibiting the
consummation of the Merger shall be in effect; <I>provided</I>, <I>however</I>, that each of the Parties shall
have used its commercially reasonable best efforts to resist, resolve or lift, as applicable, any
such Law or Order and shall have complied in all material respects with its obligations under
Section&nbsp;6.5; <I>provided</I>, <I>further</I>, that the right to assert this condition shall not be
available to any Party whose breach of any provision of this Agreement results in the
imposition of any such Order or the failure of such Order to be resisted, resolved or lifted, as
applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.2 <U>Additional Conditions to Obligations of Parent and Merger Sub</U>. The
obligations of Parent and Merger Sub to effect the Merger and the other transactions contemplated
herein are also subject to the following conditions, any one or more of which may be waived in
writing by Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.1 Representations and Warranties</I>. The representations and warranties of the
Company set forth in this Agreement shall be true and correct as of the Effective Time as if made
at and as of the Effective Time (except for those representations and warranties which address
matters only as of an earlier date which shall have been true and
</DIV>
<P align="center" style="font-size: 10pt">90
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">correct as of such earlier date),
disregarding for these purposes any exception in such representations and warranties relating to
Significance, materiality or a Company Material Adverse Effect, except for such failures to be true
and correct which, individually or in the aggregate, do not result in a Company Material Adverse
Effect; <I>provided, however, </I>that this exception does not limit the requirement that the other
conditions in this Section&nbsp;7.2 be satisfied or waived.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.2 Agreements and Covenants</I>. The Company shall have performed or complied in all
material respects with all agreements and covenants required by this Agreement to be performed or
complied with by it on or prior to the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.3 Officer&#146;s Certificate</I>. Parent shall have received a certificate of an executive
officer of the Company to the effect set forth in Sections&nbsp;7.2.1 and 7.2.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.4 </I>That none of the following events have occurred:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;any one or more of the Property Restrictions or other Liens (other than any Permitted
Encumbrances) that materially impairs the use or occupancy of any one or more of the Company
Properties causes one or more of the Institutional Lenders to reduce one or more of their loan
amounts or require reserves or funding holdbacks, individually or in the aggregate, in an amount
equal to or greater than $75,000,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;any one or more violations of any Land Use Requirement or Environmental Laws with respect
to any one or more of the Company Properties that causes one or more of the Institutional Lenders
to reduce one or more of their loan amounts or require reserves or funding holdbacks, individually
or in the aggregate (together with any reduction, reserve or holdback determined under Section
7.2.4(i)) in an amount equal to or greater than $125,000,000; the term &#147;<U>Land Use
Requirement</U>&#148; shall mean zoning, building code and other land use Law regulating the use or
occupancy of any real property or the activities conducted thereon that are imposed by any
Governmental Entity having jurisdiction over such real property but shall exclude any amounts
attributable to deferred maintenance or capital expenditures unless the subject thereof, if not
remediated, would constitute a violation of any Land Use Requirement or Environmental Law; or</DIV>

<P align="center" style="font-size: 10pt">91
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;if Purchaser has complied with its obligations arising pursuant to Section&nbsp;6.5.2,
failure to obtain any necessary License required in order to make consummation of the Merger not in
violation of any applicable Laws or, as applicable, failure to implement, in compliance with Laws,
an Alternative Structure, in each case primarily as a result of (x)&nbsp;an action or omission by the
Company or any Company Subsidiary in connection with an application for any such required License,
or (y)&nbsp;a current practice of the Company or any Company Subsidiary not in compliance with Legal
Requirements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.5 </I>The holders of no more than ten (10)&nbsp;percent of the Shares (other than Shares
beneficially owned, directly or indirectly by Parent or any Person acting in concert with Parent)
shall have perfected appraisal rights under Section&nbsp;262 of the GCL.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.6 </I>Except as set forth in Section&nbsp;7.2.6 of the Company Disclosure Schedule, no
Company Health Care Permit necessary to the operation of the Company, the Company Subsidiaries or
the Company Health Care Businesses, shall have been suspended, revoked or terminated and neither
the Company nor any Company Subsidiary shall have been excluded, debarred or disqualified from
participation in any Company Health Care Program.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.7 </I>The Company shall have given a redemption notice to the holders of the 7<FONT style="font-size: 70%"><SUP>7</SUP></FONT>/<FONT style="font-size: 60%">8</FONT>% Notes
and the Trustee under the 7<FONT style="font-size: 70%"><SUP>7</SUP></FONT>/<FONT style="font-size: 60%">8</FONT>% Notes Indenture prior to the Effective Time as contemplated by
section 6.17.1 and any Liens securing such notes shall have been released;
<I>provided, </I>that Parent has provided the funds to implement the satisfaction and discharge
thereof. The other indebtedness for borrowed money of the Company and Liens securing such
indebtedness shall be paid off and released at the Effective Time, other than Permitted Debt,
<I>provided</I>, that the Parent has arranged for provision of funds to implement such redemption, pay-off
and release.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.8 </I>Subject to the baskets provided in Sections&nbsp;7.2.4(i) and (ii), with respect to
each of the Company Owned Properties and the Company Leased Health Care Facilities, Land America
Title Insurance Company located at 1050 Wilshire Drive, Suite&nbsp;310, Troy, Michigan, 48084,
<U>Attention</U>: Carol Ann Martinelli and such co-insurers or re-insurers as reasonably required
by Parent and/or any institutional lender similar to Wachovia Bank, National Association, Capital
Source Finance LLC and Credit Suisse First Boston LLC (the &#147;<U>Title </U>
</DIV>
<P align="center" style="font-size: 10pt">92
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Company</U>&#148;), shall issue
owner, leasehold owner and mortgagee title insurance policies effective as of Closing, in each case
at reasonable rates for the respective states, subject only to the Permitted Encumbrances with such
endorsements and affirmative coverages reasonably requested by such an institutional lender and
available for issuance by the Title Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.2.9 Leasehold Consents</I>. All of the consents and approvals specified in Section
7.2.9 of the Company Disclosure Schedule shall have been obtained, except for such consents which,
if not so obtained, would, upon the consummation of the transactions contemplated by this
Agreement, not reasonably be expected to have a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.3 <U>Additional Conditions to Obligations of the Company</U>. The obligation of
the Company to effect the Merger and the other transactions contemplated herein are also subject to
the following conditions, any one of which may be waived in writing by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.3.1 Representations and Warranties</I>. The representations and warranties of Parent
and Merger Sub set forth in this Agreement shall be true and correct as of the Effective Time as if
made at and as of the Effective Time (except for those representations and warranties which address
matters only as of an earlier date which shall have been true and correct as of such earlier date),
disregarding for these purposes any exception in such
representations and warranties relating to materiality, except for such failures to be true
and correct which, individually or in the aggregate, do not have a material adverse effect on the
ability of Parent or Merger Sub to perform its obligations hereunder or which would prevent or
materially impede, interfere with, hinder or delay the consummation of the Merger; <I>provided,
however, </I>that this exception does not limit the requirement that the other conditions in this
Section&nbsp;7.3 be satisfied or waived.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.3.2 Agreements and Covenants</I>. Parent and Merger Sub shall have performed or
complied in all material respects with all agreements and covenants required by this Agreement to
be performed or complied with by Parent and/or Merger Sub on or prior to the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.3.3 Officer&#146;s Certificate</I>. The Company shall have received a certificate of an
executive officer of Parent to the effect set forth in Sections&nbsp;7.3.1 and 7.3.2.
</div>

<P align="center" style="font-size: 10pt">93
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;7.3.4 Solvency Opinion</I>. The Company shall have received (i)&nbsp;the Solvency Opinion
addressed to the Company and the Board on or before the date and in the form required by Section
6.13, and (ii)&nbsp;the &#147;bring down&#148; of the Solvency Opinion addressed to the Company Board as
contemplated by Section&nbsp;6.13.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.4 <U>Frustration of Closing Conditions</U>. None of the Company, Parent or Merger
Sub may rely on the failure of any condition set forth in Article&nbsp;7 to be satisfied if such failure
was caused by such Party&#146;s failure to act in good faith to comply with this Agreement and
consummate the transactions provided for herein.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;8<BR>
Termination, Amendment and Waiver</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.1 <U>Termination</U>. This Agreement may be terminated, and the Merger
contemplated hereby may be abandoned, at any time prior to the Effective Time, by action taken or
authorized by the
Board of Directors of the terminating Party or Parties, whether before or after the
Stockholder Approval:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;By mutual written consent of Parent and the Company;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;by either Parent or the Company (if, in the case of the Company, it complied with Section
6.4 in all material respects):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;if the Stockholder Approval is not obtained at the Company Stockholders&#146; Meeting or any
adjournment thereof at which this Agreement has been voted upon;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if the Merger shall not have been consummated by March&nbsp;1, 2006 (the &#147;<U>Termination
Date</U>&#148;); <I>provided</I>, <I>however</I>, that the right to terminate this Agreement under this Section
8.1(b)(ii) shall not be available to any Party whose breach of any provision of this Agreement has
been the cause of, or resulted in, the failure of the Merger to occur on or before the Termination
Date; <I>provided</I>, <I>further</I>, that notwithstanding the previous limitation, the Termination Date shall
not be extended in perpetuity until such breach is cured, but the non-breaching Party shall be
obligated to elect either: (i)&nbsp;to close over such breach following a reasonable period of time
necessary to cure such breach, or (ii)&nbsp;to terminate this Agreement on a
</DIV>

<P align="center" style="font-size: 10pt">94
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">date certain to not exceed
June&nbsp;30, 2006, and upon any failure to make such election, this Agreement shall automatically
terminate as of June&nbsp;30, 2006; and <I>provided</I>, <I>further</I>, that the Company or Parent shall have the
right to extend the Termination Date until June&nbsp;30, 2006 solely for the purpose of securing
Government Consents and approvals to satisfy the condition contained in Section&nbsp;7.1.3; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;if there shall be any Law that makes consummation of the Merger illegal or otherwise
prohibited or any Order of any Governmental Entity having competent jurisdiction enjoining the
Company, Parent or Merger Sub from consummating the Merger is entered and such Order has become
final and nonappealable and, prior to termination pursuant to this Section&nbsp;8.1(b)(iii) each of the
Parties shall have used its commercially reasonable best efforts to resist, resolve or lift, as
applicable, the Law or Order and shall have complied in all material respects with its obligations
under Section&nbsp;6.5; <I>provided</I>, <I>however</I>, that the right to terminate this Agreement pursuant to this
Section&nbsp;8.1(b)(iii) shall not be available to any Party
whose breach of any provision of this Agreement results in the imposition of any such Order or
the failure of such Order to be resisted, resolved or lifted, as applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;by the Company:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;if (x)&nbsp;Parent or Merger Sub shall have breached any of the covenants or agreements
contained in this Agreement to be complied with by Parent or Merger Sub such that the closing
condition set forth in Section&nbsp;7.3.2 would not be satisfied, (y)&nbsp;there exists a breach of any
representation or warranty of Parent or Merger Sub contained in this Agreement such that the
closing condition set forth in Section&nbsp;7.3.1 would not be satisfied or (z)&nbsp;Mr.&nbsp;Schron shall have
breached the Equity Commitment Letter or there shall have been a breach of Section&nbsp;6.14, and, in
the case of (x), (y)&nbsp;or (z), such breach is incapable of being cured by the Termination Date or is
not cured within twenty (20)&nbsp;Business Days (or, in the case of clause (z), ten (10)&nbsp;Business Days)
after Parent or Merger Sub receives written notice of such breach from the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if prior to the obtaining of the Stockholder Approval (w)&nbsp;the Company Board has received
a Takeover Proposal, (x)&nbsp;the Company Board determines in good faith after consultation with its
financial advisors and outside legal counsel that such Takeover
</DIV>

<P align="center" style="font-size: 10pt">95
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Proposal constitutes a Superior
Proposal and (i)&nbsp;has authorized the Company, subject to complying with this Agreement, to enter
into a binding written agreement to consummate the transaction constituting such Superior Proposal,
and (ii)&nbsp;has concluded that such action is necessary for the members of the Company Board to comply
with their fiduciary duties to the holders of Company Common Stock under applicable Law, (y)&nbsp;the
Company has complied in all material respects with Section&nbsp;6.4, and (z)&nbsp;no later than the day of
such termination, the Company has paid in immediately available funds the Termination Fee in
accordance with Section&nbsp;8.4; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Parent fails (i)&nbsp;to provide the Subsequent BIF Deposit or deliver the Letter of Credit,
or (ii)&nbsp;to provide the Solvency Opinion or (iii) provide the firm Equity Commitment Letter referred to in Section 6.18, in each case on or before 5:00 P.M. New York City time on
the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day following the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;by Parent:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;(x)&nbsp;if the Company shall have breached any of the covenants or agreements contained in
this Agreement to be complied with by the Company such that the closing condition set forth in
Section&nbsp;7.2.2 would not be satisfied or (y)&nbsp;there exists a breach of any representation or warranty
of the Company contained in this Agreement such that the closing condition set forth in Section
7.2.1 would not be satisfied, and, in the case of either (x)&nbsp;or (y), such breach is incapable of
being cured by the Termination Date or is not cured by the Company within twenty (20)&nbsp;Business Days
after the Company receives written notice of such breach from Parent or Merger Sub;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if, prior to the obtaining of the Stockholder Approval, (x)&nbsp;a Company Adverse
Recommendation Change shall have occurred,
(y)&nbsp;the Company has failed to include the Company
Recommendation in the Proxy Statement or (z)&nbsp;the Company Board approves or recommends a Takeover
Proposal to the holders of Company Common Stock or approves or recommends that holders of Company
Common Stock tender their shares of Company Common Stock in any tender offer or exchange offer that
is a Takeover Proposal;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) if the conditions set forth in Section&nbsp;7.2.4 shall not have been satisfied and the
Termination Date shall have occurred; or
</DIV>

<P align="center" style="font-size: 10pt">96
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;subject to the good faith efforts of Parent to negotiate with the relevant appraisers any
necessary revisions to such appraisals, at any time before 5:00 P.M. New York City time on August
23, 2005, in the event that either of the Institutional Lenders providing real estate related
financing in accordance with the relevant Debt Commitment Letter shall have advised Parent in
writing that they have concluded that the appraisals for the Company Owned Health Care Facilities
cannot be revised by an amount sufficient to increase the aggregate appraised value of such Company
Owned Health Care Facilities to $1,650,000,000.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.2 <U>Effect of Termination</U>. Except as otherwise set forth in this Section&nbsp;8.2,
in the event of a termination of this Agreement by either the Company or Parent as provided in
Section&nbsp;8.1, this Agreement shall forthwith become void and there shall be no liability or
obligation on the part of Parent, Merger Sub or the Company or their respective officers or
directors; <I>provided</I>, <I>however</I>, that (i)&nbsp;the provisions of this Section&nbsp;8.2, Sections&nbsp;8.3, 8.4, 8.5
and Article&nbsp;9 and the Confidentiality
Agreement shall remain in full force and effect and survive any termination of this Agreement
and (ii)&nbsp;the Termination Fee and/or Parent Expenses shall be the exclusive remedy of Parent and
Merger Sub under circumstances where the Termination Fee and/or Parent Expenses is or are payable
by the Company and the Business Interruption Fee shall be the exclusive remedy of the Company under
circumstances where the Business Interruption Fee is payable by Parent; <I>provided</I>, <I>further</I>, that no
Party shall be relieved or released from any liabilities or damages arising out of its willful and
material breach of any provision of this Agreement. In no event shall any Party be liable for
punitive damages.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.3 <U>Fees and Expenses</U>. Except as otherwise expressly set forth in this
Agreement, all fees and expenses incurred in connection herewith and the transactions contemplated
hereby shall be paid by the Party incurring such expenses, whether or not the Merger is
consummated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.4 <U>Termination Fee and Parent Expenses</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;8.4.1 </I>If this Agreement is terminated pursuant to Section&nbsp;8.1(b)(i) in the event no
Third Party shall have publicly made, proposed, communicated or disclosed an intention to make a
bona fide Takeover Proposal after the date hereof and prior to the date of termination (or such a
Takeover Proposal shall have become publicly disclosed) and neither
</DIV>
<P align="center" style="font-size: 10pt">97
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Parent, Merger Sub nor SBEV is
in material default of this Agreement at the time of such Termination, then the Company shall pay
Parent the Parent Expenses, not to exceed $30,000,000. If this Agreement is terminated pursuant to
Section&nbsp;8.1(c)(ii) and neither Parent, Merger Sub nor SBEV is in material default of this Agreement
at the time of such termination, then the Company shall pay Parent (i) $3,500,000, if such
termination occurs prior to 5:00 P.M. New York City time on August&nbsp;23, 2005, (ii) $20,000,000, in
the event of any such termination after such time and date and prior to Parent&#146;s performance of its
obligations pursuant to Section&nbsp;6.18 hereof to (i) make the Subsequent BIF Deposit or deliver the Letter
of Credit and (ii) deliver the updated Equity Commitment Letter, or (iii) $60,000,000 in the event of such termination at any time following Parent&#146;s
compliance with such obligation, in any case not later than the day of such termination. If this
Agreement is terminated pursuant to Section&nbsp;8.1(b)(i) or Section&nbsp;8.1(d)(i) and neither Parent,
Merger Sub nor
SBEV is in material default of this Agreement at the time of such termination, then, in the
event that, (i)&nbsp;after the date hereof and prior to such termination, any Third Party shall have
made, proposed, communicated or disclosed an intention to make a bona fide Takeover Proposal and
(ii)&nbsp;within nine (9)&nbsp;months of the termination of this Agreement the Company enters into a
definitive agreement with any Third Party with respect to a Takeover Proposal (with all percentages
in the definition of Takeover Proposal increased to fifty (50)&nbsp;percent) or any Takeover Proposal is
consummated by a Third Party (with all percentages in the definition of Takeover Proposal increased
to fifty (50)&nbsp;percent), then the Company shall pay, or cause to be paid to, Parent (A) $20,000,000,
in the event of such termination prior to Parent&#146;s performance of its obligations pursuant to
Section&nbsp;6.18 hereof to (i) make the Subsequent BIF Deposit or deliver the Letter of Credit and (ii) deliver the updated Equity Commitment Letter, or (B)
$60,000,000 in the event of such termination at any time following Parent&#146;s compliance with such
obligation, in either case upon consummation of such Takeover Proposal. If this Agreement is
terminated pursuant to Section&nbsp;8.1(d)(ii) in circumstances unrelated to a Takeover Proposal and
neither Parent, Merger Sub nor SBEV is in material default of this Agreement at the time of such
termination, the Company shall pay Parent the Parent Expenses, not to exceed the lesser of (x)&nbsp;the
BIF Deposit at the time of such termination (including funds available under the Letter of Credit),
and (y) $30,000,000. If this Agreement is terminated pursuant to Section&nbsp;8.1.(d)(ii) in
circumstances related to a Takeover Proposal and neither Parent, Merger Sub nor SBEV is in material
default of this Agreement at the time of such
 </DIV>
<P align="center" style="font-size: 10pt">98
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">termination, the Company shall pay Parent the lesser
of (x)&nbsp;the BIF Deposit at the time of such termination (including funds available under the Letter
of Credit) and (y) $60,000,000. Any amount paid pursuant to this Section&nbsp;8.4.1, whether
characterized as Parent Expenses or otherwise, the &#147;<U>Termination Fee</U>&#148;. The Termination Fee
(including any Parent Expenses) shall be paid by wire transfer of immediately available funds to an
account designated in writing to the Company by Parent. For the avoidance of doubt, in no event
shall the Company be obligated to pay, or cause to paid, the Termination Fee (including any Parent
Expenses) on more than one occasion.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;8.4.2 </I>The Company acknowledges that the agreements contained in this Section&nbsp;8.4 are
an integral part of the transactions contemplated in this Agreement, that the damages resulting
from termination of this Agreement under circumstances where a Termination
Fee or Parent Expenses is payable are uncertain and incapable of accurate calculation and that
the amounts payable pursuant to Section&nbsp;8.4.1 are reasonable forecasts of the actual damages which
may be incurred and constitute liquidated damages and not a penalty, and that, without these
agreements, Parent would not enter into this Agreement; accordingly, if the Company fails to
promptly pay the Termination Fee or Parent Expenses, and, in order to obtain such payments Parent
commences a suit which results in a judgment against the Company for the Termination Fee or Parent
Expenses, the Company shall pay to Parent its costs and expenses (including reasonable attorney&#146;s
fees) in connection with such suit.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.5 <U>Business Interruption Fee</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;8.5.1 </I>In the event that this Agreement is terminated:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;pursuant to Section&nbsp;8.1(b)(ii), and on the date of such termination the conditions set
forth in Sections&nbsp;7.1.1, 7.1.2, 7.1.4, 7.2.1 and 7.2.2 have been satisfied or, in the case of any
such conditions required to be satisfied on the Closing Date or as of the Effective Time, would be
reasonably capable of being satisfied on the date of termination;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;pursuant to Section&nbsp;8.1(c)(i) and on the date of such termination the conditions set
forth in Sections&nbsp;7.1.2, 7.1.4, 7.2.1 and 7.2.2 have been satisfied or, in the case of any such
conditions required to be satisfied on the Closing Date or as of the Effective Time, would be
reasonably capable of being satisfied on the date of termination;
</DIV>



<P align="center" style="font-size: 10pt">99
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;pursuant to Section&nbsp;8.1(c)(iii), and on the date of such termination the conditions set
forth in Sections&nbsp;7.1.4, 7.2.1 and 7.2.2 have been satisfied or, in the case of any such conditions
required to be satisfied on the Closing Date or as of the Effective Time, would be reasonably
capable of being satisfied on the date of termination; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;pursuant to Section&nbsp;8.1(d)(iii), and on the date of such termination the conditions set
forth in Sections&nbsp;7.1.1, 7.1.2, 7.1.4, 7.2.1 and 7.2.2 have been satisfied or, in the case of any
such conditions required to be satisfied on the Closing Date or as of the Effective Time, would be
reasonable capable of being satisfied on the date of termination, then, in the case of (i), (ii),
(iii)&nbsp;or (iv),
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then, in such event, Parent shall pay the Company the Business Interruption Fee, which amount in any case shall not
be subject to offset or deduction of any kind, except in the event of (iii), if the Company has
retained the Initial BIF Deposit, the Business Interruption Fee shall be reduced by the amount of
the Initial BIF Deposit and any interest that has accrued thereon. The Business Interruption Fee
shall be paid by application of the BIF Deposit and/or by drawing upon the Letter of Credit, or if
the funds in the BIF Deposit account and/or available under the Letter of Credit are insufficient,
by wire transfer of the balance of the Business Interruption Fee owing to the Company in
immediately available funds to an account specified by the Company in writing to Parent on (i)&nbsp;the
date of termination of this Agreement by Parent or (ii)&nbsp;the second Business Day following
termination of this Agreement by the Company. For the avoidance of doubt, in no event shall Parent
be obligated to pay, or cause to paid, the Business Interruption Fee on more than one occasion.
&#147;<U>Business Interruption Fee</U>&#148; shall mean:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;in respect of a termination described in clause (iv)&nbsp;of this Section&nbsp;8.5.1, $7,000,000;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(y)&nbsp;in respect of a termination described in clauses (i), (ii), or (iii)&nbsp;of this Section
8.5.1, (A)&nbsp;at any time prior to the receipt of the Subsequent BIF Deposit or Letter of Credit,
$7,000,000, or (B)&nbsp;at any time following receipt of the Subsequent BIF Deposit or Letter of Credit,
$60,000,000.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;8.5.2 </I>Parent acknowledges that the agreements contained in this Section&nbsp;8.5 are an
integral part of the transactions contemplated in this Agreement, that the damages
</DIV>


<P align="center" style="font-size: 10pt">100
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">resulting from
termination of this Agreement under the circumstances where a Business Interruption Fee is payable
are uncertain and incapable of accurate calculation and that the amounts payable pursuant to
Section&nbsp;8.5.1 are reasonable forecasts of the actual damages that may be incurred and constitute
liquidated damages and not a penalty, and that, without these agreements, the Company would not
enter into this Agreement; accordingly, if Parent fails to promptly pay the Business Interruption
Fee, and, in order to obtain such payment the company commences a suit which results in a judgment
against Parent for the Business Interruption Fee, Parent shall pay to the Company its costs and
expenses (including reasonable attorney&#146;s fees) in connection with such suit.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.6 <U>Extension; Waiver</U>. At any time prior to the Effective Time, the Parties
may, to the extent permitted by applicable Law, subject to Section&nbsp;8.7, (i)&nbsp;extend the time for the
performance of any of the obligations or other acts of the other Parties, (ii)&nbsp;waive any
inaccuracies in the representations and warranties contained herein or in any document delivered
pursuant hereto or (iii)&nbsp;waive compliance with any of the agreements or conditions contained
herein; <I>provided</I>, <I>however</I>, that after any approval of this Agreement by the Company&#146;s
stockholders, there may not be any extension or waiver of this Agreement which decreases the Merger
Consideration or which adversely affects the rights of the Company&#146;s stockholders hereunder without
the approval of such stockholders. Any agreement on the part of a Party to any such extension or
waiver shall be valid only if set forth in a written instrument signed on behalf of such Party.
The failure of any Party to assert any of its rights under this Agreement or otherwise shall not
constitute a waiver of those rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.7 <U>Amendment</U>. This Agreement may be amended by the Parties by action taken by or
on behalf of their respective Boards of Directors at any time prior to the Effective Time;
<I>provided</I>, <I>however</I>, that, after approval of the Agreement by the stockholders of the Company, no
amendment may be made without further stockholder approval which, by Law or in accordance with the
rules of any relevant stock exchange, requires further approval by such stockholders. This
Agreement may not be amended except by an instrument in writing signed by the Parties.
</DIV>

<P align="center" style="font-size: 10pt">101
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Article&nbsp;9<BR>
General Provisions</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.1 <U>Non-Survival of Representations and Warranties</U>. None of the
representations and warranties in this Agreement or in any instrument delivered pursuant to this
Agreement shall survive the Effective Time. This Article&nbsp;9, the agreements of Parent, Merger Sub
and the Company in Section&nbsp;3.5 (Company Equity and Long-Term Incentive Awards), 6.8 (Employee
Matters), Section&nbsp;6.9 (Indemnification of Directors and Officers) and Section&nbsp;8.3 (Fees and
Expenses) and those other covenants and
agreements contained herein that by their terms apply, or that are to be performed in whole or
in part, after the Effective Time shall survive the consummation of the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.2 <U>Notices</U>. Any notices or other communications required or permitted under,
or otherwise in connection with this Agreement, shall be in writing and shall be deemed to have
been duly given when delivered in person or upon confirmation of receipt when transmitted by
facsimile transmission or by electronic mail (but only if followed by transmittal by national
overnight courier or hand for delivery on the next Business Day) or on receipt after dispatch by
registered or certified mail, postage prepaid, addressed, or on the next business day if
transmitted by national overnight courier, in each case as follows:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">If to Parent or Merger Sub, addressed to it at:</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">North American Senior Care, Inc.<BR>
Attention: Mark Goldsmith, Esq.<BR>
Troutman Sanders LLP<BR>
405 Lexington Avenue<BR>
New York, New York 10174<BR>
Facsimile: (212)&nbsp;704-6288<BR>
Email: mark.goldsmith@troutmansanders.com</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">If to SBEV, addressed to it at:</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">SBEV Property Holdings LLC<BR>
c/o Leonard Grunstein, Esq.<BR>
Troutman Sanders LLP<BR>
405 Lexington Avenue<BR>
New York, New York 10174<BR>
Facsimile: (212)&nbsp;704-5910<BR>
Email: leonard.grunstein@troutmansanders.com</DIV>


<P align="center" style="font-size: 10pt">102
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="right">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="91%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="91%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">If to the Company, addressed to it at:</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Beverly Enterprises, Inc.</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">One Thousand Beverly Way</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Fort Smith, Arkansas 72919</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Attention: Douglas J. Babb, Esq.</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Facsimile: (479)&nbsp;201-4801</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Email: Doug_Babb@beverlycorp.com</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">with a mandated copy to:</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Latham &#038; Watkins LLP</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">885 Third Avenue</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">New York, New York 10022-4802</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Attention: Charles M. Nathan</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">John E. Sorkin</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Facsimile: (212)&nbsp;751-4864</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Email: charles.nathan@lw.com</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">john.sorkin@lw.com</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">and</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Covington &#038; Burling</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">1201 Pennsylvania Avenue, NW</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Washington, D.C. 20004</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Attention: Bruce Wilson</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Facsimile: (202)&nbsp;778-5400</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Email: bwilson@cov.com</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.3 <U>Headings</U>. The headings contained in this Agreement are for reference
purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.4 <U>Severability</U>. If any term or other provision of this Agreement is
invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other
conditions and provisions of this Agreement shall nevertheless remain in full force and effect so
long as the economic or legal substance of the transactions contemplated hereby is not affected in
any manner materially adverse to any Party. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good
faith to modify this Agreement so as to effect the original intent of the Parties as closely as
</DIV>

<P align="center" style="font-size: 10pt">103
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to
the greatest extent possible.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.5 <U>SBEV Obligations</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;9.5.1 </I>SBEV is a party to this Agreement solely for purposes of this Article&nbsp;9, and in
accordance with such limited purposes, makes the following representations and warranties: (i)&nbsp;SBEV
has all necessary limited liability company power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions provided for
herein; (ii)&nbsp;the execution and delivery of this Agreement by SBEV and the consummation by SBEV of
the transactions provided for herein have been duly and validly authorized by all necessary limited
liability company action on the part of SBEV and no other proceedings on the part of SBEV are
necessary to authorize this Agreement or to consummate the transactions provided for herein; and
(iii)&nbsp;this Agreement has been duly authorized and validly executed and delivered by SBEV and,
assuming this Agreement is a valid and binding obligation of the Company, this Agreement
constitutes a legal, valid and binding obligation of SBEV, enforceable against SBEV in accordance
with its terms, subject to the Bankruptcy and Equity Exception.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;9.5.2 </I>SBEV shall use its commercially reasonable best efforts to complete the
transactions contemplated by the Commitments in accordance with the terms of the
Commitments (including obtaining rating agency approvals, maintaining in effect the
Commitments, satisfying on a timely basis all conditions applicable to SBEV to obtaining the
financing contemplated by the Commitments (including by consummating the financing contemplated by
the Equity Commitment Letter(s)), negotiating definitive agreements with respect thereto on terms
and conditions contained therein, satisfying all conditions applicable to SBEV in such definitive
agreements that are within its control and, if necessary, borrowing pursuant to the Debt Commitment
Letters in the event the &#147;flex&#148; provisions are exercised), with such changes as SBEV may desire, in
order to have available to Parent the Merger Consideration and other transaction costs at or prior
to the Closing; <I>provided</I>, <I>however</I>, that in no event will SBEV make any changes that would be
reasonably expected to have a material adverse effect on the solvency of the Company upon the
consummation of the Merger; <I>provided</I>, <I>further</I>, that, except as expressly permitted by Section&nbsp;6.14,
such changes must be
</DIV>

<P align="center" style="font-size: 10pt">104
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">approved in writing by the Company (such approval not to be unreasonably
withheld). SBEV agrees to enforce the terms of the Commitments for the benefit of
Parent and Merger
Sub, and to provide the proceeds of loans and funding received thereunder for Parent and Merger Sub for
purposes of paying the Merger Consideration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.6 <U>Entire Agreement</U>. This Agreement (together with the Exhibits, Parent
Disclosure Schedule, Company Disclosure Schedule and the other documents delivered pursuant
hereto), the Commitments and the Confidentiality Agreement constitute the entire agreement of the
Parties and supersede all prior agreements and undertakings, both written and oral, between the
Parties, or any of them, with respect to the subject matter hereof and thereof and, except as
otherwise expressly provided herein, are not (other than in the case of Sections&nbsp;3.5, 6.8, 6.9 and
6.13) intended to confer upon any other Person any rights or remedies hereunder. EACH PARTY HERETO
AGREES THAT, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS AGREEMENT AND THE
DISCLOSURE SCHEDULES, NONE OF PARENT, MERGER SUB AND THE COMPANY MAKES ANY OTHER REPRESENTATIONS OR
WARRANTIES, AND EACH HEREBY DISCLAIMS ANY OTHER REPRESENTATIONS OR WARRANTIES MADE BY ITSELF OR ANY
OF ITS RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, FINANCIAL AND LEGAL ADVISORS OR OTHER
REPRESENTATIVES, WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT OR THE MERGER,
NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO THE OTHER OR THE OTHER&#146;S REPRESENTATIVES OF ANY
DOCUMENTATION OR OTHER INFORMATION WITH RESPECT TO ANY ONE OR MORE OF THE FOREGOING.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.7 <U>Assignment</U>. Neither this Agreement nor any of the rights, interests or
obligations hereunder shall be assigned by any of the Parties (whether by operation of law or
otherwise) without the prior written consent of the other Parties. No assignment by any Party
shall relieve such Party of any of its obligations hereunder. Subject to the foregoing, this
Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their
respective successors and permitted assigns.
</DIV>

<P align="center" style="font-size: 10pt">105
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.8 <U>Mutual Drafting</U>. Each Party has participated in the drafting of this Agreement, which each Party
acknowledges is the result of extensive negotiations between the Parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.9 <U>Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;9.9.1 </I>This Agreement shall be governed by, and construed in accordance with, the Laws
of the State of Delaware, without regard to conflict of law principles that would result in the
application of any law other than the law of the State of Delaware.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Section&nbsp;9.9.2 </I>The Parties agree that irreparable damage would occur in the event that any of
the provisions of this Agreement were not performed in accordance with their specific terms or were
otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction
or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and
provisions of this Agreement, in addition to any other remedy to which they are entitled pursuant
to the terms of this Agreement, at law or in equity. Any legal action, suit or proceeding arising
out of or relating to this Agreement or the transactions contemplated hereby shall be brought
solely in the Chancery Court of the State of Delaware; <I>provided</I>, that if (and only after) such
courts determine that they lack subject matter jurisdiction over any such legal action, suit or
proceeding, such legal action, suit or proceeding shall be brought in the Federal courts of the
United States located in the State of Delaware; <I>provided</I>, <I>further</I>, that if (and only after) both
the Chancery Court of the State of Delaware and the Federal courts of the United States located in
the State of Delaware determine that they lack subject matter jurisdiction over any such legal
action, suit or proceeding, such legal action, suit or proceeding shall be brought in the United
States District Court for the Southern District of New York. Each Party hereby irrevocably submits
to the exclusive jurisdiction of such courts in respect of any legal action, suit or proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby, and hereby
waives, and agrees not to assert, as a defense in any such action, suit or proceeding, any claim
that it is not subject personally to the jurisdiction of such courts, that the action, suit or
proceeding is brought in an inconvenient forum, that the venue of the action, suit or proceeding is
improper or that this Agreement or the transactions contemplated hereby may not be enforced in or
by such courts. Each Party agrees that notice or the service of
process in any action, suit or proceeding arising out of or relating to this Agreement or the

<P align="center" style="font-size: 10pt">106
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">transactions contemplated hereby shall be properly served or delivered if delivered in the manner
contemplated by Section&nbsp;9.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.10 <U>Counterparts</U>. This Agreement may be executed by facsimile and in one or
more counterparts, and by the different Parties in separate counterparts, each of which when
executed shall be deemed to be an original but all of which taken together shall constitute one and
the same agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.11 <U>Specific Performance</U>. The Company acknowledges and agrees that the
Parent would be damaged irreparably in the event that the obligations of the Company to close the
transactions contemplated by this Agreement and to call and hold a Company Stockholders Meeting
pursuant to Sections&nbsp;6.2.3 and 6.4.2 hereof, are not performed in accordance with their specific
terms or are otherwise breached. Accordingly, the Company agrees that Parent shall be entitled to
an injunction or injunctions, and to enforce specifically (i)&nbsp;the closing under this Agreement as
long as the Company is not entitled to terminate this Agreement and all of the conditions to the
Company&#146;s obligations in Article&nbsp;7 shall have been fulfilled and (ii)&nbsp;the obligations of the
Company under Sections&nbsp;6.2.3 and 6.4.2 to duly call, give notice of, convene and hold a Company
Stockholders Meeting for the purposes of the approving the Merger, approving and adopting this
Agreement and approving the transactions contemplated by this Agreement, in any court having
personal and subject matter jurisdiction, in addition to any other remedy to which Parent may be
entitled at law or in equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.12 <U>Representations and Warranties and Company Disclosure Schedule</U>. The
Company will identify disclosures in the Company Disclosure Schedule by referring to a specific
section of this Agreement with cross references to other sections to which the disclosure of any
such fact or item is relevant; <I>provided</I>, that the Company will be deemed to have disclosed the
relevant fact or item with respect to another section without a cross-reference so long as the
relevance of such disclosure to such other section is reasonably apparent on the face of the
Company Disclosure Schedule; <I>provided</I>, <I>further</I>, that the failure to repeat an item
identified in a section of the Company Disclosure Schedule, employ a section reference or
cross-reference such item in another section where such reference would be appropriate and is not
reasonably apparent on the face of the Company Disclosure Schedule, shall not, in and of itself,
constitute a breach of a representation or warranty of the section from which the reference is
omitted.
</DIV>

<P align="center" style="font-size: 10pt">107
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this Agreement to be
executed as of the date first written above by their respective officers thereunto duly authorized.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="66%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="7" valign="top" align="left"><B>NORTH AMERICAN SENIOR CARE, INC.</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Mark Goldsmith
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name: Mark Goldsmith</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title: President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="7" valign="top" align="left"><B>NASC ACQUISITION CORP.</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Mark Goldsmith</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name: Mark Goldsmith</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title: President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="7" valign="top" align="left"><B>BEVERLY ENTERPRISES, INC.</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ William R. Floyd</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name: William R. Floyd</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title: Chairman, President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="7" valign="top" align="left"><B>SBEV PROPERTY HOLDINGS LLC</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Leonard Grunstein</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name: Leonard Grunstein</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title: Manager</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">108
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Exhibit&nbsp;A</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>AMENDED AND RESTATED<BR>
CERTIFICATE OF INCORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>OF</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>NASC ACQUISITION CORP.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The original Certificate of Incorporation of NASC Acquisition Corp. (the &#147;Corporation&#148;), as
filed with the Delaware Secretary of State on August&nbsp;9, 2005, is hereby amended and restated as
permitted by Section&nbsp;241 of the General Corporation Law of the State of Delaware (&#147;DGCL&#148;) by
deleting said Certificate of Incorporation in its entirety and amending and restating the same as
set forth herein. In accordance with Section 241(b) of the DGCL, this Amended and Restated
Certificate of Incorporation (the &#147;Amended and Restated Certificate of Incorporation&#148;) was duly
adopted and approved by the sole Incorporator of the Corporation on August&nbsp;15, 2005. The
Corporation has not received any payment for any of its stock and the Amended and Restated
Certificate was duly adopted in accordance with the provisions of Sections&nbsp;241 and 245 of the DGCL.
The Corporation&#146;s Certificate of Incorporation is hereby amended and restated in its entirety as
follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>FIRST</U>: The name of the Corporation is NASC Acquisition Corp.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SECOND</U>: The address, including street, number, city, and county, of the registered
office of the Corporation in the State of Delaware is 1209 Orange Street, Wilmington, New Castle
County, Delaware 19801 and the name of the registered agent of the Corporation is The Corporation
Trust Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>THIRD</U>: The purpose of the Corporation is to engage in any lawful act or activity for
which a corporation may be organized under the DGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>FOURTH</U>: The aggregate number of shares that the Corporation shall have authority to
issue is 100,000 shares designated as common stock, par value $0.01 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FIFTH: &#091;Intentionally omitted.&#093;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SIXTH: The Corporation is to have perpetual existence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SEVENTH</U>: Whenever a compromise or arrangement is proposed between the Corporation and
its creditors or any class of them and/or between the Corporation and its stockholders or any class
of them, any court of equitable jurisdiction within the State of Delaware may, on the application
in a summary way of the Corporation or of any creditor or stockholder thereof or on the
application of any receiver or receivers appointed for the Corporation under the provisions of
Section&nbsp;291 of the DGCL or on the application of trustees in dissolution or of any receiver or
receivers appointed for the Corporation under Section&nbsp;279 of the DGCL order a meeting of the
creditors or class of creditors, and/or of the stockholders or class of stockholders, of the
Corporation, as the case may be, to be summoned in such manner as the
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">said court directs. If a majority in number representing three-fourths in value of the
creditors or class of creditors, and/or of the stockholders or class of stockholders, of the
Corporation, as the case may be, agree to any compromise or arrangement and to any reorganization
of the Corporation as consequence of such compromise or arrangement, the said compromise or
arrangement and the said reorganization shall, if sanctioned by the court to which the said
application has been made, be binding on all the creditors or class of creditors, and/or on all the
stockholders or class of stockholders, of the Corporation, as the case may be, and also on the
Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>EIGHTH</U>:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The governing board of the Corporation shall be known as the Board of Directors, and the
number of directors may from time to time be increased or decreased in such manner as shall be
provided by the bylaws of the Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In furtherance of and not in limitation of the powers conferred by statute, the Board of
Directors is expressly authorized to adopt, amend or repeal the bylaws of the Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Elections of directors need not be by written ballot unless the bylaws of the Corporation
shall so provide.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NINTH</U>:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A director of this Corporation shall not be liable to the Corporation or its stockholders for
monetary damages for breach of fiduciary duty as a director, except to the extent such exemption
from liability or limitation thereof is not permitted under the DGCL as the same exists or may
hereafter be amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any amendment, repeal or modification of the foregoing paragraph shall not adversely affect
any right or protection of a director of the Corporation existing hereunder with respect to any act
or omission occurring prior to such amendment, repeal or modification.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>TENTH</U>:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Corporation shall indemnify to the full extent permitted by law (such as it presently
exists or may hereafter be amended) any person made, or threatened to be made, a defendant or
witness to any action, suit or proceeding (whether civil, criminal, administrative or
investigative), by reason of the fact that such person is or was a director or officer of the
Corporation or by reason of the fact that such director or officer, at the request of the
Corporation, is or was serving any other corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise, in any capacity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any amendment, repeal or modification of the foregoing paragraph shall not adversely affect
any right or protection of such person existing hereunder with respect to any act or omission
occurring prior to such amendment, repeal or modification.
</DIV>

<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>ELEVENTH</U>: The Corporation reserves the right to amend, alter, change or repeal any
provision contained in this Amended and Restated Certificate of Incorporation, in the manner now or
hereafter prescribed by statute, and all rights conferred upon stockholders herein are granted
subject to this reservation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE UNDERSIGNED, has executed this Amended and Restated Certificate of Incorporation as of
August&nbsp;16, 2005.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">     /s/ Ron Steinfeld
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Ron Steinfeld, Incorporator&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center" style="font-size: 10pt; margin-top: 6pt">BY-LAWS
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">OF
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">NASC ACQUISITION CORP.<BR>
_____________
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">&nbsp;<BR>
ARTICLE I
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">OFFICES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1. REGISTERED OFFICE. The corporation&#146;s registered office in the State of Delaware
shall be established and maintained at the office of The Corporation Trust Company, 1209 Orange
Street, Wilmington, New Castle County, Delaware 19801, and such office shall be the registered
agent of this corporation in charge of the corporation&#146;s registered office in the State of
Delaware.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2. OTHER OFFICES. The corporation may have other offices, either within or without
the State of Delaware, at such place or places as the Board of Directors may from time to time
appoint or the business of the corporation may require.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ARTICLE II
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">MEETINGS OF STOCKHOLDERS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1. ANNUAL MEETINGS. Annual meetings of stockholders for the election of directors and
for such other business as may be stated in the notice of the meeting, shall be held at such place,
either within or without the State of Delaware, and at such time and date as the Board of
Directors, by resolution, shall determine and as set forth in the notice of the meeting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the date of the annual meeting shall fall upon a legal holiday, the meeting shall be held
on the next succeeding business day. At each annual meeting, the stockholders entitled to vote
shall elect a Board of Directors and they may transact such other corporate business as shall be
stated in the notice of the meeting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2. OTHER MEETINGS. Meetings of stockholders for any purpose other than the election
of directors may be held at such time and place, within or without the State of Delaware, as shall
be stated in the notice of the meeting.
</DIV>


<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3. VOTING. Each stockholder entitled to vote in accordance with the terms of the
corporation&#146;s certificate of incorporation and these by-laws shall be entitled to vote, in person
or by proxy, but no proxy shall be voted after three years from its date unless that proxy provides
for a longer period. Upon the demand of any stockholder, the vote for directors and the vote upon
any question before the meeting, shall be by ballot. All elections for directors shall be decided
by plurality vote and all other votes shall be decided by majority vote except as otherwise
provided by the corporation&#146;s certificate of incorporation or the laws of the State of Delaware.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4. QUORUM. Except as otherwise required by law, by the corporation&#146;s certificate of
incorporation or by these by-laws, the presence, in person or by proxy, of stockholders holding a
majority of the stock of the corporation entitled to vote shall constitute a quorum at all meetings
of the stockholders. In case a quorum shall not be present at any meeting, a majority in interest
of the stockholders entitled to vote thereat, present in person or by proxy, shall have power to
adjourn the meeting from time to time, without notice other than announcement at the meeting, until
the requisite amount of stock entitled to vote shall be present. At any such adjourned meeting at
which the requisite amount of stock entitled to vote shall be represented, any business may be
transacted that might have been transacted at the meeting as originally noticed; but only those
stockholders entitled to vote at the meeting as originally noticed shall be entitled to vote at any
adjournment or adjournments thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5. SPECIAL MEETINGS. Special meetings of the stockholders for any purpose or purposes
may be called by the Chairman of the Board, the Chief Executive Officer, the President or the
Secretary, or by resolution of the majority of the Board of Directors or by vote of the
stockholders holding 25% or more of the outstanding stock of the corporation. Any business
(regardless of whether specified in the notice of meeting) may be conducted at a special meeting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6. NOTICE OF MEETINGS. Written notice, stating the place, date and time of the
meeting, and the general nature of the business to be considered, shall be given to each
stockholder entitled to vote thereat at his address as it appears on the records of the
corporation, not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date of the meeting.
No business other than that stated in the notice shall be transacted at any meeting without the
unanimous consent of all the stockholders entitled to vote thereat.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7. ACTION WITHOUT MEETING. Unless otherwise provided by the corporation&#146;s certificate
of incorporation, any action required to be taken at any annual or special meeting of stockholders,
or any action that may be taken at any annual or special meeting, may be taken without a meeting,
without prior notice and without a vote, if a consent in writing, setting forth the action so
taken, shall be signed by the holders of outstanding stock having not less than the minimum number
of votes that would be necessary to authorize or take that action at a meeting at which all shares
entitled to vote thereon were present and voted. Prompt notice of the taking of the corporate
action without a meeting by less than unanimous written consent shall be given to those
stockholders who have not consented in writing.
</DIV>


<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ARTICLE III
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">DIRECTORS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1. NUMBER AND TERM. The number of directors constituting the Board of Directors shall
be not more than ten (10)&nbsp;nor less than one (1), as fixed from time to time in these by-laws or by
action of the Board of Directors. The initial number of directors shall be one (1). Except as
otherwise permitted in these by-laws (including but not limited to Section&nbsp;3 of this Article&nbsp;III)
or as otherwise permitted under the applicable provisions of the Delaware General Corporation Law
(including but not limited to section 223 thereof), the directors shall be elected at the annual
meeting of the stockholders. Each director shall be elected to serve until his or her successor
shall be elected and shall qualify. Directors need not be stockholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2. RESIGNATIONS. Any director, member of a committee or other officer may resign at
any time. That resignation shall be made in writing, and shall take effect at the time specified
therein, and if no time be specified, at the time of its receipt by the Chief Executive Officer,
President or Secretary. The acceptance of a resignation shall not be necessary to make it
effective.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3. VACANCIES. If the office of any director becomes vacant for whatever reason
(including by reason of retirement, resignation, death or disability, or as a result of removal for
or without cause or as a result of an increase in the number of directors), then such vacancy may
be filled by a majority of the directors then in office, though less than a quorum, or, if no such
director exists, such vacancy may be filled by the stockholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4. REMOVAL. Except as hereinafter provided, any director or directors may be removed
either for or without cause at any time by the affirmative vote of the holders of a majority of all
the shares of stock outstanding and entitled to vote, at a special meeting of the stockholders
called for the purpose, and (without limiting the power of the directors then remaining in office
to fill such vacancy pursuant to Section&nbsp;3 of this Article&nbsp;III) the vacancies thus created may be
filled, at the meeting held for the purpose of such removal, by the affirmative vote of a majority
in interest of the stockholders entitled to vote.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the holders of any class or series are entitled to elect one or more directors by the
provisions of the corporation&#146;s certificate of incorporation, these provisions shall apply, with
respect to the removal without cause of a director or directors so elected, to the vote of the
holders of the outstanding shares of that class or series and not to the vote of the outstanding
shares as a whole.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5. INCREASE OR DECREASE OF NUMBER. The number of directors may be increased or
decreased by the affirmative vote of a majority of the directors, though less than a quorum, or by
the affirmative vote of a majority in interest of the stockholders. No decrease in the number of
directors shall reduce the term of any person then serving as a director.
</DIV>


<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6. POWERS. The Board of Directors shall exercise all of the powers of the corporation
except such powers as are by law, or by the corporation&#146;s certificate of incorporation or by these
by-laws, conferred upon or reserved to the stockholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7. COMMITTEES. The Board of Directors may, by resolution or resolutions passed by a
majority of the whole board, designate one or more committees, each committee to consist of one or
more of the directors of the corporation. The board may designate one or more directors as
alternate members of any committee, who may replace any absent or disqualified member at any
meeting of the committee. In the absence or disqualification of any member of a committee, the
member or members thereof present at any meeting and not disqualified from voting, whether or not
he or they constitute a quorum, may unanimously appoint another member of the Board of Directors to
act at the meeting in the place of the absent or disqualified member or members.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any committee, to the extent provided in the resolution of the Board of Directors, or in these
by-laws, shall have and may exercise all the powers and authority of the Board of Directors in the
management of the business and affairs of the corporation; but no committee shall have the power or
authority in reference to amending the corporation&#146;s certificate of incorporation, adopting an
agreement of merger or consolidation, recommending to the stockholders the sale, lease or exchange
of all or substantially all of the corporation&#146;s property and assets, recommending to the
stockholders a dissolution of the corporation or a revocation of a dissolution, or amending the
by-laws of the corporation; and, unless the resolution, these by-laws or the corporation&#146;s
certificate of incorporation expressly so provide, no committee shall have the power or authority
to declare a dividend or to authorize the issuance of stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8. MEETINGS. The directors elected upon any annual meeting of the stockholders may
hold their first meeting for the purpose of organization and the transaction of business, if a
quorum be present, immediately after the annual meeting of the stockholders; or the time and place
of that meeting may be fixed by consent in writing of all the directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regular meetings of the directors may be held without notice at such places and times as shall
be determined from time to time by resolution of the directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special meetings of the board may be called by the Chairman of the Board, the Chief Executive
Officer, the President or the Secretary on the written request of a majority of the directors on at
least two days notice to each director and shall be held at such place or places as may be
determined by the directors, or as shall be stated in the call of the meeting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise restricted by the corporation&#146;s certificate of incorporation or these
by-laws, members of the Board of Directors, or any committee designated by the Board of Directors,
may participate in a meeting of the Board of Directors, or any committee, by means of conference
telephone or similar communications equipment by means of which all persons participating in the
meeting can hear each other, and such participation in a meeting shall constitute presence in
person at the meeting.
</DIV>


<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9. QUORUM. A majority of the directors shall constitute a quorum for the transaction
of business. If at any meeting of the board there shall be less than a quorum present, a majority
of those present may adjourn the meeting from time to time until a quorum is obtained, and no
further notice thereof need be given other than by announcement at the meeting that is so
adjourned.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 10. COMPENSATION. Directors shall not receive any stated salary for their services as
directors or as members of committees, but by resolution of the board a fixed fee and expenses of
attendance may be allowed for attendance at each meeting. Nothing in these by-laws shall be
construed to preclude any director from serving the corporation in any other capacity as an
officer, agent or otherwise, and receiving compensation therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 11. ACTION WITHOUT MEETING. Any action required or permitted to be taken at any
meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting, if
a written consent thereto is signed by all members of the board or committee, as the case may be,
and that written consent is filed with the minutes of proceedings of the board or committee.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ARTICLE IV
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">OFFICERS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1. OFFICERS. The officers of the corporation shall be a President and a Secretary,
each of whom shall be elected by the Board of Directors and who shall hold office until their
successors are elected and qualified. In addition, the Board of Directors may elect a Chairman of
the Board, a Chief Executive Officer, a Chief Operating Officer, a Chief Financial Officer, a
Treasurer, one or more Vice Presidents and such Assistant Secretaries and Assistant Treasurers as
it may deem proper. None of the officers of the corporation need be directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the foregoing officers shall have the power and authority to sign instruments and
stock certificates in accordance with section 103(a)(2) of the Delaware General Corporation Law and
to sign agreements on behalf of the corporation. The officers shall be elected at the first
meeting of the Board of Directors after each annual meeting of the stockholders. Any two or more
offices may be held at the same time by the same person. Any officer may be removed, with or
without cause, by the Board of Directors. Any vacancy may be filled by the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2. OTHER OFFICERS AND AGENTS. The Board of Directors may appoint such other officers
and agents as it may deem advisable, who shall hold their offices for such terms and shall exercise
such powers and perform such duties as shall be determined from time to time by the Board of
Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3. CHAIRMAN OF THE BOARD. The Chairman of the Board, if one be elected, shall be a
director of the corporation, shall preside at all meetings of the stockholders and at all meetings
of the Board of Directors, and shall have such other power and
</DIV>
<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">authority and perform such other duties as may be prescribed by these by-laws or as may be
assigned from time to time by the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.
CHIEF EXECUTIVE OFFICER. The Chief Executive Officer, if one be elected, shall, in
the absence or disability of the Chairman of the Board, preside at all meetings of the stockholders
and at all meetings of the Board of Directors, and shall have general supervision, direction and
control of the business and affairs of the corporation subject to the authorization and control of
the Board of Directors, and shall have such other power and authority and perform such other duties
as may be prescribed by these by-laws or as may be assigned from time to time by the Board of
Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5. PRESIDENT. The President shall, in the absence or disability of the Chairman of the
Board and the Chief Executive Officer, preside at all meetings of the stockholders and at all
meetings of the Board of Directors, and shall have such other power and authority and perform such
other duties as may be prescribed by these by-laws or as may be assigned from time to time by the
Board of Directors or the Chief Executive Officer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the absence or disability of the Chief Executive Officer, or if no Chief Executive Officer
is elected, the President, if available, shall have the authority, and shall perform the duties, of
the Chief Executive Officer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6. CHIEF OPERATING OFFICER. The Chief Operating Officer, if one be elected, shall have
such power and authority and perform such duties as may be prescribed by these by-laws or as may be
assigned from time to time by the Board of Directors, the Chief Executive Officer or the President.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the absence or disability of the President, the Chief Operating Officer, if available,
shall have the authority, and shall perform the duties, of the President. In addition, in the
absence or disability of the Chief Executive Officer and the President, the Chief Operating
Officer, if available, shall have the authority and perform the duties of the Chief Executive
Officer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7. CHIEF FINANCIAL OFFICER. The Chief Financial Officer, if one be elected, shall have
the custody of the corporate funds and securities, shall keep full and accurate account of receipts
and disbursements in books belonging to the corporation and shall deposit all moneys and other
valuables in the name and to the credit of the corporation in such depositories as may be
designated by the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Chief Financial Officer shall disburse the funds of the corporation as may be ordered by
the Board of Directors, the Chief Executive Officer or the President, taking proper vouchers for
such disbursements. He shall render to the Chief Executive Officer, the President and the Board of
Directors at the regular meetings of the Board of Directors, or whenever they may request it, an
account of all his transactions as Chief Financial Officer and of the financial condition of the
corporation. If required by the Board of Directors, he shall give the corporation a bond for the
faithful discharge of his duties in such amount and with such surety as the Board of Directors
shall prescribe.
</DIV>


<P align="center" style="font-size: 10pt">9
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8. VICE PRESIDENT. Each Vice President shall have such power and authority and
perform such duties as may be prescribed by these by-laws or as may be assigned from time to time
by the Board of Directors, the Chief Executive Officer, the President or the Chief Operating
Officer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors may designate one or more Vice Presidents, in such order of priority as
shall be specified by the Board of Directors, to have the authority and to perform the duties of
(i)&nbsp;the Chief Executive Officer in the absence or disability of the Chief Executive Officer, the
President and the Chief Operating Officer, (ii)&nbsp;the President in the absence or disability of the
President and the Chief Operating Officer, and (iii)&nbsp;the Chief Operating Officer in the absence or
disability of the Chief Operating Officer; provided, however, that no Vice President shall have
such authority or perform such duties unless specifically designated for that purpose by the Board
of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9. TREASURER. The Treasurer, if one be elected, shall have such power and authority
and perform such other duties as may be prescribed by these by-laws or as may be assigned from time
to time by the Board of Directors, the Chief Executive Officer, the President or the Chief
Financial Officer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the absence or disability of the Chief Financial Officer, the Treasurer, if available,
shall have the authority, and shall perform the duties, of the Chief Financial Officer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 10. SECRETARY. The Secretary shall give, or cause to be given, notice of all meetings
of stockholders and directors, and all other notices required by law or by these by- laws, and in
case of his absence or refusal or neglect so to do, any such notice may be given by any person
thereunto directed by the Chief Executive Officer, the President, the Chairman of the Board or by
the Board of Directors or stockholders, upon whose requisition the meeting is called as provided in
these by- laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Secretary shall record all the proceedings of the meetings of the corporation and of the
directors in a book to be kept for that purpose, and shall perform such other duties as may be
assigned to him by the Chief Executive Officer, the President or the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 11. ASSISTANT TREASURERS AND ASSISTANT SECRETARIES. Assistant Treasurers, if any shall
be elected, shall, in the absence of the Treasurer, have the authority, and perform the duties, of
the Treasurer, and shall have such other power and authority and perform such other duties as may
be prescribed by these by-laws or as may be assigned from time to time by the Board of Directors,
the Chief Executive Officer, the President or the Treasurer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assistant Secretaries, if any shall be elected, shall, in the absence of the Secretary, have
the authority, and perform the duties, of the Secretary, and shall have such other power and
authority and perform such other duties as may be prescribed by these by-laws or as may be assigned
from time to time by the Board of Directors, the Chief Executive Officer, the President or the
Secretary.
</DIV>


<P align="center" style="font-size: 10pt">10
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ARTICLE V
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">INDEMNIFICATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1. RIGHT TO INDEMNIFICATION. The Corporation shall indemnify and hold harmless, to
the fullest extent permitted by applicable law as it presently exists or may hereafter be amended,
any person who was or is made or is threatened to be made a party or is otherwise involved in any
action, suit or proceeding, whether civil, criminal, administrative or investigative (a
&#147;proceeding&#148;) by reason of the fact that he or she, or a person for whom he or she is the legal
representative, is or was a Director or Officer of the Corporation, a Director or Officer of
Beverly Enterprises, Inc., a Delaware corporation (&#147;Beverly&#148;), a Director or Officer of Beverly
Enterprises, a California corporation (&#147;Beverly California&#148;), prior to the merger of Beverly
Merger, Inc., a subsidiary of Beverly organized under California law, into Beverly California, or
is or was serving at the request of the Corporation as a Director, Officer, employee, fiduciary or
agent of another corporation or of a partnership, joint venture, trust, enterprise or nonprofit
entity, including service with respect to employee benefit plans, against all liability and loss
suffered and expenses reasonably incurred by such person. The Corporation shall indemnify a person
in connection with a proceeding initiated by such person only if the proceeding was authorized by
the Board of Directors of the Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2. PREPAYMENT OF EXPENSE. The Corporation shall pay the expenses incurred in
defending any proceeding in advance of its final disposition, <U>provided</U>, <U>however</U>, that the payment
of expenses incurred by a Director or Officer in his or her capacity as a Director or Officer in
advance of the final disposition of the proceeding shall be made only upon receipt of an
undertaking by the Director or Officer to repay all amounts advanced if it should be ultimately
determined by that the Director or Officer is not entitled to be indemnified under this Article or
otherwise.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3. CLAIMS. If a claim for indemnification or payment of expenses under this Article&nbsp;V
is not paid in full within ninety (90)&nbsp;days after a written claim therefor has been received by the
Corporation, the claimant may file suit to recover the unpaid amount of such claim arid, if
successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim.
In any such action the Corporation shall have the burden of proving that the claimant was not
entitled to the requested indemnification or payment of expenses under applicable law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4. NONEXCLUSIVITY OF RIGHTS. The rights conferred on any person by this Article&nbsp;V
shall not be exclusive of any other right which such person may have or hereafter acquire under any
statute, provision of the Certificate of Incorporation of the Corporation, these By-laws,
agreement, vote of stockholders or disinterested directors or otherwise.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5. CONTRACTS AND ARRANGEMENTS. The Corporation may enter into contracts providing
indemnification to the full extent authorized or permitted by the General Corporation Law of the
State of Delaware and may create a trust fund, grant a security
</DIV>

<P align="center" style="font-size: 10pt">11
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">interest and/or use other means (including, without limitation, letters of credit, surety
bonds and other similar arrangements) to ensure the payment of such amounts as may become necessary
to effect indemnification pursuant to such contracts or otherwise.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6. AMENDMENT OR REPEAL. Any repeal or modification of the foregoing provisions of
this Article&nbsp;V shall not adversely affect any right or protection of any person in respect of any
act or omission occurring prior to the time of such repeal or modification.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ARTICLE VI
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">MISCELLANEOUS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1. CERTIFICATES OF STOCK. Certificates of stock, signed by the Chairman of the Board
of Directors, the Chief Executive Officer, the President or a Vice President, and the Chief
Financial Officer or the Treasurer or an Assistant Treasurer or Secretary or an Assistant
Secretary, shall be issued to each stockholder certifying the number of shares owned by him in the
corporation. Any or all the signatures may be facsimiles.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2. FRACTIONAL SHARE INTERESTS. The Corporation may, but shall not be required to,
issue fractions of a share. If the Corporation does not issue fractions of a share, the Board of
Directors shall determine how to compensate those entitled to such fractions of a share.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3. LOST CERTIFICATES. A new certificate of stock may be issued in the place of any
certificate theretofore issued by the corporation, alleged to have been lost or destroyed, and the
directors may, in their discretion, require the owner of the lost or destroyed certificate, or his
legal representatives, to give the corporation a bond, in such sum as they may direct, not
exceeding double the value of the stock, to indemnify the corporation against any claim that may be
made against it on account of the alleged loss of the certificate or the issuance of the new
certificate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4. TRANSFER OF SHARES. The shares of stock of the corporation shall be transferable
only upon its books by the holders thereof in person or by their duly authorized attorneys or legal
representatives, and upon transfer the old certificates shall be surrendered to the corporation by
the delivery thereof to the person in charge of the stock and transfer books and ledgers, or to
such other person as the directors may designate, by whom they shall be canceled, and new
certificates shall thereupon be issued. A record shall be made of each transfer and whenever a
transfer shall be made for collateral security, and not absolutely, it shall be so expressed in the
entry of the transfer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5. STOCKHOLDERS RECORD DATE. In order that the corporation may determine the
stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment
thereof, or to express consent to corporate action in writing without a meeting, or entitled to
receive payment of any dividend or other distribution or allotment of any rights, or entitled to
exercise any rights in respect of any change, conversion or

<P align="center" style="font-size: 10pt">12
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">exchange of stock or for the purpose of any other lawful action, the Board of Directors may
fix, in advance, a record date, which shall not be more than sixty (60)&nbsp;nor less than ten (10)&nbsp;days
before the date of the meeting, nor more than sixty (60)&nbsp;days before any other action. A
determination of stockholders of record entitled to notice of or to vote at a meeting of
stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of
Directors may fix a new record date for the adjourned meeting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6. DIVIDENDS. Subject to the provisions of the corporation&#146;s certificate of
incorporation, the Board of Directors may, out of funds legally available therefor at any regular
or special meeting, declare dividends upon the capital stock of the corporation as and when they
deem expedient. Before declaring any dividend there may be set apart out of any funds of the
corporation available for dividends, such sum or sums as the directors from time to time in their
discretion deem proper for working capital or as a reserve fund to meet contingencies or for
equalizing dividends or for such other purposes as the directors shall deem conducive to the
interests of the corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7. FISCAL YEAR. The fiscal year of the corporation shall be determined by resolution
of the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8. CHECKS. All checks, drafts or other orders for the payment of money, notes or
other evidences of indebtedness issued in the name of the corporation shall be signed by such
officer or officers or agent or agents of the corporation, and in such manner, as shall be
determined from time to time by resolution of the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9. NOTICE AND WAIVER OF NOTICE. Whenever any notice is required by these by-laws to
be given, personal notice is not meant unless expressly so stated, and any notice so required shall
be deemed to be sufficient if given by depositing the same in the United States mail, postage
prepaid, addressed to the person entitled thereto at his address as it appears on the records of
the corporation, and such notice shall be deemed to have been given on the day of the mailing.
Stockholders not entitled to vote shall not be entitled to receive notice of any meetings except as
otherwise provided by statute.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever any notice whatsoever is required to be given under the provisions of any law, or
under the provisions of the corporation&#146;s certificate of incorporation or these by-laws, a waiver
thereof in writing, signed by the person or persons entitled to that notice, whether before or
after the time stated therein, shall be deemed equivalent to that notice.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ARTICLE VII
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">AMENDMENTS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These by-laws may be altered or repealed and by-laws may be made at any annual meeting of the
stockholders or at any special meeting thereof if notice of the proposed alteration or repeal of
the by-law or by-laws to be made be contained in the notice of that special meeting, by the
affirmative vote of a majority of the stock issued and outstanding and entitled to vote thereat or
by action without a meeting of stockholders pursuant to Section&nbsp;7 of Article&nbsp;II of these
</DIV>

<P align="center" style="font-size: 10pt">13
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">by-laws, or by the affirmative vote of a majority of the Board of Directors, at any regular
meeting of the Board of Directors, or at any special meeting of the Board of Directors, if notice
of the proposed alteration or repeal, or of the by-law or by-laws to be made, be contained in the
notice of that special meeting or by action without a meeting of directors pursuant to Section&nbsp;11
of Article&nbsp;III of these by-laws.
</DIV>


<P align="center" style="font-size: 10pt">14
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>Exhibit&nbsp;B</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">FORM OF LETTER OF CREDIT
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="43%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">ISSUE DATE: &#091;_________ __&#093;, 2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">L/C NO.: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">APPLICANT:</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">&#091;_________________________&#093;<BR>
&#091;_________________________&#093;<BR>
&#091;_________________________&#093;<BR>
&#091;_________________________&#093;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">BENEFICIARY:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">BEVERLY ENTERPRISES, INC.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">AMOUNT: USD 53,000,000.00</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ONE THOUSAND BEVERLY WAY
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(FIFTY THREE MILLION AND 00/100</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">FORT SMITH, ARKANSAS 72919
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UNITED STATES DOLLARS)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WE HEREBY ESTABLISH THIS IRREVOCABLE STANDBY LETTER OF CREDIT NO. <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (THIS &#147;LETTER
OF CREDIT&#148;) FOR AN AGGREGATE AMOUNT NOT TO EXCEED THE AMOUNT INDICATED ABOVE (THE &#147;STATED AMOUNT&#148;),
EXPIRING AT OUR COUNTERS WITH OUR CLOSE OF BUSINESS ON <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (THE &#147;SCHEDULED TERMINATION
DATE&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ADDITIONAL TERMS AND CONDITIONS OF THIS LETTER OF CREDIT ARE SET FORTH IN ANNEX I HERETO AND SUCH
TERMS AND CONDITIONS ARE HEREBY INCORPORATED INTO THIS LETTER OF CREDIT. THIS LETTER OF CREDIT
CANNOT BE MODIFIED OR REVOKED WITHOUT THE CONSENT OF THE BENEFICIARY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THIS LETTER OF CREDIT IS AVAILABLE WITH &#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;, AGAINST PRESENTATION OF YOUR DRAW
CERTIFICATE IN THE FORM ATTACHED HERETO AS ANNEX II WITH BLANKS APPROPRIATELY FILLED IN.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ANY AMOUNT DRAWN HEREUNDER MAY NOT EXCEED THE STATED AMOUNT OF THE LETTER OF CREDIT.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ALL CORRESPONDENCE AND ANY DRAWINGS HEREUNDER ARE TO BE DIRECTED TO:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 6%; margin-top: 6pt">&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;<BR>
&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-left: 6%; margin-top: 6pt">&#091;_____________ __ _________&#093;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WE HEREBY AGREE WITH YOU THAT DRAFTS DRAWN UNDER AND IN COMPLIANCE WITH THE TERMS AND CONDITIONS OF
THIS LETTER OF CREDIT WILL BE DULY HONORED.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">PAYMENT UNDER THIS LETTER OF CREDIT SHALL BE MADE IN IMMEDIATELY AVAILABLE FUNDS BY WIRE TRANSFER
TO SUCH ACCOUNT AS MAY BE SPECIFIED BY THE BENEFICIARY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THIS IRREVOCABLE STANDBY LETTER OF CREDIT IS ISSUED SUBJECT TO THE INTERNATIONAL STANDBY PRACTICES
1998, INTERNATIONAL CHAMBER OF COMMERCE PUBLICATION NO. 590 (ISP98) AND AS TO MATTERS NOT
ADDRESSED BY THE ISP98 THIS LETTER OF CREDIT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THE NUMBER AND THE DATE OF OUR CREDIT AND THE NAME OF OUR BANK MUST BE QUOTED ON ALL DRAFTS
REQUIRED.
</DIV>


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ANNEX I
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">to Irrevocable Standby Letter of Credit No. &#091;______________&#093;
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">issued by &#091;______________&#093;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Additional Terms and Conditions of the Letter of Credit
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Letter of Credit is issued in connection with the transactions provided for in that certain
Agreement and Plan of Merger, dated as of August&nbsp;16, 2005 (the &#147;<U>Merger Agreement</U>&#148;), by and
among North American Senior Care, Inc. (&#147;<U>Parent</U>&#148;), NASC Acquisition Corp. (&#147;<U>Merger
Sub</U>&#148;), and Beverly Enterprises, Inc. (the &#147;<U>Company</U>&#148;). Unless otherwise noted,
capitalized terms used herein but not otherwise defined herein are used as defined in, or as
referred to in, the Merger Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Letter of Credit shall automatically expire upon the first to occur of (i)&nbsp;the receipt of the
Merger Consideration by the Exchange Agent or, if later, the Effective Time, or (ii)&nbsp;the receipt by
&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093; of a written notice from the Company that (i)&nbsp;the Merger Agreement was terminated
pursuant to any provision other than 8.1(b)(ii), 8.1(c)(i), 8.1(c)(iii) or 8.1(d)(iii) thereof.
</DIV>


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ANNEX II
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">to Irrevocable Standby Letter of Credit No. &#091;______________&#093;
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt">issued by &#091;_____________&#093;
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="92%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">To:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Re:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Irrevocable Standby Letter of Credit No. &#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Drawing Certificate</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We refer to your Irrevocable Standby Letter of Credit No. &#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;, dated &#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;,
200&#091;_&#093; (the &#147;<U>Letter of Credit</U>&#148;). Terms defined or defined by reference in the Letter of
Credit have the same meanings when used herein. The undersigned individual, a duly authorized
officer of Beverly Enterprises, Inc. (the &#147;<U>Beneficiary</U>&#148;), hereby certifies on behalf of the
Beneficiary as follows with respect to the Letter of Credit:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Beneficiary is the beneficiary under the Letter of Credit.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Attached as Exhibit&nbsp;I hereto is a copy of an officer&#146;s certificate of the
Company, executed by the Chief Executive Officer, certifying that (x)&nbsp;Parent has
failed to extend, or arrange for the extension of, the term of the Letter of Credit or
provide, or arrange for the provision of, a substitute letter of credit in accordance
with Section&nbsp;6.18 of the Merger Agreement or (y)&nbsp;that the Business Interruption Fee is
payable pursuant to Section&nbsp;8.5 of the Merger Agreement.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>We hereby make demand for payment under the Letter of Credit in the amount of
U.S. $&#091;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&#093;, which demand is evidenced hereby. The amount demanded hereunder is
equal to the amount of the Business Interruption Fee less the Initial BIF Deposit (plus
any interest earned by the Company thereon), as set forth in the Merger Agreement.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>We hereby direct you to make payment of the amount demanded by wire transfer to
account no. <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> at <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, this Certificate has been executed this &#95;&#95;&#95;day of <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Beverly Enterprises, Inc.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">4
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
